Medizin
Refine
Year of publication
Document Type
- Article (3563) (remove)
Has Fulltext
- yes (3563)
Is part of the Bibliography
- no (3563) (remove)
Keywords
- inflammation (47)
- glioblastoma (29)
- apoptosis (27)
- breast cancer (26)
- cancer (26)
- Inflammation (19)
- biomarker (18)
- COVID-19 (17)
- autophagy (17)
- Depression (15)
- immunotherapy (15)
- mitochondria (15)
- Cancer (14)
- Germany (14)
- pain (14)
- Apoptosis (13)
- Breast cancer (13)
- depression (13)
- macrophage (13)
- prevention (13)
- prostate cancer (13)
- reactive oxygen species (13)
- Biomarkers (12)
- Cirrhosis (12)
- HIV (12)
- Mammakarzinom (12)
- Neuroscience (12)
- chemotherapy (12)
- Biomarker (11)
- SARS-CoV-2 (11)
- Stroke (11)
- aging (11)
- diagnosis (11)
- epilepsy (11)
- microRNA (11)
- obesity (11)
- schizophrenia (11)
- Chemotherapy (10)
- Gene expression (10)
- Human behaviour (10)
- Mitochondria (10)
- Research article (10)
- angiogenesis (10)
- attention (10)
- cirrhosis (10)
- cytokines (10)
- glioma (10)
- hypoxia (10)
- multiple sclerosis (10)
- ADHD (9)
- COPD (9)
- Children (9)
- Hemorrhage (9)
- MRI (9)
- Oncology (9)
- Primary care (9)
- Treatment (9)
- cell death (9)
- children (9)
- complications (9)
- human (9)
- invasion (9)
- leukemia (9)
- macrophages (9)
- migration (9)
- neuroblastoma (9)
- proliferation (9)
- quality of life (9)
- surgery (9)
- treatment (9)
- Atrial fibrillation (8)
- Behandlung (8)
- Evaluation (8)
- General practice (8)
- Hepatocellular carcinoma (8)
- Liver diseases (8)
- Metastasen (8)
- NADPH oxidase (8)
- Parkinson’s disease (8)
- Prognosis (8)
- Prävention (8)
- Quality of life (8)
- ROS (8)
- cognition (8)
- data science (8)
- differentiation (8)
- fMRI (8)
- mTOR (8)
- psoriasis (8)
- radiotherapy (8)
- Autophagy (7)
- Blood (7)
- Diagnostic markers (7)
- Drug therapy (7)
- Europe (7)
- HDAC (7)
- Immunotherapy (7)
- Machine learning (7)
- Multimorbidity (7)
- Outcome (7)
- Patients (7)
- Schizophrenia (7)
- Surgery (7)
- Survival (7)
- child (7)
- development (7)
- endothelial cells (7)
- epidemiology (7)
- epigenetics (7)
- hepatitis C virus (7)
- hereditary angioedema (7)
- macrophage polarization (7)
- medical education (7)
- metabolism (7)
- metastases (7)
- natural killer cells (7)
- proteomics (7)
- sepsis (7)
- Borrelia (6)
- CDK4/6 (6)
- Cancer treatment (6)
- Cardiovascular magnetic resonance (6)
- Death rates (6)
- Diabetes mellitus (6)
- Hepatitis C virus (6)
- Liver transplantation (6)
- Magnetic resonance imaging (6)
- Mental health and psychiatry (6)
- NASH (6)
- PD1/PDL1 (6)
- PI3K (6)
- Pain (6)
- Radiotherapy (6)
- Studien (6)
- Suicide (6)
- Surgical and invasive medical procedures (6)
- TRAIL (6)
- VEGF (6)
- bipolar disorder (6)
- brain metastases (6)
- diffusion tensor imaging (6)
- extracellular matrix (6)
- gender (6)
- infection (6)
- information theory (6)
- innate immunity (6)
- integrins (6)
- lung cancer (6)
- medizinische Ausbildung (6)
- metastasis (6)
- miRNA (6)
- microbiome (6)
- monocytes (6)
- mouse (6)
- neurodegeneration (6)
- outcome (6)
- particulate matter (6)
- physical activity (6)
- portal hypertension (6)
- prophylaxis (6)
- safety (6)
- targeted therapy (6)
- therapy (6)
- toxicity (6)
- ubiquitin (6)
- vitamin D (6)
- ACLF (5)
- Acute myeloid leukemia (5)
- Angiogenesis (5)
- Atherosclerosis (5)
- Cell signalling (5)
- Clinical trial (5)
- Crohn’s disease (5)
- DNA methylation (5)
- Diagnosis (5)
- EEG (5)
- EGFR (5)
- Epidemiology (5)
- Experimental models of disease (5)
- HCV (5)
- HIV-1 (5)
- Heart failure (5)
- Histology (5)
- IL-6 (5)
- MEG (5)
- Macrophages (5)
- Malaria (5)
- Medical education (5)
- Molecular biology (5)
- Morbidity (5)
- Mortality (5)
- Multiple sclerosis (5)
- Multivariate analysis (5)
- NKG2D (5)
- Non-small cell lung cancer (5)
- Obesity (5)
- Oral anticoagulation (5)
- PCR (5)
- PD-L1 (5)
- RUCAM (5)
- Smac (5)
- T cell (5)
- T cells (5)
- Targeted therapy (5)
- Trauma (5)
- Viral load (5)
- acute coronary syndrome (5)
- acute-on-chronic liver failure (5)
- adhesion (5)
- aortic stenosis (5)
- asthma (5)
- ataxia telangiectasia (5)
- atherosclerosis (5)
- atrial fibrillation (5)
- bevacizumab (5)
- biomarkers (5)
- cardiac surgery (5)
- cell therapy (5)
- chimeric antigen receptor (5)
- chronic kidney disease (5)
- cochlear implant (5)
- colorectal cancer (5)
- complement (5)
- conduct disorder (5)
- coronavirus (5)
- curcumin (5)
- cytotoxicity (5)
- efficacy (5)
- elderly (5)
- environmental tobacco smoke (5)
- fibrosis (5)
- forensic entomology (5)
- gene therapy (5)
- guideline (5)
- integrin (5)
- liver (5)
- magnetic resonance imaging (5)
- mutual information (5)
- natural killer cell (5)
- ovarian cancer (5)
- p53 (5)
- periodontitis (5)
- plasticity (5)
- polytrauma (5)
- prevalence (5)
- prognosis (5)
- regeneration (5)
- renal cell carcinoma (5)
- resistance (5)
- signal transduction (5)
- sphingosine-1-phosphate (5)
- stroke (5)
- transcranial magnetic stimulation (5)
- trauma (5)
- valproic acid (5)
- ABCB1 (4)
- ATM (4)
- Age groups (4)
- Anticoagulation (4)
- Aortic valve (4)
- Ascites (4)
- Aspergillus fumigatus (4)
- Attention (4)
- Autism spectrum disorder (4)
- B cells (4)
- Bipolar disorder (4)
- CIK cells (4)
- CRISPR/Cas9 (4)
- Cell biology (4)
- Cell staining (4)
- Cell therapy (4)
- Clinical trials (4)
- Communication (4)
- Consensus (4)
- Cytokines (4)
- DILI (4)
- DNA damage (4)
- Decision making (4)
- Denosumab (4)
- Developmental biology (4)
- Diagnostic medicine (4)
- Diagnostik (4)
- E-Learning (4)
- Emotions (4)
- Epilepsy (4)
- Ewing sarcoma (4)
- Fibrosis (4)
- Flow cytometry (4)
- Gastric cancer (4)
- Gender (4)
- Guidelines (4)
- Hematology (4)
- Hodgkin lymphoma (4)
- Homeostasis (4)
- IAP proteins (4)
- Immunohistochemistry (4)
- Immunology (4)
- Kinematic analysis (4)
- Liver cirrhosis (4)
- MRSA (4)
- MSD (4)
- Mechanisms of disease (4)
- Medizindidaktik (4)
- MicroRNAs (4)
- Molecular medicine (4)
- Mouse models (4)
- NK cell (4)
- NK cells (4)
- NK-92 (4)
- Neonates (4)
- Neutropenia (4)
- NoxO1 (4)
- OSCE (4)
- Osteoporosis (4)
- Outcomes (4)
- Parkinson's disease (4)
- Personalized medicine (4)
- Physicians (4)
- Portal hypertension (4)
- Pregnancy (4)
- Prevention (4)
- Proliferation (4)
- Proteomics (4)
- Psychiatric disorders (4)
- Randomized controlled trial (4)
- Reactive oxygen species (4)
- Risiko (4)
- Roussel Uclaf Causality Assessment Method (4)
- Sepsis (4)
- Sex differences (4)
- Stem cells (4)
- Surgical oncology (4)
- Thrombosis (4)
- Ubiquitination (4)
- Validation (4)
- XIAP (4)
- acute kidney injury (4)
- acute lymphoblastic leukemia (4)
- adjuvant therapy (4)
- adjuvante Therapie (4)
- adolescents (4)
- aggression (4)
- alirocumab (4)
- anaemia (4)
- antibodies (4)
- antioxidants (4)
- bibliometry (4)
- cancer stem cells (4)
- cell biology (4)
- climate change (4)
- clinical trial (4)
- cytomegalovirus (4)
- dementia (4)
- dendritic cells (4)
- dental implants (4)
- direct-acting antivirals (4)
- drug resistance (4)
- early breast cancer (4)
- entropy (4)
- evaluation (4)
- faculty development (4)
- fibroblasts (4)
- frühes Mammakarzinom (4)
- gene expression (4)
- graph theory (4)
- heart failure (4)
- hematopoietic stem cell transplantation (4)
- hepatitis C (4)
- hepatocellular carcinoma (4)
- immune evasion (4)
- liver cirrhosis (4)
- liver transplantation (4)
- management (4)
- melanoma (4)
- meningioma (4)
- metabolic syndrome (4)
- mortality (4)
- p21 (4)
- pancreatic cancer (4)
- peripheral artery disease (4)
- precision medicine (4)
- pregnancy (4)
- proteome (4)
- qualitative research (4)
- radiation (4)
- radical prostatectomy (4)
- rapamycin (4)
- registry (4)
- rhabdomyosarcoma (4)
- risk (4)
- risk factors (4)
- seizure (4)
- smoking (4)
- sphingolipids (4)
- spirochetes (4)
- survival (4)
- transfusion (4)
- trials (4)
- tumor microenvironment (4)
- tumor progression (4)
- vector (4)
- working memory (4)
- (surface) partial differential equations (3)
- Acute inflammation (3)
- Adverse events (3)
- Aging (3)
- Allgemeinmedizin (3)
- Alzheimer's disease (3)
- Aortic valve replacement (3)
- Aspergillus (3)
- Attitude (3)
- Autism (3)
- B-cell lymphoma (3)
- BCR/ABL (3)
- BRAF (3)
- Blood pressure (3)
- Blood-brain barrier (3)
- Brain metastasis (3)
- C-reactive protein (3)
- C. elegans (3)
- CXCR3 (3)
- CXCR4 (3)
- Cancer chemotherapy (3)
- Cancer detection and diagnosis (3)
- Cancer genetics (3)
- Cardiac surgery (3)
- Cardiology (3)
- Cardiovascular disease (3)
- Catheter ablation (3)
- Cell proliferation (3)
- Chromatin accessibility (3)
- Citation analysis (3)
- Clinical competence (3)
- Clinical genetics (3)
- Cognition (3)
- Cognitive neuroscience (3)
- Cohort studies (3)
- Colorectal cancer (3)
- Complex I (3)
- Complications (3)
- Conduct disorder (3)
- Cytoskeleton (3)
- DMEK (3)
- DNase1-seq (3)
- DTI (3)
- Data processing (3)
- Data science (3)
- Decorin (3)
- Density equalizing mapping (3)
- Diabetes (3)
- Dopamine (3)
- EEG microstates (3)
- Endoscopy (3)
- Endothelial cells (3)
- European Union (3)
- Everolimus (3)
- Exercise (3)
- Eyes (3)
- FTY720 (3)
- Fingolimod (3)
- Finite Volumes (3)
- Fistula (3)
- Functional clustering (3)
- Genetics (3)
- Genome-wide association studies (3)
- Glioblastoma (3)
- Global health (3)
- HAE (3)
- HBV (3)
- HCC (3)
- HER2/neu (3)
- HNSCC (3)
- HPV (3)
- Heart (3)
- Heart transplantation (3)
- Hereditary angioedema (3)
- Hippocampus (3)
- Hospitals (3)
- Human genetics (3)
- Hypertension (3)
- IAPs (3)
- IBD (3)
- In vitro (3)
- Incidence (3)
- Inflammatory diseases (3)
- Innate immunity (3)
- Intensive care (3)
- Kidney transplantation (3)
- Knees (3)
- Knowledge (3)
- Kommunikation (3)
- LCMV (3)
- Langerhans cell histiocytosis (3)
- Language (3)
- Lehrqualifikation (3)
- Lesions (3)
- Liver fibrosis (3)
- Long non-coding RNAs (3)
- Lumbar spine (3)
- MCAK (3)
- MLL (3)
- Machine-learning (3)
- Mesenchymal stem cells (3)
- Messenger RNA (3)
- Molecular neuroscience (3)
- Morphogenesis (3)
- Motor control (3)
- Mouse (3)
- Musculoskeletal disorder (3)
- Musculoskeletal system (3)
- NF-κB (3)
- Neuroinflammation (3)
- Nivolumab (3)
- Nox4 (3)
- Observational study (3)
- PARK2 (3)
- PDGFRβ (3)
- Patient blood management (3)
- Pediatric patients (3)
- Phosphorylation (3)
- Pneumonia (3)
- Prediction (3)
- Predictive markers (3)
- Prevalence (3)
- Prostate cancer (3)
- Public health (3)
- Quantitative MRI (3)
- RITA (3)
- Radiomics (3)
- Rare diseases (3)
- Reaction time (3)
- Rectal cancer (3)
- Registries (3)
- Regression analysis (3)
- Respiration (3)
- Rheumatoid arthritis (3)
- STAT3 (3)
- Signaling (3)
- Statistical data (3)
- Stereotactic body radiation therapy (3)
- Surgeons (3)
- TKI (3)
- Tacrolimus (3)
- Tissue engineering (3)
- Torque (3)
- Training (3)
- Transcription factors (3)
- Transfusion (3)
- Translational research (3)
- Zika virus (3)
- Zoonosis (3)
- acetaminophen (3)
- adaptation (3)
- ageing (3)
- allogeneic stem cell transplantation (3)
- anal cancer (3)
- animal (3)
- anti-angiogenic therapy (3)
- antiviral (3)
- antiviral therapy (3)
- arteriogenesis (3)
- artificial intelligence (3)
- ascites (3)
- astrocytes (3)
- augmentation (3)
- autism spectrum disorder (3)
- bioinformatics (3)
- blood (3)
- body mass index (3)
- brachytherapy (3)
- breast (3)
- cGMP (3)
- cardiac (3)
- caspase-2 (3)
- caspase-8 (3)
- catheter ablation (3)
- ceramides (3)
- cerebellum (3)
- chemoresistance (3)
- cholesterol (3)
- cisplatin (3)
- clinical benefit (3)
- clinical study (3)
- clock genes (3)
- combination therapy (3)
- computational virology (3)
- connectivity (3)
- cortex (3)
- cortisol (3)
- cystic fibrosis (3)
- cytokine-induced killer cells (3)
- dental profession (3)
- dentate gyrus (3)
- dentist (3)
- diabetes mellitus (3)
- didactic (3)
- doxorubicin (3)
- drug induced liver injury (3)
- echocardiography (3)
- electroencephalography (3)
- electrolytic cleaning (3)
- endocannabinoids (3)
- endoplasmic reticulum (3)
- everolimus (3)
- exercise (3)
- exosomes (3)
- fatigue (3)
- flow cytometry (3)
- focal adhesion (3)
- functional magnetic resonance imaging (3)
- gamma (3)
- gastric cancer (3)
- head and neck cancer (3)
- health-related quality of life (3)
- hematopoietic stem and progenitor cells (3)
- herb induced liver injury (3)
- histology (3)
- histone acetylation (3)
- hyperglycemia (3)
- imaging (3)
- immune reconstitution (3)
- immunity (3)
- immunohistochemistry (3)
- immunology (3)
- impulsivity (3)
- inflammasome (3)
- iron (3)
- irradiation (3)
- leukocytes (3)
- lipocalin-2 (3)
- liver fibrosis (3)
- liver injury (3)
- lyme disease (3)
- lymphoma (3)
- mTORC1 (3)
- machine learning (3)
- mass spectrometry (3)
- massively parallel multigrid solvers (3)
- medical students (3)
- memory (3)
- mesenchymal stromal cells (3)
- mesenchymal stromal/stem cells (3)
- metastatic (3)
- metformin (3)
- miRNAs (3)
- mice (3)
- mitophagy (3)
- mitosis (3)
- molecular mechanisms (3)
- mouse model (3)
- multimorbidity (3)
- mycophenolic acid (3)
- neoadjuvant therapy (3)
- neoplasms (3)
- neuropathic pain (3)
- oncology (3)
- osteoarthritis (3)
- osteoporosis (3)
- oxidative stress (3)
- p47phox (3)
- patient blood management (3)
- perfusion (3)
- periimplantitis (3)
- platelets (3)
- polypharmacy (3)
- predictive coding (3)
- preeclampsia (3)
- primary care (3)
- primary health care (3)
- primary immunodeficiency (3)
- prognostic factors (3)
- prostaglandins (3)
- psoriatic arthritis (3)
- rat (3)
- realistic geometries (3)
- reliability (3)
- remodelling (3)
- renal cell cancer (3)
- renal function (3)
- resting state (3)
- review (3)
- rheumatoid arthritis (3)
- screening (3)
- senescence (3)
- skeletal muscle (3)
- sphingolipid (3)
- sphingosine 1-phosphate (3)
- spinal cord (3)
- stress (3)
- stress response (3)
- tobacco prevention (3)
- transplantation (3)
- tumor growth (3)
- tumor-associated macrophages (3)
- ubiquitination (3)
- ultrasound (3)
- viral dynamics (3)
- working conditions (3)
- wound healing (3)
- 3D spatio-temporal resolved mathematical models (2)
- A/D transition (2)
- ABCC1 (2)
- ABCG2 (2)
- AKI (2)
- ALL (2)
- AML (2)
- AMPK (2)
- ATP-citrate lyase (2)
- Academic medicine (2)
- Access (2)
- Acoustics (2)
- Acute lymphocytic leukaemia (2)
- Addison’s disease (2)
- Adenocarcinoma (2)
- Adipose tissue (2)
- Adipose-derived mesenchymal stem cells (2)
- Adolescents (2)
- Adults (2)
- Alcohol consumption (2)
- Alcoholic liver disease (2)
- Alleles (2)
- Allergic asthma (2)
- Allergy (2)
- Alpelisib (2)
- Alzheimer (2)
- Alzheimer’s disease (2)
- Amblyopia (2)
- Anemia (2)
- Antibodies (2)
- Anticoagulant therapy (2)
- Antiretroviral therapy (2)
- Antiretrovirals (2)
- Antiviral therapy (2)
- Aortic dissection (2)
- Apheresis (2)
- Artificial intelligence (2)
- Asphyxia (2)
- Assessment (2)
- Atezolizumab (2)
- Aurora A (2)
- Austria (2)
- Autopsy (2)
- Azacitidine (2)
- BCL2 (2)
- BCL6 (2)
- BDNF (2)
- BMC (2)
- BRCA1 (2)
- BRCA2 (2)
- BRD4 (2)
- Babesia divergens (2)
- Babesia microti (2)
- Bacterial infection (2)
- Benefit (2)
- Big Data (2)
- Biochemistry (2)
- Bioinformatics (2)
- Biopsy (2)
- Biosynthetic mesh (2)
- Bladder cancer (2)
- Blood groups (2)
- Body mass index (2)
- Bone defect (2)
- Bone marrow (2)
- Bone marrow-derived mesenchymal stem cells (2)
- Bone regeneration (2)
- Bone tissue engineering (2)
- Brain tumor (2)
- Breast neoplasms (2)
- Breast tumors (2)
- Brustkrebs (2)
- Burden of disease (2)
- C1 inhibitor (2)
- CAD/CAM (2)
- CAR (2)
- CBA (2)
- CC16 (2)
- CD19 (2)
- CD36 (2)
- CDKN1A (2)
- CLP (2)
- CPE (2)
- CT (2)
- CTGF (2)
- CUELA (2)
- CV9202 (2)
- CXCL12 (2)
- Calcium (2)
- Callous-unemotional traits (2)
- Cancer epidemiology (2)
- Cancer genomics (2)
- Cancer models (2)
- Candida (2)
- Cannabidiol (2)
- Cannabis (2)
- Capecitabine (2)
- Capsule endoscopy (2)
- Cardiac hypertrophy (2)
- Cardiac magnetic resonance (2)
- Cardioprotection (2)
- Cardiovascular diseases (2)
- Case management (2)
- Cats (2)
- Causality assessment (2)
- Celiac disease (2)
- Cell binding (2)
- Cell differentiation (2)
- Cell salvage (2)
- Cerebrospinal fluid (2)
- Cesarean section (2)
- Chaperone (2)
- Checkpoint inhibitor (2)
- Chemical biology (2)
- Chemoradiotherapy (2)
- Chronic disease (2)
- Chronic diseases (2)
- Chronic hepatitis (2)
- Chronic kidney disease (2)
- Chronic obstructive pulmonary disease (2)
- Clinical presentation (2)
- Clinical studies (2)
- Clinical study (2)
- Cocaine (2)
- Cognitive behavioral therapy (2)
- Cognitive impairment (2)
- Community based intervention (2)
- Compliance (2)
- Complication management (2)
- Connective tissue (2)
- Coronary heart disease (2)
- Cortex (2)
- Costs (2)
- Croatia (2)
- Crohn's disease (2)
- Crystal structure (2)
- CspZ (2)
- Cuela (2)
- CyberKnife robotic radiosurgery (2)
- Cytogenetics (2)
- Cytoskeletal proteins (2)
- DAA (2)
- DMARDs (biologic) (2)
- DNA damage response (2)
- DNA mismatch repair (2)
- DSM (2)
- Daptomycin (2)
- Data visualization (2)
- Decision (2)
- Decision trees (2)
- Dentist (2)
- Dentistry (2)
- Deutschland (2)
- Diagnose (2)
- Diagnostics (2)
- Differentiation (2)
- Digestive system procedures (2)
- Direct current electrical stimulation (2)
- Disease Activity (2)
- Docetaxel (2)
- Dose response (2)
- Dravet syndrome (2)
- Drug development (2)
- Drug resistance (2)
- E3 ligase (2)
- ECMO (2)
- EEG-fMRI (2)
- ENCODE-DREAM in vivo Transcription Factor binding site prediction challenge (2)
- EQ-5D (2)
- Ears (2)
- Eccentric fixation (2)
- Education (2)
- Efficiency (2)
- Ejection fraction (2)
- Elderly (2)
- Electroencephalography (2)
- Emotion regulation (2)
- EndMT (2)
- Endothelial permeability (2)
- Ensemble learning (2)
- Enzyme-linked immunoassays (2)
- Epidermal growth factor receptor (2)
- Epigenetics (2)
- Epstein-Barr virus (2)
- Ergonomics (2)
- Etiology (2)
- Evidence-based medicine (2)
- Extended donor criteria (2)
- Extracellular matrix (2)
- Eye movements (2)
- Face (2)
- Family practice (2)
- Fatty liver (2)
- Fibroblasts (2)
- Flaps (2)
- Forensic entomology (2)
- Fortbildung (2)
- Frailty (2)
- Früherkennung (2)
- Frühgeburt (2)
- Functional magnetic resonance imaging (2)
- Funding (2)
- G-CSF (2)
- GFAP (2)
- GWAS (2)
- Gadobutrol (2)
- Galaktografie (2)
- Galaktomosynthese (2)
- Gene regulation (2)
- Gene therapy (2)
- General practitioners (2)
- Genetic testing (2)
- Genetics research (2)
- German people (2)
- Glucose metabolism (2)
- Grafts (2)
- Growth factors (2)
- HDACi (2)
- HER2 (2)
- HOD (2)
- HSCT (2)
- HSV (2)
- Head and neck cancer (2)
- Health economics (2)
- Health services research (2)
- Healthcare worker (2)
- Hematologic malignancies (2)
- HepG2 (2)
- Hepatocytes (2)
- Herb induced liver injury (2)
- High-density lipoprotein (2)
- Hirnforschung (2)
- Holmes tremor (2)
- Hypoxia (2)
- ICU (2)
- IHC (2)
- IL-10 (2)
- IL-1β (2)
- IR-A (2)
- Image analysis (2)
- Immune suppression (2)
- Implementation (2)
- Incisional hernia (2)
- Indirect-binding (2)
- Infection (2)
- Infection control (2)
- Infectious diseases (2)
- Inflammatory bowel disease (2)
- Intensive care units (2)
- Interdisciplinarity (2)
- Interleukin-22 (2)
- Interleukin-6 (2)
- Internet (2)
- Iron deficiency anemia (2)
- Ischemia (2)
- Ischemia/reperfusion injury (2)
- Jaw (2)
- KGF (2)
- Katherine (2)
- Klebsiella pneumoniae (2)
- Klinische Kompetenz (2)
- Kompetenzen (2)
- L2 (2)
- LPS (2)
- LVAD (2)
- Labor and delivery (2)
- Left hemisphere (2)
- Legs (2)
- Leukemias (2)
- Linear regression analysis (2)
- Lipid signalling (2)
- Liver Transplantation (2)
- Lokalrezidiv (2)
- Long-term care (2)
- Longitudinal (2)
- Low back pain (2)
- Luciferase (2)
- Lyme disease (2)
- Lymph nodes (2)
- Lymphocytes (2)
- Lysosome (2)
- MALAT1 (2)
- MCAO (2)
- MCI (2)
- MICA (2)
- MMP9 (2)
- MRT (2)
- MYC (2)
- Macroautophagy (2)
- Mamma (2)
- Markovianity (2)
- Masquelet technique (2)
- Mass spectrometry (2)
- Maxillary sinus (2)
- Medical risk factors (2)
- Medication Appropriateness Index (2)
- Medicine (2)
- Medizinstudium (2)
- Meldepflicht (2)
- Membrane potential (2)
- Mesh (2)
- Metastatic breast cancer (2)
- Microbiome (2)
- Microsurgery (2)
- Migrants (2)
- Minimal residual disease (2)
- Mitosis (2)
- MitraClip (2)
- Mixed methods (2)
- Molecular profiling (2)
- Morphometry (2)
- Multidrug resistance (2)
- Multiple chronic conditions (2)
- Musculoskeletal diseases (2)
- Mutation (2)
- Myocardial infarction (2)
- NADH:ubiquinone oxidoreductase (2)
- NAFLD (2)
- NK cells (2)
- NOTCH1 (2)
- Nachsorge (2)
- Neoplasms (2)
- Nepal (2)
- Nerve fibers (2)
- Nerve regeneration (2)
- Neural circuits (2)
- Neuroimaging (2)
- Neurology (2)
- Neuronal morphology (2)
- Neurons (2)
- Nevirapine (2)
- Next-generation sequencing (2)
- Nitric oxide (2)
- Non-REM sleep (2)
- Non-interventional study (2)
- Normal distribution (2)
- Nox (2)
- Nox1 (2)
- Nrf2 (2)
- OSPE (2)
- Occlusion treatment (2)
- Operation/Chirurgie (2)
- Ophthalmology (2)
- Optogenetics (2)
- Oral surgery (2)
- Organ dysfunction (2)
- Organ dysfunctions (2)
- Oroantral (2)
- Osteogenic differentiation (2)
- Outcome assessment (2)
- Ovarian cancer (2)
- Oxidative stress (2)
- P600 (2)
- PARP (2)
- PD1/ PDL1 (2)
- PD‑L1 (2)
- PET (2)
- PINK1 (2)
- Palliative care (2)
- Palliative care [MeSH] (2)
- Parkin (2)
- Parkinson disease (2)
- Patient-centred care (2)
- Pediatric (2)
- Pediatric infections (2)
- Percutaneous coronary intervention (2)
- Periodontitis (2)
- Peritonitis (2)
- Persistence (2)
- Personal- und Organisationsentwicklung (2)
- Philadelphia chromosome (2)
- Phylogenetic analysis (2)
- Physiology (2)
- Plasmodium (2)
- Platelet-rich fibrin (2)
- Platelets (2)
- Plerixafor (2)
- Plk1 inhibitors (2)
- Podospora anserina (2)
- Polypharmacy (2)
- Portal veins (2)
- Post-translational modifications (2)
- Postoperative radiochemotherapy (2)
- Postural control (2)
- Practical skills (2)
- Professionalisierung (2)
- Prognosefaktoren (2)
- Prognostic (2)
- Prognostic markers (2)
- Programm (2)
- Progranulin (2)
- Prophylaxis (2)
- Prostatic neoplasms (2)
- Protease inhibitor therapy (2)
- Proteasome (2)
- Protein translation (2)
- Prädiktivfaktoren (2)
- Psychology (2)
- Pulmonary hypertension (2)
- Pulmonary veins (2)
- Quality of care (2)
- Questionnaires (2)
- RIPK3 (2)
- RNA binding proteins (2)
- RNA interference (2)
- RNA interference (RNAi) (2)
- RNA isolation (2)
- Red blood cell transfusion (2)
- Regeneration (2)
- Register (2)
- Registry (2)
- Relapse (2)
- Reliabilität (2)
- Renal cell carcinoma (2)
- Renal system (2)
- Research architecture (2)
- Respiratory chain (2)
- Rhabdomyosarcoma (2)
- Rheumatoid Arthritis (2)
- Richtlinie (2)
- Roussel Uclaf Causality Assessment Method (RUCAM) (2)
- S1P (2)
- SARS (2)
- SARS‐CoV‐2 (2)
- SD-OCT (2)
- SKAP1 (2)
- SPTAN1 (2)
- STING (2)
- Safety (2)
- Sarcoidosis (2)
- Sarcoma (2)
- Schmerz (2)
- Scientists (2)
- Screening (2)
- Senescence (2)
- Sensory processing (2)
- Sestrin 2 (2)
- Simulated patients (2)
- Skills (2)
- Sleep (2)
- Social participation (2)
- Socioeconomic status (2)
- Sorafenib (2)
- Sphingolipids (2)
- Sports and exercise medicine (2)
- Staff development (2)
- Stem cell (2)
- Stem-cell therapies (2)
- Strength training (2)
- Streptococcus pneumoniae (2)
- Structural plasticity (2)
- Study protocol (2)
- Subarachnoid hemorrhage (2)
- Sunitinib (2)
- Superoxide (2)
- Supportivtherapie (2)
- Survival analysis (2)
- Survivin (2)
- Sweden (2)
- Synaptic plasticity (2)
- Systematic reviews (2)
- TBSS (2)
- TF-complexes (2)
- TGFβ (2)
- Target identification (2)
- Teeth (2)
- Tele-EEG (2)
- Tenofovir (2)
- Thailand (2)
- Therapie (2)
- Therapy (2)
- Thermoregulation (2)
- Thoracic trauma (2)
- Thromboembolism (2)
- Thrombolysis (2)
- Toll-like receptor (2)
- Tomosynthese (2)
- Toxicity (2)
- Transarterial chemoembolization (2)
- Transcription Factors (2)
- Transmission (2)
- Traumatic injury (2)
- Treatment outcome (2)
- Tumor microenvironment (2)
- T‑DM1 (2)
- Ulcerative colitis (2)
- Ultraschall (2)
- Ultrasonography (2)
- Ultrasound (2)
- Urology (2)
- VDR (2)
- VIGALL (2)
- Vaccination (2)
- Validität (2)
- Vascularization (2)
- Veins (2)
- Video (2)
- Vision (2)
- Visual acuity (2)
- Vitamin D (2)
- Vitamin D deficiency (2)
- Vmem (2)
- Warburg effect (2)
- Working memory (2)
- Wound healing (2)
- Wundheilung (2)
- abuse (2)
- acetyl-CoA (2)
- acute decompensation (2)
- acute lung injury (2)
- acute myeloid leukaemia (2)
- acute myeloid leukemia (2)
- adalimumab (2)
- additives (2)
- adenosine (2)
- adenovirus (2)
- adherence (2)
- adipose-derived mesenchymal stem cells (2)
- admission test (2)
- adoptive cancer immunotherapy (2)
- advanced (2)
- advanced care planning (2)
- adverse reaction (2)
- age (2)
- age-related macular degeneration (2)
- aged (2)
- air flow (2)
- albumin (2)
- alcohol (2)
- alpelisib (2)
- alveolar ridge augmentation (2)
- analgesics (2)
- animal experiment (2)
- animal models (2)
- antibacterial activity (2)
- antibiotic therapy (2)
- anticonvulsants (2)
- antiepileptic drugs (2)
- antisocial behavior (2)
- arousal (2)
- arthritis (2)
- astrocytoma (2)
- atezolizumab (2)
- audiovisual (2)
- autoimmune diabetes (2)
- autoimmune disease (2)
- autoimmunity (2)
- autologous stem cell transplantation (2)
- behavior (2)
- betulinic acid (2)
- biocompatibility (2)
- biologics (2)
- biopsy (2)
- blood flow restriction (2)
- bone healing (2)
- bone metabolism (2)
- borrelia (2)
- brain imaging (2)
- brain states (2)
- brain-derived neurotrophic factor (2)
- brainstem (2)
- burden of illness (2)
- cAMP (2)
- cART (2)
- calcitriol (2)
- calretinin (2)
- cancer immunotherapy (2)
- capsaicin (2)
- carbapenemase (2)
- carbapenemases (2)
- cardiovascular (2)
- cardiovascular disease (2)
- case-referent study (2)
- cell migration (2)
- cell motility (2)
- cell proliferation (2)
- cells (2)
- ceramide (2)
- cerebrospinal fluid (2)
- cervical cancer (2)
- chemoradiotherapy (2)
- chemotherapy resistance (2)
- chest trauma (2)
- chronic myeloid leukemia (2)
- chronic thromboembolic pulmonary hypertension (2)
- cigarette (2)
- circadian (2)
- circadian rhythm (2)
- circadian rhythms (2)
- cisplatin resistance (2)
- citation (2)
- classical Hodgkin lymphoma (2)
- cleaning (2)
- clinical research (2)
- clinical studies (2)
- cochlea (2)
- collagen (2)
- colon cancer (2)
- colon carcinoma cells (2)
- colorectal carcinoma (2)
- communication (2)
- complementary and alternative medicine (2)
- complex I (2)
- compliance (2)
- computed tomography (2)
- continuous performance test (2)
- corneal edema (2)
- corneal transplantation (2)
- coronary artery bypass graft surgery (2)
- coronary artery disease (2)
- critical care (2)
- criticality (2)
- cryoballoon (2)
- cyclooxygenase (2)
- cyclosporin A (2)
- cytochrome P450 2E1 (2)
- cytotoxic T cells (2)
- dabrafenib (2)
- deafness (2)
- decision making (2)
- decompensated liver cirrhosis (2)
- dental assistants (2)
- dental education (2)
- dental implant (2)
- dentists (2)
- detoxification (2)
- diabetes (2)
- dietary supplements (2)
- dihydroceramide (2)
- disease models (2)
- disintegration (2)
- distress (2)
- drug discovery (2)
- drug release (2)
- drug-induced liver injury (2)
- dual task (2)
- e-Learning (2)
- eLearning (2)
- education (2)
- eicosanoids (2)
- elderly patients (2)
- electrocardiography (2)
- electron transport chain (2)
- encoding (2)
- endothelial (2)
- endothelial cell (2)
- entorhinal cortex lesion (2)
- epigenetic (2)
- epileptogenesis (2)
- esophageal cancer (2)
- event-related potentials (2)
- expertise (2)
- extraversion (2)
- factor H (2)
- fasting (2)
- feedback (2)
- femoral artery ligation (2)
- fenfluramine (2)
- follow‑up (2)
- fortgeschritten (2)
- fracture (2)
- functional connectivity (2)
- functional genetics (2)
- functional genomics (2)
- gait analysis (2)
- galactography (2)
- galactomosynthesis (2)
- gene regulation (2)
- general practice (2)
- genetics (2)
- glucose metabolism (2)
- growth (2)
- growth factor (2)
- growth inhibition (2)
- guidelines (2)
- health (2)
- health information exchange (2)
- heart rate (2)
- hedgehog signaling (2)
- hematopoiesis (2)
- hematopoietic stem cells (2)
- hemodialysis (2)
- hemolysis (2)
- hepatic encephalopathy (2)
- hepatitis B (2)
- hepatitis C virus (HCV) (2)
- herbal hepatotoxicity (2)
- hippocampus (2)
- histological validation (2)
- histone deacetylase inhibitor (2)
- human biology and medicine (2)
- human cytomegalovirus (2)
- hyperactivity (2)
- hyperhomocysteinemia (2)
- iDILI (2)
- iPS (2)
- immune escape (2)
- immune response (2)
- immune system (2)
- immunocytochemistry (2)
- in vitro (2)
- induced membrane (2)
- inertial motion capture (2)
- infiltration (2)
- inflammatory bowel disease (2)
- inner ear (2)
- insulin resistance (2)
- integration (2)
- interferon (2)
- interferon gamma (2)
- interleukin-18 (2)
- interleukin-22 (2)
- interleukin-4 (2)
- interleukins (2)
- invasive fungal disease (2)
- invasive fungal infection (2)
- job-exposure matrix (2)
- kidney (2)
- kidney transplantation (2)
- kinase inhibitor (2)
- kinase regulation (2)
- kinematics (2)
- klinischer Nutzen (2)
- knowledge discovery (2)
- lapatinib (2)
- leukopenia (2)
- levetiracetam (2)
- lipoxygenase (2)
- liver disease (2)
- liver metastases (2)
- lncRNA (2)
- local control (2)
- local information dynamics (2)
- local recurrence (2)
- long-term prophylaxis (2)
- long-term survival (2)
- longevity (2)
- lung function (2)
- machine-learning (2)
- magnetoencephalography (2)
- maintenance (2)
- mandatory reporting (2)
- marginal bone loss (2)
- mathematical modeling (2)
- mathematical models of viral RNA cycle (2)
- matrix (2)
- medical studies (2)
- melatonin (2)
- metabolomics (2)
- methylprednisolone (2)
- microdosing (2)
- microenvironment (2)
- microglia (2)
- microwave ablation (2)
- mild cognitive impairment (2)
- minimalinvasive Biopsie (2)
- minimally invasive biopsies (2)
- mitochondrial disease (2)
- modeling (2)
- modularity (2)
- molecular mimicry (2)
- morphogenesis (2)
- motility (2)
- multidrug resistance (2)
- multinucleated giant cells (2)
- musculoskeletal (2)
- musculoskeletal disorders (2)
- music (2)
- myelodysplastic syndrome (2)
- nanoparticles (2)
- natural product (2)
- necroptosis (2)
- neoadjuvant chemotherapy (2)
- neoadjuvante Chemotherapie (2)
- neoadjuvante Therapie (2)
- neonate (2)
- network analysis (2)
- neural network (2)
- neural oscillations (2)
- neurocritical care (2)
- neurogenesis (2)
- neuroimaging (2)
- neuromodulation (2)
- neurophysiology (2)
- neuroticism (2)
- neutrophils (2)
- newborn (2)
- next generation sequencing (2)
- next generation sequencing (NGS) (2)
- nitric oxide (2)
- non-coding RNA (2)
- nursery schools (2)
- nutlin-3 (2)
- observational study (2)
- occupational exposure (2)
- occupational health (2)
- omega-3 fatty acids (2)
- oncogene (2)
- oscillations (2)
- osteogenesis (2)
- outcomes (2)
- overall survival (2)
- overweight (2)
- paclitaxel (2)
- paired associative stimulation (2)
- palatal tremor (2)
- pandemic (2)
- partial information decomposition (2)
- patient (2)
- patient safety (2)
- patient triage (2)
- pelvic packing (2)
- peptide aptamer (PA) (2)
- perception (2)
- perforant path transection (2)
- peri‐implantitis (2)
- phagocytosis (2)
- pharmacodynamics (2)
- pharmacoresistance (2)
- pharmacovigilance (2)
- phosphate (2)
- plasmid (2)
- platelet-rich fibrin (2)
- polo-like kinase 1 (2)
- poly(lactic-co-glycolic acid) (PLGA) (2)
- polygenic risk score (2)
- polymerase chain reaction (2)
- polymorphism (2)
- population dynamics (2)
- postoperative complications (2)
- posttraumatic stress disorder (2)
- predictive factors (2)
- prefrontal cortex (2)
- preterm birth (2)
- primary cilium (2)
- primary sclerosing cholangitis (2)
- prognostic value (2)
- prostaglandin (2)
- proteasome inhibitor (2)
- protein kinase (2)
- protein quality control (2)
- proteoglycan (2)
- proximal tubule (2)
- psychophysiology (2)
- psychosis (2)
- public health (2)
- pulmonary hypertension (2)
- pulmonary vein isolation (2)
- quality (2)
- quality assurance (2)
- quantitative MRI (2)
- questionnaire (2)
- rare diseases (2)
- re-osseointegration (2)
- real-world data (2)
- recommendations (2)
- reference values (2)
- reproducibility (2)
- research (2)
- revision surgery (2)
- ribavirin (2)
- risk prediction (2)
- rituximab (2)
- school-based prevention (2)
- scientometrics (2)
- scientometry (2)
- second-hand smoke (2)
- secretion (2)
- secretome (2)
- secukinumab (2)
- seizures (2)
- sensory neuropathy (2)
- severe acute respiratory syndrome coronavirus 2 (2)
- sex (2)
- sex differences (2)
- short essay questions (2)
- shunt (2)
- siRNA (2)
- signal transducer and activator of transcription 5 (Stat5) (2)
- signaling (2)
- signature (2)
- simulation (2)
- simulation training (2)
- single-sided deafness (2)
- skin (2)
- sleep (2)
- smoking cessation (2)
- soft tissue sarcoma (2)
- soluble MICA (2)
- spiking neural networks (2)
- spreadsheet (2)
- stability (2)
- stationarity (2)
- status epilepticus (2)
- stem cell transplantation (2)
- studies (2)
- sulforaphane (2)
- supportive therapy (2)
- surgical procedures (2)
- survival rate (2)
- survivin (2)
- synchronization (2)
- synchrony (2)
- synergy (2)
- systematic review (2)
- telemedicine (2)
- temozolomide (2)
- temperature (2)
- temporal lobe epilepsy (2)
- temsirolimus (2)
- therapy monitoring (2)
- therapy resistance (2)
- thymus (2)
- tissue Doppler imaging (2)
- tobacco (2)
- tobacco smoke (2)
- tomosynthesis (2)
- training (2)
- transcriptome (2)
- transient elastography (2)
- trastuzumab (2)
- treatment/therapy (2)
- trophoblast (2)
- tumor angiogenesis (2)
- tumor infiltrating lymphocytes (2)
- tumor suppressor (2)
- tumor-infiltrating lymphocytes (2)
- undergraduate medical education (2)
- ustekinumab (2)
- uteroglobin (2)
- vaccination (2)
- vaccine (2)
- validity (2)
- vemurafenib (2)
- vitamin B deficiency (2)
- von Willebrand factor (2)
- weight loss (2)
- within-host viral modelling (2)
- workflow (2)
- zebrafish (2)
- zinc (2)
- (cardiac) surgery (1)
- (novel) brominated flame retardants ((N)BFR) (1)
- 1,2-dichloroethane (1)
- 1,25-Dihydroxyvitamin D (1)
- 14-3-3 gene family (1)
- 15-PGDH (1)
- 16 segment AHA model (1)
- 16S rRNA sequencing (1)
- 16p11.2 (1)
- 17-AAG (1)
- 17‐OH itraconazole (1)
- 19F MR spectroscopy (1)
- 1H MR spectroscopy (1)
- 1α,25(OH)2D3 (1)
- 2-deoxyglucose (2-DG) (1)
- 2-hydroxyglutarate (1)
- 2019-nCoV (1)
- 2‑methoxyestradiol (1)
- 3-hydroxyanthranilic acid (1)
- 32D progenitor cells (1)
- 3Cs technology (1)
- 3D printed cell-free scaffold (1)
- 3D printing (1)
- 3D rapid prototyping (1)
- 3D spatiotemporal resolved mathematical models (1)
- 3D tissue models (1)
- 3years (1)
- 4-1BB (1)
- 4-FA (1)
- 5 lipoxygenase (1)
- 5' UTR (1)
- 5-lipoxygenase (1)
- 6-Schritt-Methode (1)
- 90% or more improvement in baseline Psoriasis Area and Severity Index (1)
- 99mTc-MIBI (1)
- 99mTc-pertechnetate (1)
- A-FFIP (1)
- A-PRF+ (1)
- A2BP1 (1)
- A375 human melanoma cell line (1)
- A375 human melanoma cells (1)
- A549 (1)
- AA-amylodosis (1)
- AB-serum (1)
- ABS (1)
- ABT-737 (1)
- ACE-Bestimmung (1)
- ACE-inhibitor (1)
- ACL (1)
- ACURATE neo (1)
- ADAM-17 (1)
- ADAM10 (1)
- ADAM15 (1)
- ADAMTS-13 (1)
- ADHD differential diagnosis (1)
- AGC kinase (1)
- AICAR (1)
- AIDS (1)
- AIH immunopathogenesis (1)
- AIS (1)
- AJAP1 (1)
- ALF (1)
- ALK gene (1)
- ALK-rearranged NSCLC (1)
- AMD3100 (1)
- AMH (1)
- AML – acute myeloid leukemia (1)
- AMP-activated kinase (1)
- AOSpine (1)
- AOSpine injury score (1)
- APMPPE - acute posterior multifocal placoid pigment epitheliopathy (1)
- APP (1)
- APP processing (1)
- APRI (1)
- ARA (1)
- ARDS (1)
- ARID5B (1)
- ASA404 (1)
- ASAP (1)
- ASCT (1)
- ASD-specific (1)
- ASO (1)
- AT-101 (1)
- ATO (1)
- ATP (1)
- ATXN2 (1)
- AVM hemorrhage (1)
- AZD7762 (1)
- Abatacept (1)
- Abdominal aortic aneurysm (1)
- Abdominal infections (1)
- Abdominal surgery (1)
- Abdominal trauma (1)
- Abdominelles Aortenaneurysma (1)
- Abiraterone acetate (1)
- Abl kinase inhibitors (1)
- Absenteeism (1)
- Academic health centres (1)
- Academics (1)
- Accelerometry (1)
- Accessibility (1)
- Acellular dermis (1)
- Acer platanoides (1)
- Acid ceramiase (1)
- Acquired drug resistance (1)
- Actin (1)
- Actinomycin D (1)
- Action potential (1)
- Activities of daily living (1)
- Activity control (1)
- Acute HIV infection (1)
- Acute Hemiparesis (1)
- Acute Myeloid Leukemia (1)
- Acute Myeloid Leukemia (AML) (1)
- Acute bronchitis (1)
- Acute calcolous cholecystitis (1)
- Acute coronary syndrome (1)
- Acute cough (1)
- Acute decompensation (1)
- Acute heart failure (1)
- Acute hospital (1)
- Acute leukemia (1)
- Acute lymphoblastic leukemia (1)
- Acute myeloid leukaemia (1)
- Acute-on-chronic liver failure (1)
- Adenylyl cyclase (1)
- Adherence (1)
- Adherence junctions (1)
- Adhesion (1)
- Adipose tissue-derived mesenchymal stem cells (1)
- Adjustment of dosage at steady state (1)
- Adjuvant therapies (1)
- Adolescence (1)
- Adult (1)
- Adult T-cell acute lymphoblastic leukemia (1)
- Adult neurogenesis (1)
- Advanced biliary tract cancer (1)
- Advanced breast cancer (1)
- Advanced glycation endproducts (1)
- Adverse drug reaction (1)
- Aedes aegypti (1)
- Aedes albopictus (1)
- Affective disorders (1)
- Africa (1)
- Age (1)
- Age determination by skeleton (1)
- Aggregation (1)
- Aggressive periodontitis (1)
- Agoraphobia (1)
- Agreement (1)
- Air traffic (1)
- Airways (1)
- Akaike information criterion (AIC) (1)
- Akute Leukämie (1)
- Akutes Koronarsyndrom (1)
- Algorithms (1)
- Aliphatic halogenated hydrocarbons (1)
- Alisertib (1)
- All oral (1)
- All-trans retinoic acid (1)
- Allergen immunotherapy (1)
- Allergic rhinitis (1)
- Allergoid (1)
- Allochromatium vinosum (1)
- Allogeneic Stem Cell Transplantation (SCT) (1)
- Allogeneic hematopoietic stem (1)
- Allogeneic hematopoietic stem cell transplantation (1)
- Allogeneic stem cell transplantation (1)
- Allograft bone block (1)
- Allosteric inhibition (1)
- Alpha oscillations (1)
- Alpha-synuclein (1)
- Alpha-synuclein deficiency (1)
- Alternative oxidase (1)
- Alveolar ridge augmentation (1)
- Alzheimer’s dementia (1)
- Ambroxol (1)
- Ameloblastoma (1)
- Amino acid analysis (1)
- Aminosäuremetabolismus (1)
- Aminosäuren (1)
- Aminotransferases (1)
- Amizon (1)
- Amygdala (1)
- Amyloid precursor protein (1)
- Amyloid-beta 42 (1)
- Amyotrophic lateral sclerosis (1)
- Anaemia (1)
- Anaesthesia (1)
- Anal cancer (1)
- Anamneseerhebung (1)
- Anaplastic astrocytoma (1)
- Anatomic competence (1)
- Anatomie (1)
- Anatomie und Histologie (1)
- Anatomy (1)
- Andersen-Tawil syndrome (1)
- Andexanet alpha (1)
- Andropogon virginicus (1)
- Anesthesia, Intravenous (1)
- Aneurysm (1)
- Aneurysmal subarachnoid hemorrhage (1)
- Aneurysms (1)
- Angioedema (1)
- Angiogenèse (1)
- Angiography (1)
- Angioplasty (1)
- Angiotensin Converting Enzyme (1)
- Angiotensin-converting enzyme (1)
- Animal wings (1)
- Ankle arthrometer (1)
- Anopheles (1)
- Anosmia (1)
- Antagonist (1)
- Antarctic marine sponges (1)
- Anterior cingulate cortex (1)
- Anterior cruciate ligament reconstruction (1)
- Anti platelet therapy (1)
- Anti-CMV IgG (1)
- Anti-Müller-Hormon (1)
- Anti-TNF (1)
- Anti-tumor immunity (1)
- Antiangiogenesis (1)
- Antibiotic (1)
- Antibiotic generic drugs (1)
- Antibiotic stewardship (1)
- Antibiotic therapy (1)
- Antibiotics (1)
- Antibody isotypes (1)
- Antibody-mediated rejection (1)
- Anticoagulants (1)
- Anticoagulants [MeSH] (1)
- Antidepressant (1)
- Antifungal agents (1)
- Antigen-presenting cells (1)
- Antigens (1)
- Antihormone therapy (1)
- Antimicrobial resistance (1)
- Antimicrobial treatment (1)
- Antiplatelet therapy (1)
- Antireflux surgery (1)
- Antirheumatic agents (1)
- Antithrombotic therapy (1)
- Antivenom (1)
- Antiviral agents (1)
- Antiviral immune response (1)
- Antiviral response (1)
- Anura (1)
- Anxiety (1)
- Aortic Valve Replacement (1)
- Aortic arch replacement (1)
- Aortic debranching (1)
- Aortic stenosis (1)
- Aortic stiffness (1)
- Aortic valve sparing (1)
- Apes (1)
- Apixaban (1)
- Aquaporins (1)
- Arabin pessary (1)
- Arabin-Pessar (1)
- Area deprivation (1)
- Arms (1)
- Aromatase Inhibitors (1)
- Arrhythmia (1)
- Arrhythmia/all (1)
- Artemether-lumefantrine (1)
- Artemisinin-combination-therapy (1)
- Arteriogenesis (1)
- Artesunate (1)
- Arthroscopy (1)
- Asian bush mosquito (1)
- Aspergillosis (1)
- Aspergillus species (1)
- Assay variation (1)
- Assessment of care (1)
- Asthma (1)
- Asthma and allergic disorders (1)
- Astrocytoma grades (1)
- Ataxia (1)
- Ataxia telangiectasia (1)
- Ataxia-telangiectasia (1)
- Atazanavir (1)
- Atelopus carbonerensis (1)
- Atelopus mucubajiensis (1)
- Atelopus tamaense (1)
- Atención centrada en el paciente (1)
- Atrial appendage occlusion (1)
- Atrial function (1)
- Attack (1)
- Attention Deficit Hyperactivity Disorder (1)
- Attention-deficit / hyperactivity disorder (1)
- Atxn2 (1)
- Audio equipment (1)
- Audio signal processing (1)
- Audiology (1)
- Auditory (1)
- Auditory cortex (1)
- Auditory system (1)
- Auric nanoparticles (1)
- Aurora (1)
- Aurora Ax (1)
- Aurora kinase inhibitor (1)
- Australia (1)
- Autism spectrum disorders (1)
- Autistic Behavior (1)
- Autistic disorder (1)
- Auto transfusion (1)
- Autogenous bone block (1)
- Autoimmune encephalomyelitis (1)
- Autoimmunity (1)
- Autologous stem cell transplantation (1)
- Automated Tube Potential Selection (1)
- Automatic Environmental Tobacco Smoke Emitter (1)
- Autonomic nervous system (1)
- Autosomal recessive cutis laxa type 1C (1)
- Awareness (1)
- Axon (1)
- Axons (1)
- Azan trichrome stain (1)
- Azathioprine (1)
- Azidothymidine (1)
- B cell malignancies (1)
- B cell precursor acute lymphoblastic leukemia (1)
- B cell receptor (1)
- B cell subpopulations (1)
- B-cell antigen receptor (1)
- B-cell immunology (1)
- B-cell non-Hodgkin lymphoma (1)
- B-cell receptor (1)
- B16 cells (1)
- BAG3 (1)
- BATF3 (1)
- BBB (1)
- BCL-2 (1)
- BCL11b (1)
- BCR signaling (1)
- BCR-ABL (1)
- BCX7353 (1)
- BFIS (1)
- BG-index (1)
- BI1361849 (1)
- BIAM switch assay (1)
- BIAM-switch (1)
- BIRC5 (1)
- BK channel (1)
- BMAC (1)
- BMI (1)
- BMSC (1)
- BNC2 (1)
- BPD (1)
- BPDCN (1)
- BRAF V600E (1)
- BRAF inhibitors (1)
- BRAF mutation (1)
- BRD4-NUT (1)
- BRUCE (1)
- BRVO (1)
- BTC (1)
- BTK (1)
- BV6 (1)
- Babesia venatorum (1)
- Back pain (1)
- Backpropagating action potential (1)
- Bacterial meningitis (1)
- Bacterial pathogenesis (1)
- Bacterial pathogens (1)
- BadA, (1)
- Bag6 (1)
- Ballet (1)
- Bariatric surgery (1)
- Barlow disease (1)
- Bartonella (1)
- Basal Ganglia (1)
- Basel Consensus Statement (1)
- Basler Consensus Statement (1)
- Bathyergidae (1)
- Batten disease (1)
- Bayesian (1)
- Bayesian inference (1)
- Bayesian model (1)
- Bcl-2 (1)
- Bcr-Abl (1)
- Becton Dickinson (1)
- Bee venom allergy (1)
- Behavior (1)
- Behavioral analysis (1)
- Benchmarks (1)
- Benign disorder (1)
- Benign pulmonary diseases (1)
- Benigne Lungenerkrankungen (1)
- Beratung (1)
- Berci needle (1)
- Best practice (1)
- Best-practice model (1)
- Bestimmungsmethoden (1)
- Bevacizumab (1)
- Bewegungsanalyse mit Inertialsensoren (1)
- Bias (1)
- Bibliometric analysis (1)
- Bibliometrics (1)
- Bidirectional genes (1)
- Big Five (1)
- Big data (1)
- Big five (1)
- Biglycan (1)
- Bilateral cochlear implant (1)
- Bildung (1)
- Biliary physiology (1)
- Biliary tree (1)
- Biliary tree stones (1)
- Bilirubin (1)
- Bioactivity-guided fractionation (1)
- Bioavailability prediction (1)
- Biofilm (1)
- Biofluids (1)
- Biological (1)
- Biological Activity (1)
- Biological heart valves (1)
- Biological invasion (1)
- Biological markers (1)
- Biomarkers & Diagnostic Imaging (1)
- Biomechanical analysis (1)
- Biophysical models (1)
- Bioprosthesis (1)
- Biotechnology (1)
- Bipolar (1)
- Birth weight (1)
- Bisphosphonates (1)
- Blended learning curriculum · (1)
- Blended-Learning-Curriculum (1)
- Blended-learning (1)
- Blog (1)
- Blood cells (1)
- Blood loss (1)
- Blood plasma (1)
- Blood transfusion (1)
- Bloodstream infection (1)
- Bloodstream infections (1)
- Blow fly (1)
- Blowflies (1)
- BluePrint (1)
- Blurred vision (1)
- Body limbs (1)
- Body-contouring surgery (1)
- Bologna process (1)
- Bologna-Prozess (1)
- Bone and joint mechanics (1)
- Bone cancer (1)
- Bone marrow aspirate concentrate (1)
- Bone marrow aspiration (1)
- Bone marrow cells (1)
- Bone marrow fibrosis (1)
- Bone marrow mononuclear cells (1)
- Bone metastasis (1)
- Bone strength assessment (1)
- Borrelia Garinii (1)
- Borrelia burgdorferi (1)
- Borrelia miyamotoi (1)
- Bortezomib (1)
- Bottom-up (1)
- Bradykinin (1)
- Brain (1)
- Brain anatomy (1)
- Brain damage (1)
- Brain development (1)
- Brain injury (1)
- Brain ischemia (1)
- Brain repair (1)
- Brain tumors (1)
- BrainNet Europe consortium (1)
- Breast neoplasm (1)
- Breast reconstruction (1)
- Breathing (1)
- Breech delivery (1)
- Bright light therapy (1)
- Brij 35 (1)
- BrijL23 (1)
- Brms (1)
- Bronchial inflammation (1)
- Bronchitis severity scale (1)
- Bronchodilator agents (1)
- Bronchopulmonary dysplasia (1)
- Bufonidae (1)
- Bungarus niger (1)
- Burst (1)
- Bypass liner (1)
- C-clamp (1)
- C-reactive proteins (1)
- C1 esterase inhibitor (human) (1)
- C1-INH (C1 inhibitor, C1-esterase inhibitor) (1)
- C1-esterase inhibitor protein (1)
- C1-inhibitor (1)
- C1-inhibitor deficiency (1)
- C2 domain (1)
- C3M (1)
- C4M (1)
- C5 acylcarnitine (1)
- C57BL/6J mice (1)
- C57BL/6N mice (1)
- C6 ceramide (1)
- CA (1)
- CA1 (1)
- CAKUT (1)
- CAM (1)
- CAR-NK cell (1)
- CAR-T cell (1)
- CAT (1)
- CCL2 (1)
- CCN2 (1)
- CD137 (1)
- CD16 (1)
- CD23 (1)
- CD271 (1)
- CD3 (1)
- CD3/19 depletion (1)
- CD3/CD19 depletion (1)
- CD34 (1)
- CD34 selection (1)
- CD4 binding site (1)
- CD41 (1)
- CD44 (1)
- CD45RA naïve lymphocytes (1)
- CD49d (1)
- CD56 (1)
- CD62P (1)
- CD74 (1)
- CD8 (1)
- CD8+ T cell (1)
- CD8+ T lymphocytes (1)
- CD8+ T-cell mediated tumor suppression (1)
- CD8+ tumor infiltrating lymphocytes (1)
- CD95/Fas receptor (1)
- CDK inhibitor (1)
- CDK4/6 inhibitor (1)
- CDK4/CDK6 (1)
- CDK9 (1)
- CDKN2A (1)
- CEBPE (1)
- CGD (1)
- CGN codon (1)
- CHA2DS2-VASc-score (1)
- CHIP (1)
- CHRNA10 (1)
- CHRNA7 (1)
- CHRNA9 (1)
- CIK cell (1)
- CIOMS (1)
- CLEC-2 (1)
- CMS (1)
- CMVepidemiology (1)
- CNS (1)
- CNS cancer (1)
- CNS toxicity (1)
- CNVs (1)
- CO2-induced forced ventilation (1)
- COBAS Taqman (1)
- COI (1)
- COII (1)
- COMT (1)
- COPD course and therapy (1)
- CPT1A (1)
- CRE-dependent transcription (1)
- CRE-luciferase (1)
- CREB inhibitor (1)
- CRISPR/Cas (1)
- CRISPR/dCas9 (1)
- CRM (1)
- CRM1 (1)
- CRP (1)
- CRT-D (1)
- CRVO (1)
- CSC marker (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CT-guidance (1)
- CT-guided interventions (1)
- CTLA-4 (1)
- CTX (1)
- CUELA system (1)
- CUP (1)
- CVD biomarker (1)
- CVID (1)
- CWS Studiengruppe (1)
- CXCL10 (1)
- CXCL16 (1)
- CY-503 (1)
- CYBA/p22phox (1)
- CYP1A1 (1)
- Ca2+ imaging (1)
- Caco 2 cells/metabolism (1)
- Caco-2 cells (1)
- Caco‐2 cells (1)
- Caffeine (1)
- Calcium signalling (1)
- Calliphoridae (1)
- Calnexin (1)
- Canada (1)
- Cancer Staging (1)
- Cancer detection (1)
- Cancer epigenetics (1)
- Cancer of unknown primary (1)
- Cancer risk factors (1)
- Cancer staging (1)
- Cancer stem cells (1)
- Cancer therapeutic resistance (1)
- Candida spp (1)
- Carbapenem-resistente Gram-negative Bakterien (CRGN) (1)
- Carbapenemasen (1)
- Carbohydrates (1)
- Carbon tetrachloride (1)
- Carcinoma, Ductal, Breast (1)
- Cardiac (1)
- Cardiac Fibrosis (1)
- Cardiac acoustic biomarkers (1)
- Cardiac device therapy (1)
- Cardiac fibroblast (1)
- Cardiac function (1)
- Cardiac masses (1)
- Cardiac monitoring (1)
- Cardiac necroenzymes (1)
- Cardiac output (1)
- Cardiac remodelling (1)
- Cardiac surgery patients (1)
- Cardiac troponin (1)
- CardioMEMS™ HF system (1)
- Cardiogenic shock (1)
- Cardiomyocyte signaling pathways (1)
- Cardiomyopathy (1)
- Cardiopulmonary bypass (1)
- Cardiovascular Magnetic Resonance (CMR) (1)
- Cardiovascular biology (1)
- Cardiovascular epidemiology (1)
- Cardiovascular genetics (1)
- Cardiovascular mortality (1)
- Career promotion (1)
- Careers (1)
- Carrier-bound fibrin sealant (1)
- Cas9 inhibitor (1)
- Case management [MeSH] (1)
- Case report (1)
- Castleman’s disease (1)
- Catch-up validation study (1)
- Causality (1)
- Cause of death (1)
- Cdk1/cyclin B1 (1)
- Cell Adhesion (1)
- Cell adhesion (1)
- Cell cortex (1)
- Cell cultures (1)
- Cell cycle (1)
- Cell distribution (1)
- Cell division (1)
- Cell membranes (1)
- Cell metabolism (1)
- Cell motility (1)
- Cell plasticity (1)
- Cell processing (1)
- Cell-assisted lipotransfer (1)
- Cell-based therapies (1)
- Cell-to-Cell Spread (1)
- Cellular (1)
- Cellular imaging (1)
- Cellular inflammatory response (1)
- Cellular neuroscience (1)
- Cellular stress (1)
- Cellular stress responses (1)
- Cementation (1)
- Center-specific time in therapeutic range (cTTR) (1)
- Central nervous system (1)
- Central nervous system metastases (1)
- Centrifugation (1)
- Ceramic (1)
- Cerasorb (1)
- Cerclage (1)
- Cerebellar ataxia (1)
- Cerebellum (1)
- Cerebral Vasospasm (1)
- Cerebral cortex (1)
- Cerebral ischemia (1)
- Cerebral toxoplasmosis HIV (1)
- Cerebral vasospasm (1)
- Cerebrovascular (1)
- Certification (1)
- Cervical (1)
- Cesarean delivery (1)
- Change Management (1)
- Checkpoint kinase (1)
- Checkpoints (1)
- Chemical company (1)
- Chemical ecology (1)
- Chemical modification (1)
- Chemiluminescence (1)
- Chemobrain (1)
- Chemoembolization (1)
- Chemokine CCL2 (1)
- Chemokines (1)
- Chemoradiation (1)
- Chemorefractory advanced gastric cancer (1)
- Chemosensitivity (1)
- Chest pain unit (1)
- Chikungunya virus (1)
- Child (1)
- Child adiposity (1)
- Children and adolescents (1)
- Chimerism (1)
- Chlorides (1)
- Chloroform (1)
- Cholecystectomy (1)
- Cholesterin (1)
- Cholesterol (1)
- Chondral Lesion (1)
- Chondrocyte (1)
- Chondrocyte signalling (1)
- Chondrocytes (1)
- Chorion (1)
- Chromatin and Epigenetics (1)
- Chromatin conformation (1)
- Chromoendoscopy (1)
- Chromosomal deletion (1)
- Chromosomale Translokation (1)
- Chronic Hepatitis C (1)
- Chronic ankle instability (1)
- Chronic care model (1)
- Chronic conditions (1)
- Chronic depression (1)
- Chronic disease [MeSH] (1)
- Chronic health condition (1)
- Chronic heart failure (1)
- Chronic hepatitis C virus (1)
- Chronic illness (1)
- Chronic infection (1)
- Chronic inflammation (1)
- Chronic intestinal failure (1)
- Chronic medical conditions (1)
- Chronic obstructive airway disease (1)
- Chronic pancreatitis (1)
- Chronic periodontiti (1)
- Chronification (1)
- Chronology of disease (1)
- Cigarettes (1)
- Cinnarizine (1)
- Cinryze® (1)
- Circadian rhythms and sleep (1)
- Circulation (1)
- Cirugía (1)
- Citation (1)
- Citationrate (1)
- Cities (1)
- Classification (1)
- Claudin 5 (1)
- Cleanliness level (1)
- Cleft palate (1)
- Clincial pharmacology (1)
- CliniMACS (1)
- Clinical Global Impression of Change (1)
- Clinical Skills (1)
- Clinical Trials and Observations (1)
- Clinical effectiveness (1)
- Clinical frailty scale (1)
- Clinical outcome (1)
- Clinical pathways (1)
- Clinical psychometry (1)
- Clinical skills (1)
- Clinical variation (1)
- Cln3 (1)
- Clonidine (1)
- Clostridioides difficile (1)
- Clostridium (1)
- Closure (1)
- Cluster (1)
- Cluster randomization (1)
- Clustering (1)
- Co-culture (1)
- Co-morbidity (1)
- Coagulopathy management (1)
- Coexistence (1)
- Cofilin (1)
- Cognitive neurology (1)
- Cognitive psychology (1)
- Cohort Analysis (1)
- Cohort study (1)
- Colchicum (1)
- Cold pain (1)
- Colitis Ulcerosa (1)
- Collagen antibody-induced arthritis (1)
- Collagen hemostat (1)
- Collagen type I (1)
- Collagen type III (1)
- Collagens (1)
- Colloids (1)
- Colon cancer (1)
- Colon capsule endoscopy (1)
- Colonisation (1)
- Combined immune checkpoint blockade (1)
- Combo® DTS (1)
- Communicable diseases (1)
- Community health services (1)
- Comorbidities (1)
- Comorbidity (1)
- Comparative effectiveness research (1)
- Comparative study (1)
- Comparators (1)
- Compartmental modeling (1)
- Competencies (1)
- Complement Regulator (1)
- Complement cascade (1)
- Complement system (1)
- Complementary medicine (1)
- Complementation rate (1)
- Complete heart block (1)
- Complex II (1)
- Complex hernia (1)
- Complex networks (1)
- Complexin 1 (1)
- Complexin-1 (1)
- Complexome profiling (1)
- Complication (1)
- Comprehensive cancer centers (1)
- Computational biology and bioinformatics (1)
- Computational model (1)
- Computed axial tomography (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computer hardware (1)
- Computer science (1)
- Computer simulation (1)
- Computer software (1)
- Computer-aided drug design (1)
- Computers (1)
- Concept paper (1)
- Conception (1)
- Concurrent chemoradiotherapy (1)
- Conditional gene trap (1)
- Conduct problems (1)
- Conduit function (1)
- Confocal endomicroscopy (1)
- Conformational change (1)
- Congenital CMVinfection (1)
- Congenital anomalies (1)
- Congenital duodenal obstruction (1)
- Congenital ocular motor apraxia (1)
- Coniosporium corticale (1)
- Consciousness (1)
- Consensus methods (1)
- Conservative (1)
- Consortia (1)
- Constrained posture (1)
- Contact precautions (1)
- Contractile function (1)
- Contrast-Enhancing Lesions (1)
- Contrast-enhanced (1)
- Conventional Chemotherapeutic (1)
- Conventional synthetic disease-modifying antirheumatic drug (1)
- Coping (1)
- Copy number variation (1)
- Cord blood transplantation (1)
- Core needle biopsy (1)
- Cornea (1)
- Coronary artery disease (1)
- Coronary artery disease (CAD) (1)
- Coronary intervention (1)
- Cost-effectiveness (1)
- Cost-effectiveness analysis (1)
- Couch tracking (1)
- Council for International Organizations of Medical Sciences (1)
- CoxVa (1)
- Coxibs (1)
- Craniomandibular disorders (1)
- Credentialing (1)
- Creeping Disease (1)
- Crispr/Cas (1)
- Critical Online Reasoning Assessment (1)
- Critical bleeding (1)
- Critical care (1)
- Critical care and emergency medicine (1)
- Critical haematocrit (1)
- Critical pathway (1)
- Cross-contamination (1)
- Cross-sectional (1)
- Cross-sectional study (1)
- Crosscorrelation (1)
- Crossmodal (1)
- Cryo-electron microscopy (1)
- Cryoablation (1)
- Cryoballoon (1)
- Cryptococcus (1)
- Cryptostroma corticale (1)
- CspA (1)
- Cumulative dose (1)
- Cure (1)
- Curriculum (1)
- Curvilinear dose response (1)
- CyberKnife (1)
- Cyp46a1 (1)
- CysLTR1 (1)
- Cysteine‐Rich Domain (CRD) (1)
- Cystic fibrosis (1)
- Cytokine (1)
- Cytology (1)
- Cytomegalovirus (CMV) (1)
- Cytoplasm (1)
- Cytoplasmic staining (1)
- Cytotoxic CD8+ T cell (1)
- C‐reactive protein (1)
- D-dimer (1)
- D2-autoreceptor (1)
- DAMP (1)
- DAMPs (1)
- DBH genotype (1)
- DCM (1)
- DDA (1)
- DDIT4 (1)
- DEE (1)
- DFNB9 (1)
- DHA (1)
- DILI database case quality (1)
- DKK1 (1)
- DKTK-ROG (1)
- DLBCL (1)
- DLI (1)
- DMARDs (synthetic) (1)
- DME (1)
- DMXAA (1)
- DNA Damage (1)
- DNA double-strand break repair (1)
- DNA repair (1)
- DNA replication (1)
- DNA sequence analysis (1)
- DNA sequencing (1)
- DNA-binding proteins (1)
- DNA-protein crosslinks (1)
- DOK1 (1)
- DR5 (1)
- DSAEK (1)
- DSS /AOM (1)
- DTHR (1)
- DUBs (1)
- DYRK1A (1)
- DYT1 (1)
- Dabigatran (1)
- Dancer (1)
- Darmerkrankung (1)
- Darreichungsform (1)
- Darunavir (1)
- Data acquisition (1)
- Data mining (1)
- Data monitoring (1)
- Data protection (1)
- Data validation (1)
- Database (1)
- Database searching (1)
- Databases (1)
- Dataset bias (1)
- Datenqualität (1)
- Datenschutz (1)
- David technique (1)
- Decision impact (1)
- Decision-making (1)
- Decitabine (1)
- Decolonization (1)
- Deep brain stimulation (1)
- Deficient Inhibition (1)
- Deformation (1)
- Delayed Cerebral Ischemia (1)
- Delayed union (1)
- Deletion mutation (1)
- Delivery mode (1)
- Delivery quality assurance (1)
- Delphi Survey (1)
- Delphie-Befragung (1)
- Dementia (1)
- Dendritic cell (1)
- Dendritic cell population (1)
- Dendritic cells (1)
- Dendritic spines (1)
- Denervation (1)
- Dengue (1)
- Dengue fever (1)
- Dengue virus (1)
- Denguefieber (1)
- Density equalizing (1)
- Density-equalizing mapping (1)
- Dental implants (1)
- Dental phobia (1)
- Dental training (1)
- Dentition (1)
- Depolarization (1)
- Dermal fat (1)
- Dermatomyositis (1)
- Desinfektion von Flugzeugen (1)
- Desmin (1)
- Determination method (1)
- Developmental disorders (1)
- Devic disease (1)
- Devic syndrome (1)
- Diabetic nephropathy (1)
- Diagnostic differentiation (1)
- Diagnostic techniques and procedures (1)
- Diagnostic test (1)
- Diagnostik von MLL Translokationen (1)
- Diary Data (1)
- Dicer (1)
- Dichloromethane (1)
- Didaktik (1)
- Diesel (1)
- Dietary intake (1)
- Differential expression (1)
- Diffuse astrocytoma (1)
- Diffuse large B cell lymphoma (1)
- Diffusion of Innovations (1)
- Digenic model (1)
- Digestive system (1)
- Digital breast tomosynthesis (DBT) (1)
- Digital ethics (1)
- Digital hybrid visualization (1)
- Digital mammography (1)
- Digital rectal examination (1)
- Digital transformation (1)
- Digitale Ethik (1)
- Digitale Transformation (1)
- Digitalisierung (1)
- Digitalization (1)
- Dilated cardiomyopathy (1)
- Dimer (1)
- Dimers (Chemical physics) (1)
- Dipeptide (1)
- Diphosphonates (1)
- Direct Acting Antivirals (DAA) (1)
- Direct acting antiviral therapies (1)
- Direct-acting antiviral agents (DAAs) (1)
- Disabilities (1)
- Disabling back pain (1)
- Disc herniation (1)
- Discs large (1)
- Disease burden (1)
- Disease management (1)
- Diseases (1)
- Disinfection of aircraft (1)
- Disintegration (1)
- Dissemination (1)
- Dissociative seizures (1)
- Distance to water (1)
- Distress (1)
- Distress screening (1)
- Distribution (1)
- Dog (1)
- Dogs (1)
- Domestic (1)
- Donor Selection (1)
- Dorsolateral prefrontal cortex (1)
- Dose optimization (1)
- Doubling time (1)
- Down's syndrome (1)
- Doxorubicin (1)
- Drug (1)
- Drug Discovery (1)
- Drug Therapy (1)
- Drug discovery (1)
- Drug hepatotoxicity (1)
- Drug induced liver injury (1)
- Drug interactions (1)
- Drug permeability (1)
- Drug resistance/synergy (1)
- Drug screens (1)
- Drug targeting (1)
- Dual energy CT (1)
- Dual therapy (1)
- Dual-Source CT (1)
- Duchenne’s muscular dystrophy (1)
- Dumon stents (1)
- Duodenal atresia (1)
- Duodenal stenosis (1)
- Dvc1 (1)
- E protein structure (1)
- E-cadherin (1)
- E-cadhérine (1)
- E-learning (1)
- E. coli (1)
- E/I-Balance (1)
- E3-Ligases (1)
- EBM (1)
- ECLS (1)
- ECM (1)
- EDB (1)
- EDTA-plasma (1)
- EEG reference choices (1)
- EFP1 (1)
- EGF (1)
- EGFL7 (1)
- EGFP (1)
- EGFR inhibitor (1)
- EGFR pathway (1)
- EGR1-dependent transcription (1)
- EIIIB (1)
- ELISA (1)
- ELSID-Diabetes (1)
- EMD 55900 (1)
- EMD 72000 (1)
- EMT (1)
- EPA (1)
- EQ (1)
- EQIP (1)
- ER stress (1)
- ERBB2 (1)
- ERBB2 (HER2/neu) (1)
- ERK3/MAPK6 (1)
- ERM (1)
- ERMS (1)
- ERP (1)
- ERSCongress (1)
- ES (1)
- ES cells (1)
- ESBL (1)
- ESMO-MCBS (1)
- ET (1)
- ETP-ALL (1)
- ETS (1)
- EWS/Fli1 (1)
- EZ-IO® needle driver (1)
- Early Rheumatoid Arthritis (1)
- Early diagnosis (1)
- Early goal-directed therapy (1)
- Early intervention (1)
- Early recurrence (1)
- Ebola virus (1)
- Echocardiography (1)
- Echovirus-30 (1)
- Eclampsia (1)
- Ecological momentary assessment (1)
- Economic analysis (1)
- Economic benchmarks (1)
- Economic evaluation (1)
- Economic impact (1)
- Economics (1)
- Ectopic bone formation (1)
- Edentulous jaw (1)
- Edoxaban (1)
- Educación médica (1)
- Efavirenz (1)
- Effective connectivity (1)
- Effectivity (1)
- Efficacy (1)
- Eicosanoids (1)
- Eignungsprüfung (1)
- Einfachauswahlverfahren (1)
- Eingangstest (1)
- Einreibetechnik (1)
- Elastogenesis (1)
- Elderly patients (1)
- Elective caesarean section (1)
- Electrical accident (1)
- Electrical instability (1)
- Electrical stimulation (1)
- Electroencephalography – EEG (1)
- Electrolytes (1)
- Electron transport chain (1)
- Electronic cigarettes (1)
- Electrophysiology (1)
- Electrotonic analysis (1)
- Elektroenzephalographie (1)
- Elektronenmikroskopie (1)
- Elevation (1)
- Elimination (1)
- Ellipsoids (1)
- Embolization (1)
- Embryos (1)
- Emergency (1)
- Emergency medicine (1)
- Emotion (1)
- Emotion processing (1)
- Emotional recognition (1)
- Empathy (1)
- Empfehlungen (1)
- Emphysema (1)
- Employment (1)
- Employment effect (1)
- End-of-life decisions (1)
- Endocrine cancer (1)
- Endometrial cancer (1)
- Endometriosis (1)
- Endoplasmic reticulum (1)
- Endoscopic coronary revascularisation (1)
- Endoscopic retrograde Cholangiopancreatography (ERCP) (1)
- Endoscopic ultrasound (1)
- Endoskopik koroner revaskülarizasyon (1)
- Endosomes (1)
- Endothelial cell (EC) (1)
- Endothelial nitric oxide synthase (1)
- Endothelium (1)
- Endotoxins (1)
- Endovascular repair (1)
- Endovaskuläre Behandlung (1)
- Endpoints (1)
- Enfermedades crónicas (1)
- England (1)
- Enteral nutrition (1)
- Enteric nervous system (1)
- Enterobacteriaceae (1)
- Enterostomy (1)
- Enterostomy closure (1)
- Enterostomy formation (1)
- Entfernung (1)
- Entorhinal cortex lesion (1)
- Entrenamiento práctico (1)
- Entzündung (1)
- EnvZ signalling (1)
- Envenomation (1)
- Environmental chemistry (1)
- Enzyme kinetics (1)
- Enzyme mechanisms (1)
- Enzyme regulation (1)
- Epidemiological data (1)
- Epidermolysis bullosa simplex with muscular dystrophy (1)
- Epidural block (1)
- Epilepsie (1)
- Epileptic seizures (1)
- Epileptische Anfälle (1)
- Epithelial cells (1)
- Epstein–Barr virus (1)
- Equipment (1)
- Equity (1)
- Eradication (1)
- Ergonomic analysis (1)
- Ergonomie am Arbeitsplatz (1)
- Ergonomische Analyse (1)
- Erythema migrans (1)
- Erythrocytes (1)
- Erythropoiesis (1)
- Esophageal adenocarcinoma (1)
- Esophageal adenocarcinoma (EAC) (1)
- Esophagectomy (1)
- Esophagogastric (1)
- Estradiol (1)
- Estrogen Receptor Modulators (1)
- Ethnicity (1)
- European Society for Immunodeficiencies (ESID) (1)
- European babesiosis (1)
- European registry for idiopathic pulmonary fibrosis (eurIPFreg) (1)
- Evaluation in microsurgery (1)
- Evaluationspraxis (1)
- Everolimus resistance (1)
- Evidence based medicine (1)
- Evidence-based dentistry (1)
- Evidence-based guidelines (1)
- Evidenzbasierte Medizin (1)
- Evolutionary biology (1)
- Exacerbations (1)
- Examination questions (1)
- Excitability (1)
- Exercise challenge at an ambient temperature (1)
- Exercise challenge in a cold chamber (1)
- Exercise testing (1)
- Exercise therapy (1)
- Exercise-induced bronchoconstriction (1)
- Exosomes (1)
- Experimental autoimmune encephalomyelitis (1)
- Experts (1)
- Expression (1)
- Extended Glasgow outcome scale (eGOS) (1)
- Extension study (1)
- External-/self-assessment (1)
- Extinction (1)
- Extracellular RNA (1)
- Extracellular RNA (eRNA) (1)
- Extracellular matrix proteins (1)
- Extracellular signal-regulated kinase 1/2 (1)
- Extracellular vesicles (1)
- Extracorporeal circulation (1)
- Extracorporeal life support (1)
- Extracorporeal purification (1)
- Extreme hypo-fractionation (1)
- F508del homozygous (1)
- FAAM (1)
- FAIR (1)
- FAK (1)
- FAM134B (1)
- FAV00A (1)
- FEV1 (1)
- FFLU (1)
- FFPE (1)
- FGFR (1)
- FIB-4 (1)
- FIV (1)
- FLT3 (1)
- FOLFIRI (1)
- FOXO3a (1)
- FREEDOM (1)
- FSS (1)
- FX06 (1)
- Facet joint osteoarthritis (1)
- Factor H (1)
- Factor analysis (1)
- Faculty Development (1)
- Falciparum (1)
- Fallbeispiele (1)
- Family Physician (1)
- Fascia (1)
- Fast-track (1)
- Fat layer (1)
- Fatty acids (1)
- Fbw7 (1)
- Fc receptor (1)
- Fear conditioning (1)
- Feasibility (1)
- Feature tracking (1)
- Feedback (1)
- Feedback loop (1)
- Feline bartonellosis (1)
- FemNAT-CD (1)
- Female (1)
- Female adolescents (1)
- Females (1)
- Feminismus (1)
- Femoral neck (1)
- Fertigkeiten (1)
- Fertilität (1)
- Fertilité (1)
- Fetal bovine serum (1)
- Fever (1)
- Fevers (1)
- Fibrinolytic (1)
- Fibroblast growth factor (1)
- Fibronectin (1)
- Fibrotest (1)
- Fibulin-4 (1)
- Fibulin-5 (1)
- Filovirus cell entry; attachment factors redundancy; SH-SY5Y cell line; host–pathogen interactions (1)
- Finanzierung (1)
- Finite Element Method (1)
- First experience with patients (1)
- First site of metastatic disease (1)
- First-line combination antiretroviral therapy (1)
- First-line regimen (1)
- Five-Konzept (1)
- Fleas (1)
- FlexTouch (1)
- Flexibility (1)
- Flexible Endoscopic Evaluation of Swallowing (1)
- Fluorescence imaging (1)
- Fluorescence-in-situ-hybridization (FISH) (1)
- Fluorescent Probes (1)
- Foam rolling (1)
- Folic acid (1)
- Follow-up (1)
- Food effects (1)
- Foramen ovale (1)
- Forensics (1)
- Forkhead box (1)
- Formation dance (1)
- Foxp1 (1)
- Fracture risk (1)
- Francisella tularensis (1)
- Francisella tularensis subspecies holarctica (1)
- Frankfurt <Main> / Klinikum (1)
- Frankfurt microsurgery course (1)
- Fresh frozen plasma (1)
- Frontotemporal dementia (1)
- Frühgeborenes (1)
- Fuchs endothelial dystrophy (1)
- Fuctional connectivity (1)
- Functional ankle instability (1)
- Functional capacity (1)
- Functional characterization (1)
- Functional connectivity (1)
- Functional electrical stimulation (1)
- Functional mitral regurgitation (1)
- Functional outcome (1)
- Functionally-impaired elderly (1)
- FungiScope® registry (1)
- Fusarium (1)
- Fusion Proteins, BCR-ABL (1)
- G-protein (1)
- G-protein-coupled receptors (1)
- G/P (1)
- G2A (1)
- G3BP (1)
- G9a/EHMT2/KMT1C (1)
- GABA (1)
- GABAergic interneurons (1)
- GHQ-28 (1)
- GLI inhibitors (1)
- GLUT1 (1)
- GM-CSF (1)
- GPCR (1)
- GPVI (1)
- GRADE (1)
- GRK2 (1)
- GRX1-roGFP2 (1)
- GSK2334470 (1)
- GSK3α (1)
- GSK3β (1)
- GVHD (1)
- GVL (1)
- Gaba (1)
- Gadopentate dimeglumine (1)
- Gads (1)
- Gait analysis (1)
- Gallbladder percutaneous drainage (1)
- Galleria mellonella (1)
- Games (1)
- Gamma-Band Activity (1)
- Gamma-aminobutyric acid (1)
- Gap junctions (1)
- Gas gangrene (1)
- Gastritis (1)
- Gastroesophageal reflux disease (1)
- Gastroesophageal reflux disease symptoms (1)
- Gastrointestinal bleeding (1)
- Gastrointestinal cancer (1)
- Gastrointestinal neoplasm (1)
- Gastrointestinal tract (1)
- Gaucher disease type III (1)
- Gaucher’s disease (1)
- Gebärmutterhalskrebs (1)
- Gemcitabine (1)
- Gender analysis (1)
- Gender equality (1)
- Gender gap (1)
- Gender reassigning surgery (1)
- Gene Regulation (1)
- Gene engineering (1)
- Gene expression prediction (1)
- Gene fusion (1)
- Gene microarray analysis (1)
- Gene ontology (1)
- Gene polymorphism (1)
- Gene prediction (1)
- Gene set analysis (1)
- Gene-protein assay (1)
- GeneMANIA (1)
- General clinical cardiology (1)
- General dental practice (1)
- General practice/family medicine (1)
- General practitioner (1)
- Generation Y (1)
- Generation time (1)
- Generic drugs (1)
- Genetic causes of cancer (1)
- Genome annotation (1)
- Genomic instability (1)
- Geographically weighted regression (GWR) (1)
- German (1)
- German PID-NET registry (1)
- Gesprächsführung (1)
- Gestational age (1)
- Gestational diabetes (1)
- Gesundheitsamt (1)
- Gezielte Therapie (1)
- Giant lymph node hyperplasia (1)
- Gift (1)
- Gimbaled tracking (1)
- Glaucoma (1)
- Gleason Score (1)
- Gleason upgrading (1)
- Glioma (1)
- Glivec® (1)
- Global protein synthesis rates (1)
- Glomerular Filtration Rate (1)
- Glomerular diseases (1)
- Glomerulonephritis (1)
- Glucocorticoids (1)
- Glucose Transporter Type 1 (1)
- Glycogen synthase kinase 3 beta (1)
- Glycolysis (1)
- Glycosphingolipids (1)
- Glyoxalase I (1)
- Goal-oriented care (1)
- Gold (1)
- Goserelin (1)
- Grado en medicina (1)
- Graft function (1)
- Graft survival (1)
- Gram negative bacteria (1)
- Gram-positive infection (1)
- Granule cell (1)
- Grass pollen (1)
- Greater tuberosity fractures (1)
- Gross tumor volume optimization (1)
- Growth cone (1)
- Growth factor (1)
- Growth factor signalling (1)
- Guided surgery (1)
- Guided tissue regeneration (1)
- Guideline (1)
- Guideline adherence (1)
- Gut-liver-axis (1)
- GvHD (1)
- Gαq/11 (1)
- H-Index (1)
- H1N1 (1)
- H3 receptor (1)
- H5N1 (1)
- HACA (1)
- HAEGARDA (1)
- HAI‐1 (1)
- HBV filaments (1)
- HBV genotypes (1)
- HBV reactivation (1)
- HBV surface protein (1)
- HCC recurrence (1)
- HCMV (1)
- HCV treatment (1)
- HDAC-inhibition (1)
- HER2 c-erbB2 (1)
- HER2-positive (1)
- HER2/neu (ERBB2) (1)
- HEV (1)
- HFrEF (1)
- HGF (1)
- HH (1)
- HIBCPP cells (1)
- HIF (1)
- HIF1α (1)
- HIFU (1)
- HILI (1)
- HIV protease inhibitors (1)
- HIV serodiagnosis (1)
- HIV therapy (1)
- HIV-1 escape restriction (1)
- HIV-RNA (1)
- HLA DQ haplotypes (1)
- HLA class I loss (1)
- HLA class II (1)
- HLA peptidome (1)
- HMA (1)
- HMGB1 (1)
- HODE (1)
- HRM (1)
- HRas (1)
- HSPC (1)
- HSV-1 (1)
- HSV-2 (1)
- HUVEC (1)
- Haematoma expansion (1)
- Haematopoietic stem cells (1)
- Haemodynamic monitoring (1)
- Haemostatics (1)
- Hand-foot syndrome (1)
- Haploidentical stem cell transplantation (1)
- Haplotypes (1)
- Hard-to-reach population (1)
- Hashimoto’s thyroiditis (1)
- Hausarztmangel (1)
- HbA1c (1)
- Head and neck Cancer (1)
- Head injury (1)
- Health Policy (1)
- Health Systems (1)
- Health care (1)
- Health care access (1)
- Health care resource utilization (1)
- Health care sector (1)
- Health care workers (1)
- Health education and awareness (1)
- Health information (1)
- Health literacy (1)
- Health policy (1)
- Health risk analysis (1)
- Health services (1)
- Health services research [MeSH] (1)
- Health-related quality of life (1)
- Health-seeking behaviour (1)
- Health‐related quality of life (1)
- Heart regeneration (1)
- Heat dissipation (1)
- Heat pain (1)
- Hebbian plasticity (1)
- Hedgehog (1)
- Hedgehog pathway (1)
- Helpline (1)
- Hemagglutination inhibition assay (1)
- Hematocrit value (1)
- Hematopoietic stem and progenitor cells (HSPCs) (1)
- Hematopoietic stem cell transplantation (1)
- Hematopoietic stem cells (1)
- Hematoxylin staining (1)
- Hemodilution (1)
- Hemodynamic management (1)
- Hemodynamics (1)
- Hemoglobin (1)
- Hemophilia A (1)
- Hemorrhagic shock (1)
- Hemostasis (1)
- Hemostatics (1)
- HepaRG cells (1)
- Hepatic encephalopathy (1)
- Hepatitis (1)
- Hepatitis B (1)
- Hepatitis B infection (1)
- Hepatitis B vaccination (1)
- Hepatitis B virus (1)
- Hepatitis C (1)
- Hepatitis C, Chronic (1)
- Hepatitis c (1)
- Hepatotoxicity (1)
- Herbal hepatotoxicity (1)
- Herbalife (1)
- Herbs (1)
- Herd immunity (1)
- Hereditary breast and ovarian cancer (1)
- Hereditary breast cancer (1)
- Hereditary ovarian cancer (1)
- Heregulin (1)
- Hernia recurrence (1)
- Hernia surgery (1)
- Heterogeneity (1)
- Hexavalent vaccine (1)
- HhAntag (1)
- HiC (1)
- HiChIP (1)
- Hif-1 alpha (1)
- Hif1α (1)
- High-dose chemotherapy (1)
- High-income countries (1)
- High-intensity interval endurance training (1)
- High-risk cardiac surgery (1)
- High-risk patient (1)
- High-throughput screening (1)
- Highly infectious diseases (1)
- Hindu Kush Himalayas (1)
- Hip (1)
- Hippo signaling (1)
- Hippocampal volume (1)
- Hirnverletzung (1)
- Hispanic people (1)
- Histone post-translational modifications (1)
- Histoplasma qPCR (1)
- Hmox1 (1)
- Hochansteckende Krankheiten (1)
- Hochschuldidaktik (1)
- Hodgkin’s lymphoma (1)
- Homeostatic plasticity (1)
- Homicide (1)
- Homocysteine (1)
- Hormone de régression müllérienne (1)
- Horner's syndrome (1)
- Horses (1)
- Hospital (1)
- Hospitalization (1)
- Hospitalizations (1)
- Host-directed therapies (1)
- Host-targeting agents (HTAs) (1)
- House dust mite allergy (1)
- Household contacts (1)
- Hrvaška (1)
- Hsp70 (1)
- Hsp90 inhibitor (1)
- HuR (1)
- Huh7 (1)
- Human (1)
- Human experimental pain models (1)
- Human immunodeficiency virus (HIV) (1)
- Human olfaction (1)
- Human physiology (1)
- Human prostate (1)
- Humangenetik (1)
- Humans (1)
- Humeral fractures (1)
- Humerus (1)
- Hungary (1)
- Hydrocephalus (1)
- Hydroxyapatite (1)
- Hydroxychloroquine (1)
- Hydroxycut (1)
- Hydroxyurea (1)
- Hymenoptera venom immunotherapy (1)
- Hyperammonemic encephalopathy (1)
- Hypofractionated radiotherapy (1)
- Hypomethylating agents (1)
- Hyponatremia (1)
- Hypoxia inducible factor (1)
- Hypoxic responses (1)
- Hysterektomie-Prävalenz (1)
- I-FABP (1)
- I-PRF (1)
- ICSI (1)
- IDH mutation (1)
- IDH1 inhibitor (1)
- IDO1 (1)
- IFA (1)
- IFN (1)
- IFN-γ expression (1)
- IGF (1)
- IGRA (1)
- IKKε (1)
- IKZF1 (1)
- IL -17 (1)
- IL -23 (1)
- IL 23p19 knockout mouse (1)
- IL-11 (1)
- IL-12 (1)
- IL-13 (1)
- IL-15 (1)
- IL-18 binding protein (1)
- IL-18BP (1)
- IL-21 (1)
- IL-22 (1)
- IL-27 cytokine (1)
- IL-33 (1)
- IL10R (1)
- ILUVIEN (1)
- IMiD® (1)
- IPEX (1)
- IPS e.max system (1)
- IRES translation (1)
- ISS (1)
- ITGA7 (1)
- IUIS classification 2017 (1)
- IV iron (1)
- IVA interference tandem mass spectrometry (1)
- IVD degeneration (IVDD) (1)
- IVDU (1)
- IVF (1)
- Iceland (1)
- Idarucizumab (1)
- Identity (1)
- Idiopathic pulmonary fibrosis (IPF) (1)
- IgE (1)
- IgG (1)
- IgG substitution therapy (1)
- IgG4-related disease (1)
- IgGAM (1)
- Illumina (1)
- Image processing (1)
- Image processing (computer-assisted) (1)
- Imaging (1)
- Imaging genetics (1)
- Imaging in LGG (1)
- Imaging, three-dimensional (1)
- Immediate loading (1)
- Immediate placement (1)
- Immobilization (1)
- Immune Response (1)
- Immune cells (1)
- Immune receptor signaling (1)
- Immune response (1)
- Immune system (1)
- Immunity (1)
- Immunmodulation (1)
- Immunoassays (1)
- Immunocompromised (1)
- Immunoglobulin Therapy (1)
- Immunohistochemistry techniques (1)
- Immunological techniques (1)
- Immunologie (1)
- Immunology and Microbiology Section (1)
- Immunomodulation (1)
- Immunomonitoring (1)
- Immunosenescence (1)
- Immunostaining (1)
- Immunosuppression (1)
- Immunosuppressive Agents (1)
- Immunosuppressive agents (1)
- Immunosuppressive therapy (1)
- Impfung (1)
- Implant-supported bars (1)
- Implementación (1)
- Impulse control (1)
- In vivo (1)
- In-hospital cardiac arrest (1)
- In-line filtration (1)
- In-vivo (1)
- IncL (1)
- Incidence rate (1)
- Incomplete colonoscopy (1)
- Independent component analysis (1)
- Independent laboratories (1)
- Indeterminate biliary stricture (1)
- Index (1)
- Indication (1)
- Individualisierung des Studiums (1)
- Individualized intervention (1)
- Individuelle Studienbegleitung (1)
- Indonesia (1)
- Indoor air pollution (1)
- Induced membrane technique (1)
- Induced pluripotent stem cells (1)
- Induced sputum (1)
- Inertial motion capture (1)
- Infant (1)
- Infant leukemia (1)
- Infants (1)
- Infarction (1)
- Infections (1)
- Infectious disease (1)
- Infectious disease epidemiology (1)
- Infektionsabwehr (1)
- Infektionsprophylaxe (1)
- Infliximab (1)
- Inflow obstruction (1)
- Influenza (1)
- Information theory (1)
- Information transfer (1)
- Infusion management (1)
- Injuries (1)
- Injury (1)
- Inner ear therapy (1)
- Inpatients (1)
- Inside-out Signaling (1)
- Insula (1)
- Insulin (1)
- Insulin secretion (1)
- Insulin therapy (1)
- Integrated multimodal training (1)
- Integration (1)
- Integrin (1)
- Integrins (1)
- Intelligence (1)
- Intelligence tests (1)
- Intensive care outcome (1)
- Intensive care unit (1)
- Inter-study reproducibility (1)
- Interdisziplinarität (1)
- Interferon-free HCV treatment (1)
- Interferons (1)
- Interleukin-17A (1)
- Interleukin-18 (1)
- Interleukin-18 binding protein (1)
- Interleukin-22 binding protein (1)
- Intermediate filaments (1)
- International body passport (1)
- Internet citation (1)
- Interspecific competition (1)
- Interstitial lung diseases (ILD) (1)
- Interventional Trials (1)
- Interventional cardiology (1)
- Intervertebral disc degeneration (1)
- Intestinal failure-associated liver disease (1)
- Intestinal neoplasms (1)
- Intolerance (1)
- Intra-abdominal infection (1)
- Intracellular pathogens (1)
- Intracerebral haemorrhage (1)
- Intracranial embolism (1)
- Intracranial haemorrhage (1)
- Intracranial hemorrhage (1)
- Intragastric balloon (1)
- Intraoral scanners (1)
- Intraosseous access (1)
- Intratumoral (1)
- Intratympanic drug delivery (1)
- Intravenous Drug User (1)
- Intravenous injections (1)
- Invasive candidiasis (1)
- Invasive fungal infection (1)
- Invasive fungal infections (1)
- Inzidenzkorrektur (1)
- Ionenkanal (1)
- Ipilimumab (1)
- Ireb2 (1)
- Ireland (1)
- Iron Overload (1)
- Iron chelation (1)
- Iron deficiency (1)
- Irregular vaccination (1)
- Ischemia-reperfusion injury (1)
- Ischemia–reperfusion injury (1)
- Isolierung <Medizin> (1)
- Isoproterenol (1)
- Issue 96 (1)
- Italy (1)
- Itpr1 (1)
- Ivor Lewis esophagectomy (1)
- Ixodes ricinus (1)
- JAK inhibition (1)
- JNK3 (1)
- Jak2(V617F) (1)
- Joint destruction (1)
- Joint loading (1)
- Joubert syndrome (1)
- Jumping (1)
- Juvenile myoclonic epilepsy (1)
- KAP (1)
- KCGS (1)
- KCNJ2 mutation (1)
- KCNQ4 (1)
- KDIGO (1)
- KIF (1)
- KIF11 (1)
- KIR (1)
- KLK5 (1)
- KOOS IV (1)
- KRAS (1)
- Kaisidis plate (1)
- Karyotypes (1)
- Kegelschnecke (1)
- Keratinocytes (1)
- Ketogenic Diet (1)
- Ki-67 (1)
- Ki-67/MIB1 (1)
- Ki67 transgenic c‐myc/TGFα mice (1)
- Kidney Transplantation (1)
- Kidney disease (1)
- Kidney neoplasm (1)
- Kidney transplant recipients (1)
- Kiefer (1)
- Kim-1 (1)
- Kinases (1)
- Kinder (1)
- Kindheit (1)
- Kinematic posture analysis (1)
- Kinematics (1)
- Kinetochore (1)
- Klinische Ergebnisse (1)
- Klinische Fertigkeiten (1)
- Knee joint (1)
- Knockout (1)
- Kongress (1)
- Konsensus Methode (1)
- Konzeption (1)
- Konzeptpapier (1)
- Krait (1)
- Kraniomandibuläre Dysfunktion (1)
- Krebs (1)
- Krebsforschung (1)
- Kupffer cells (1)
- Kynurenine (1)
- Körperbild (1)
- Körpermodifikation (1)
- L1 cell-adhesion molecule (L1-CAM) (1)
- LABAs (1)
- LAMP3 (1)
- LAMTOR2 (1)
- LAT (1)
- LC-NE system (1)
- LC3 I/II (1)
- LC3B (1)
- LCH (1)
- LC–MS/MS (1)
- LDL (1)
- LDL-cholesterol (1)
- LFA-1 (1)
- LFP (1)
- LHRH receptor (1)
- LIR interaction, (1)
- LIVIN (1)
- LM11A 31 (1)
- LN229 (1)
- LNS (1)
- LOS (1)
- LPP (1)
- LRBA (1)
- LSCC (1)
- LTB4 (1)
- LTBI (1)
- LUBAC (1)
- LUT (1)
- Laboratory techniques and procedures (1)
- Lack of immunity (1)
- Lactation (1)
- Lactic acidosis (1)
- Lactobacillus (1)
- Lafora disease (1)
- Lamivudine (1)
- Landarztprogramm (1)
- Langzeitpflege (1)
- Laparoscopic fundoplication (1)
- Laparostomy (1)
- Laparotomy. Joel-Cohen (1)
- Laser navigation system (1)
- Late Gadolinium Enhancement (LGE) (1)
- Late gadolinium enhancement (1)
- Late presentation (1)
- Latent transforming growth factor β-binding protein 4 (1)
- Lateral recess stenosis (1)
- Laterality (1)
- Le carcinome épidermoïde oral (1)
- Leadership (1)
- Learning algorithms (1)
- Learning and memory (1)
- Learning outcomes (1)
- Leber congenital amaurosis (1)
- Lectin affinity plasmapheresis (1)
- Lecture (1)
- Leflunomide (1)
- Left Ventricular Mass (1)
- Left ventricular assist device (1)
- Left ventricular function (1)
- Left ventricular mass (1)
- Left ventricular non-compaction, (1)
- Leg alignment (1)
- Lehre (1)
- Lehrerausbildung (1)
- Leistungsorientierte Mittelvergabe (1)
- Leitlinie (1)
- Lenalidomide (1)
- Length of stay (1)
- Lentiviral vectors (1)
- Lernerfolgsmessung (1)
- Lernziele (1)
- Les macrophages associés aux tumeurs (1)
- Lesion (1)
- Leukemia (1)
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)
- Leukocyte elastase (1)
- Leukocytes (1)
- Leukodystrophy (1)
- Leukotriene (1)
- Lice (1)
- Light sheet fluorescence microscopy (1)
- Lineage (1)
- Lineage tracing (1)
- Linkage (1)
- Lipid metabolism (1)
- Lipid signaling (1)
- Lipid trafficking (1)
- Lipidol (1)
- Lipiodol (1)
- Lipodystrophy (1)
- Lipopolysaccharide-binding protein (1)
- Liquid filled MicroLion ion chamber array (1)
- Lithium (1)
- Liver (1)
- Liver cancer (1)
- Liver enzymes (1)
- Liver injury (1)
- Liver metastases (1)
- Liver resection (1)
- Liver transplant (1)
- Liver-Related Complications (1)
- Liver-related complications (1)
- LiverTox (1)
- Livestock (1)
- LncRNA (1)
- LncRNA - long noncoding RNA (1)
- Local IgE (1)
- Local allergic rhinitis (1)
- Local climate (1)
- Local control (1)
- Localized prostate cancer (1)
- Locally advanced (1)
- Loco-regional control (1)
- Locomotor circuit (1)
- Lomentospora prolificans (1)
- Long term output (1)
- Long term result (1)
- Long-term (1)
- Long-term follow up (1)
- Longitudinal analysis (1)
- Low birth weight infant (1)
- Low volume prep (1)
- Low-dose X-irradiation (1)
- Low-dose ionizing radiation (1)
- Low-grade glioma (1)
- Low-virulent infection (1)
- Lower back pain (1)
- Lpar2 (1)
- Ltbp-4 (1)
- Ltbp-4L (1)
- Ltbp-4S (1)
- Ltbp4 (1)
- Lucigenin (1)
- Luftverkehr (1)
- Lumbar spinal canal stenosis (1)
- Lumbar stenosis (1)
- Lumican (1)
- Lung (1)
- Lung Cancer (1)
- Lung adenocarcinoma (1)
- Lung cancer (1)
- Lung failure (1)
- Lungenerkrankungen (1)
- Lyme Borreliosis (1)
- Lyme borreliosis (1)
- Lyme disease - Borreliosis (1)
- Lymph node (1)
- Lymphadenopathy (1)
- Lymphangiogenesis (1)
- Lymphangioleiomyomatosis (1)
- Lymphedema (1)
- Lymphocyte (1)
- Lymphoepithelioma (1)
- Lymphoid Neoplasia (1)
- Lymphoid tissues (1)
- Lymphoma (1)
- Lymphomas (1)
- Lysophosphatidic acids (1)
- Lysosomal storage disease (1)
- MACE (1)
- MAGGIC score (1)
- MAIT cell (1)
- MC-Fragen (1)
- MCP (1)
- MCP-1 (1)
- MDM2 (1)
- MDR1 (1)
- MEDIC (1)
- MEIS2 (1)
- MELD (1)
- MET (1)
- MK-0457 (1)
- MKP1 (1)
- MLC tracking (1)
- MLH1 (1)
- MLKL (1)
- MLL-rearranged leukemia (1)
- MLN8237 (1)
- MLV (1)
- MM-121 (1)
- MMF (1)
- MMP14 (1)
- MMP2 (1)
- MOLLI (1)
- MPA (1)
- MPM (1)
- MPN (1)
- MPN-U (1)
- MR spectroscopy (1)
- MR-based histology (1)
- MR-proADM (1)
- MR-spectroscopy (1)
- MRI patterns of gliomas (1)
- MRP4 (1)
- MSC-subsets (1)
- MSM (1)
- MTCL (1)
- MTRNR1 (1)
- MTT (1)
- MTT assay (1)
- Machine learning algorithms (1)
- Machine teaching (1)
- Macrophage Transdifferentiation (1)
- Macrophage polarization (1)
- Macular neovascularization (1)
- Magnetic resonance (1)
- Magnetic resonance imaging (MRI) (1)
- Magnetoencephalography (1)
- Magnetresonanztomografie (1)
- Maintenance treatment (1)
- Major bleeding (1)
- Major infection after cardiac surgery (1)
- Malaria prevalence (1)
- Malariae (1)
- Male (1)
- Male Population (1)
- MammaPrint (1)
- Mammalian target of rapamycin (1)
- Mammaplasty (1)
- Mammary gland (1)
- Manatee invariant (1)
- Mandible (1)
- Mania (1)
- Manner of death (1)
- Manufacturing (1)
- Maple bark disease (1)
- Maple bark strippers’ lung (1)
- Mapping (1)
- Marburg virus (1)
- Marginal grafts (1)
- Marker genes (1)
- Markov model (1)
- Massive Online Open Course (1)
- Mastectomy (1)
- Maternal morbidity (1)
- Mathematical methods (1)
- Mathematical model (1)
- Mathematical models (1)
- Mathematische Biologie (1)
- Mcl-1 (1)
- MdM2 (1)
- Measles (1)
- Measurement equipment (1)
- Mechanical ankle instability (1)
- Meckel’s diverticulum (1)
- Medical (1)
- Medical Education (1)
- Medical communication (1)
- Medical ethics (1)
- Medical hypoxia (1)
- Medical imaging (1)
- Medical implants (1)
- Medical management (1)
- Medical research (1)
- Medical school (1)
- Medical staff (1)
- Medical student (1)
- Medical traineeship (1)
- Medication changes (1)
- Medicine and health sciences (1)
- Medizin (1)
- Medizinische Abbildung (1)
- Medizinische Ausbildung (1)
- Medizinische Ethik (1)
- Medizinische Lehre (1)
- Medizinische Psychologie (1)
- Medizinstudierende (1)
- Melanoma (1)
- Membrane Attack Complex (1)
- Membrane Trafficking (1)
- Membrane assays (1)
- Membrane proteins (1)
- Membrane staining (1)
- Memory (1)
- Mena/VASP (1)
- Mental health (1)
- Mental health disorders (1)
- Mental health problems (1)
- Menthol (1)
- Mentor (1)
- Mesangial cells (1)
- Mesenchymal stem cell (1)
- Mesenchymal stem/stromal cells (1)
- Mesenchymal stromal cells (1)
- Mesenchymal stromal cells (MSC) (1)
- Mesh repair (1)
- Meta-analysis (1)
- Metaanalysis (1)
- Metabolic diseases (1)
- Metabolic syndrome (1)
- Metabolism (1)
- Metabolism, Inborn Errors (1)
- Metalloproteases (1)
- Metastasis (1)
- Metastatic (1)
- Metastatic castration-resistant prostate cancer (1)
- Metastatic tumors (1)
- Methacholine challenge test (1)
- Methicillin resistance (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Methionine (1)
- Methoden (1)
- Methotrexate (1)
- Mgm1p (1)
- MiSpEx Network (1)
- Mice (1)
- Micro RNAs (1)
- Micro-CT (1)
- MicroRNA-181a (1)
- MicroRNAs (miRNAs) (1)
- Microalgae (1)
- Microarray (1)
- Microbial mutation (1)
- Microfluidics (1)
- Microglia (1)
- Microglial cells (1)
- Micrognathia (1)
- Microphones (1)
- Microphysiological models (1)
- Microsatellite instability (1)
- Microstates (1)
- Microtubule (1)
- Midbrain/brainstem expression changes (1)
- Middle East respiratory syndrome coronavirus (1)
- Midkine (1)
- Midline laparotomy (1)
- Midwifery (1)
- Migration (1)
- Mild cognitive impairment (1)
- Minimal Residual Disease (MRD) (1)
- Minimal core of imaging (1)
- Minimal invasive (1)
- Minimally invasive surgical procedures (1)
- Minimally invasive transforaminal interbody fusion (1)
- Mislocalised proteins (1)
- Mitochondrial ROS (1)
- Mitochondrial amino acid tRNA synthetases (1)
- Mitochondrial complex I (1)
- Mitochondrial disease (1)
- Mitochondrial disorder (1)
- Mitochondrial dysfunction (1)
- Mitochondrial function (1)
- Mitochondrial proteins (1)
- Mitochondrial respiration (1)
- Mitochondrial shuttles (1)
- Mitochondrien (1)
- Mitomycin C (1)
- Mitoxantrone (1)
- Mobilization (1)
- Model Organism (1)
- Modell-Curriculum (1)
- Modellprojekt, (1)
- Moderating factors (1)
- Modified FDI criteria (1)
- Molar tooth sign (1)
- Mole-rat (1)
- Molecular diagnostic testing (1)
- Molecular genetics (1)
- Molecular imaging (1)
- Molecular marker (1)
- Molecular matched therapy (1)
- Molecular signatures (1)
- Molecular subtype (1)
- Molecular subtypes (1)
- Molecular therapy (1)
- Molecularly targeted therapy (1)
- Molekulare Therapie (1)
- Monacolin K (1)
- Monitoring (1)
- Monoclonal antibodies (1)
- Monocytes and macrophages (1)
- Monolithic crown (1)
- Monosaccharide Transport Proteins (1)
- Monte Carlo method (1)
- Monte Carlo simulation (1)
- Morbus Crohn (1)
- Morphological modeling (1)
- Mortalitätskorrektur (1)
- Motility disorder (1)
- Motivating factor (1)
- Motor neuron disease (1)
- Motor skills (1)
- Mountain (1)
- Mouse model (1)
- Moviprep (1)
- Mucomaix® matrix (1)
- Mucopolysaccharidoses (1)
- Multi-center (1)
- Multi-modal feedback (1)
- Multi-nucleated cardiomyocytes (1)
- Multi-resistant pathogens (1)
- Multidetector Computed Tomography (1)
- Multidetector computed tomography (1)
- Multidisciplinary management (1)
- Multidrug-resistant bacteria (1)
- Multidrug-resistant tuberculosis (1)
- Multilevel two-part modelling (1)
- Multimedia (1)
- Multimodal imaging (1)
- Multimorbid patients (1)
- Multimorbilidad (1)
- Multinomial logistic regression (1)
- Multinucleated giant cells (1)
- Multiomics (1)
- Multiple Sclerosis (1)
- Multiple choice Fragen (1)
- Multiple myeloma (1)
- Multiple trauma (1)
- Multisensory (1)
- Multivariable analysis (1)
- Muscarinic acetylcholine receptor (1)
- Muscle atrophy (1)
- Muscle tissue (1)
- Muscular diseases (1)
- Musculoskeletal (1)
- Musculoskeletal ultrasound (1)
- Music chair concepts (1)
- Musical rhythm (1)
- Musician (1)
- Musician-specific seating position (1)
- Muskuloskeletales System (1)
- Muskuloskelettale Erkrankungen (1)
- Mutation databases (1)
- Mutations (1)
- Myalgia (1)
- Mycoses (1)
- Myelin or myeloarchitecture (1)
- Myelodysplastic syndrome (1)
- Myelofibrosis (1)
- Myeloperoxidase (1)
- Myeloproliferative disease (1)
- Myocardial perfusion (1)
- Myocardial revascularization (1)
- Myocardial segmentation (1)
- Myonecrosis (1)
- Myotonic dystrophy (1)
- Mφs (1)
- N-Acetylaspartate (1)
- N-acetyl-L-cysteine (1)
- N-acetylcysteine (1)
- N-cadherin (1)
- N-cadhérine (1)
- N-hydroxysuccinimide (1)
- N-methyl-D-aspartate receptor (1)
- N-myc (1)
- N2 (1)
- NADH dehydrogenase (1)
- NADPH oxidase 4 (1)
- NAFL (1)
- NCAM (1)
- NCH93 (1)
- NDBI (1)
- NDNF interneurons (1)
- NDR1 (1)
- NDUFA6 (1)
- NDUFAF8 (1)
- NEAT1 (1)
- NEAT2 (1)
- NETs (1)
- NF-ĸB (1)
- NF-κB pathway (1)
- NF-кB (1)
- NFAT (1)
- NFκB (1)
- NGS (1)
- NHE (1)
- NHEJ (1)
- NIRS (1)
- NK cell subset (1)
- NK receptors (1)
- NKG2A blocking (1)
- NKT cell (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NMDAR subunit GluN2B (1)
- NMO-IgG (1)
- NO (1)
- NOD2 (1)
- NOXA (1)
- NPC disease (1)
- NPH insulin (1)
- NPSR1 (1)
- NRAS (1)
- NS1608 (1)
- NS3 protease inhibitor (1)
- NS3-4A protease inhibitor (1)
- NS3/4A protease inhibitors (PI) (1)
- NS5A inhibitors (1)
- NS5B polymerase inhibitor (1)
- NSAIDs (1)
- NSC350625 (1)
- NSE (1)
- NSF (1)
- NSG mice (1)
- NSTEMI (1)
- NXF1 (1)
- Nackenmuskulatur (1)
- NanoBone (1)
- Nanocrystalline (1)
- Nanoparticles (1)
- Nanopore (1)
- National catalogue of competence-based learning objectives in dentistry (1)
- Native T1 (1)
- Native T1 mapping (1)
- Natriuretic peptide (1)
- Naturwissenschaften (1)
- Nav channel activity (1)
- Nav1.7 (1)
- Neck muscles (1)
- Necrosis (1)
- Necrotic area (1)
- Necrotizing enterocolitis (1)
- Necrotizing fasciitis (1)
- Needs assessment [MeSH] (1)
- Negative staining (1)
- Negative-pressure wound therapy (1)
- Neoadjuvant radiochemotherapy (1)
- Neoadjuvant therapy (1)
- Neonatal (1)
- Neonatal brain damage (1)
- Neonatal intensive care unit (1)
- Neonatal morbidity (1)
- Neonatal outcome (1)
- Neonatal urea cycle disorders (1)
- Neosexualitäten (1)
- Nephrectomy (1)
- Nephrons (1)
- Nerves (1)
- Nervous system diseases (1)
- Nesplora Aquarium (1)
- Network analysis (1)
- Network model (1)
- Neugeborenes (1)
- Neural function (1)
- Neural networks (1)
- Neural stem cells (1)
- Neuro-ophthalmology (1)
- Neurobiology of disease and regeneration (1)
- Neuroblastoma (1)
- Neurochemistry (1)
- Neurodegeneration (1)
- Neurodegenerative diseases (1)
- Neurodevelopment (1)
- Neurodevelopmental disorders (1)
- Neuroendocrine cancer (1)
- Neurogenese (1)
- Neurogenesis (1)
- Neuromyelitis optica (1)
- Neuronal dendrites (1)
- Neuronal homeostasis (1)
- Neuronal networks (1)
- Neuronal nitric oxide synthase (1)
- Neuronal plasticity (1)
- Neuropathic pain (1)
- Neurophysiology (1)
- Neuropsychological testing (1)
- Neuropsychology (1)
- Neurotoxicity (1)
- Neurotransmitter (1)
- Neurowissenschaften (1)
- Neutrophils (1)
- New Developments (1)
- Next generation sequencing (1)
- Nfe2l2 (1)
- Niche differentiation (1)
- Nicolaides-Baraitser syndrome (1)
- Nicotine (1)
- Nimotuzumab (1)
- Nociception (1)
- Nodular lymphocyte predominant Hodgkin lymphoma (1)
- Non-RCT (1)
- Non-alcoholic fatty liver disease (1)
- Non-allergic-rhinitis (1)
- Non-aneurysmal (1)
- Non-clear cell renal cell cancer (1)
- Non-coding RNAs (1)
- Non-falciparum (1)
- Non-invasive brain stimulation (1)
- Non-neuronal cholinergic system (1)
- Non-nucleoside polymerase inhibitors (NNI) (1)
- Non-operative (1)
- Non-perimesencephalic (1)
- Non-responder (1)
- Non-small-cell lung cancer (1)
- Non-steroidal anti-inflammatory drugs (1)
- Non-trauma (1)
- Non-urothelial (1)
- Noncoding RNA (1)
- Noninferiority (1)
- Nonsteroidal anti-inflammatory drugs (1)
- Nonunion (1)
- Non–small-cell lung cancer (1)
- Nordic questionnaire (1)
- Notch (1)
- Novel treatment target (1)
- NoxA1 (1)
- Nucleolus (1)
- Nucleophosmin-1 (1)
- Nucleus pulposus cells (1)
- Numerical simulation (1)
- Nurses (1)
- Nursing (1)
- Nutrition (1)
- Nutrition risk stratification (1)
- Nymphs (1)
- O-GlcNAcylation (1)
- OCT (1)
- OECD performance standards (1)
- OGTT (1)
- ONC201 (1)
- OPRM1 methylation (1)
- OPS (1)
- OR time (1)
- OXA-48 (1)
- Object perception (1)
- Object vision (1)
- Objectives (1)
- Objektivität (1)
- Observational (1)
- Observational studies (1)
- Obstetric care (1)
- Obstetrics (1)
- Obstetrics and gynecology (1)
- Occupational Accidents (1)
- Occupational disease (1)
- Occupational exposure (1)
- Occupational health (1)
- Occupational medicine (1)
- Ocular findings (1)
- Oesophageal cancer (1)
- Oesophagogastric cancer oxaliplatin (1)
- Off-pump surgery (1)
- Offene Versorgung (1)
- Okinawa (1)
- Okinawa diet (1)
- Older adults (1)
- Oldest-old (1)
- Olfactory diagnostics (1)
- Olfactory system (1)
- Omics (1)
- Oncologic surgery (1)
- Oncolytic adenovirus (1)
- Oncolytic virus (1)
- Oncotargets (1)
- One health (1)
- Online-Lehre (1)
- Online-Lernen (1)
- Online-Magazine (1)
- Opacity (1)
- Open abdomen (1)
- Open repair (1)
- Open source concept (1)
- Opioids (1)
- Oposterior urethral valve (1)
- Opportunistic infections (1)
- Oppositional defant disorder (1)
- Oppositional defiant disorder (1)
- Optic nerve atrophy (1)
- Optical coherence tomography angiography (1)
- Optical lenses (1)
- Oral Health Impact Profile (OHIP) (1)
- Oral and maxillofacial trauma (1)
- Oral implantology (1)
- Ordinary least squares (OLS) (1)
- Organ allocation (1)
- Organ motion (1)
- Organ preservation (1)
- Organ rinse (1)
- Organ shortage (1)
- Organ support (1)
- Organoids (1)
- Organs at Risk (1)
- Oroantral communication (1)
- Orphan disease (1)
- Orthodontist (1)
- Oryctolagus cuniculus (1)
- Osimertinib (1)
- Osmosensing (1)
- OspE (1)
- Osteoinduction (1)
- Osteonecrosis (1)
- Osteoporosis diagnosis (1)
- Oswestry Disability Score (1)
- Outcome assessment [MeSH] (1)
- Outcomes research (1)
- Outpatients (1)
- Ovale (1)
- Ovarian carcinoma (1)
- Overall survival (1)
- Oxaliplatin (1)
- Oxidativer Stress (1)
- OxyELITE Pro (1)
- Oxygen (1)
- Oxygen consumption (1)
- Oxygen uptake (1)
- Oxygen-derived free radicals (1)
- P-gp (1)
- P1NP (1)
- P2X7 receptor (1)
- PAH (1)
- PAI-1 (1)
- PAR (1)
- PARK4 (1)
- PARK6 (1)
- PARK7 (1)
- PAX3/FOXO1 (1)
- PBMC (peripheral blood mononuclear cells) (1)
- PBPK simulation (1)
- PBX1 (1)
- PC12 cells (1)
- PC12 neuronal differentiation (1)
- PCP (1)
- PCSK9 protein (1)
- PCV (1)
- PD-1 (1)
- PD-1 inhibitor (1)
- PDCD4 (1)
- PDD - Assessment - Screening (1)
- PDE inhibition (1)
- PDE‐5‐inhibitor (1)
- PDI (1)
- PDK1 (1)
- PEA-15 (1)
- PEGylated PLGA (PLGA-PEG) (1)
- PEI (1)
- PELICAN (1)
- PEM-technology (1)
- PF-06273340 (1)
- PFL (1)
- PGE2 (1)
- PID prevalence (1)
- PIF pocket (1)
- PKA (1)
- PKCε (1)
- PKD (1)
- PKD/IC (1)
- PLK1 (1)
- PLK1 inhibitors (1)
- PLX4032 (1)
- PLX4720 (1)
- PM (1)
- PMF (1)
- PML (1)
- POLG (1)
- PPAR (Peroxisome proliferator-activated receptors) (1)
- PPARγ (1)
- PRG-1 (1)
- PRLTS3 (1)
- PRNT (1)
- PROM (1)
- PROMISE (1)
- PROTAC (1)
- PRRT2 (1)
- PRoMPT (1)
- PSA (1)
- PTCH (1)
- PTCH-1 (1)
- PTDM (1)
- PTEN (1)
- PTK2B (1)
- PUMA (1)
- PV (1)
- PXA (1)
- PYGL (1)
- Pacemaker (1)
- Paediatric Investigation Plan (1)
- Paediatric oncology (1)
- Paediatric research (1)
- Paediatrics (1)
- Pain management (1)
- Pain sensation (1)
- Pancreas transplantation (1)
- Pancreatic islet (1)
- Pancreatic surgery (1)
- Pancreatitis (1)
- Pancreatoduodenectomy (1)
- Panel testing (1)
- Panic disorder (1)
- Par-4 (1)
- Paracetamol (1)
- Parainfluenza (1)
- Paraneoplastic syndrome (1)
- Parapneumonic pleural effusion (1)
- Parent support (1)
- Parenteral nutrition (1)
- Parkinson (1)
- Parkinsonerkrankung (1)
- Parkinsons disease (1)
- Particles (1)
- Particulate matter (1)
- Patellofemoral Joint (1)
- Pathogen reduction (1)
- Pathogenesis (1)
- Pathologic changes (1)
- Pathological complete response (1)
- Pathologists (1)
- Pathology (1)
- Pathology Section (1)
- Patient Blood Management (1)
- Patient Outcome Assessment (1)
- Patient care planning (1)
- Patient education (1)
- Patient information materials (1)
- Patient isolation (1)
- Patient knowledge (1)
- Patient manikins (1)
- Patient preference (1)
- Patient preferences (1)
- Patient reported outcomes (1)
- Patient safety (1)
- Patient satisfaction (1)
- Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (1)
- Patient-centered care (1)
- Patient-reported outcomes (1)
- Pattern recognition receptors (1)
- Pause (1)
- Pdgfrβ (1)
- Pediatric burn injury (1)
- Pediatric neuroimaging (1)
- Pediatric sarcoma (1)
- Pediatrics (1)
- Pediatrics [MeSH] (1)
- Peer Teaching (1)
- Peer teaching (1)
- Peer-feedback (1)
- Peer-teaching (1)
- Peg3 (1)
- Pegylated liposomal doxorubicin (1)
- Penile carcinomas (1)
- Pentaglobin (1)
- Peptides and proteins (1)
- Percutaneous (1)
- Performing Artists (1)
- Pericardial effusion (1)
- Pericarditis (1)
- Perilymph (1)
- Perimesencephalic (1)
- Periodontal disease (1)
- Periodontal diseases (1)
- Periodontal therapy (1)
- Peripheral vascular disease (1)
- Personalised medicine (1)
- Personalisierte translationale Therapie (1)
- Personality (1)
- Personality disorder (1)
- Pessar (1)
- Petri net (1)
- Pfannenstiel (1)
- Pflege (1)
- Pflegeeinrichtungen (1)
- Pgrmc1 (1)
- Phagocytosis (1)
- Phantom study (1)
- Pharm-fMRI (1)
- Pharmaco-nutrition (1)
- Pharmacodynamic (1)
- Pharmacological treatment (1)
- Pharmacology (1)
- Pharmacometrics (1)
- Pharmacy setting (1)
- Pharmakoepidemiologie (1)
- Pharyngeal reflex (1)
- Phase 2 (1)
- Phase I trials (1)
- Phase II trial (1)
- Phase rotors (1)
- Phase-IV research (1)
- Philadelphia Chromosome (1)
- Philadelphia Chromosome-positive leukemia (1)
- Phospho-soda (1)
- Phospho-tau (1)
- Phospholipids (1)
- Physical activity (1)
- Physical environment (1)
- Physical fitness (1)
- Physical therapist (1)
- Physician report (1)
- Physician-assisted suicide (1)
- Phytochemicals (1)
- Piercing (1)
- Pierre Robin sequence (1)
- Pill Count (1)
- PillCamColon2 (1)
- Pilocytic astrocytoma (1)
- Pim-1 (1)
- Pink esthetic score (1)
- Placental growth factor (1)
- Planning target volume (1)
- Plasma (1)
- Plasma fibronectin (1)
- Plasma transfusion (1)
- Plasma usage (1)
- Plasmacytoid dendritic cell (1)
- Plasminogen (1)
- Plastic endoprosthesis (1)
- Platelet (1)
- Platelet dysfunction (1)
- Platelet lysate (1)
- Platelet releasate (1)
- Platzierung (1)
- Plectin (1)
- Pleural empyema (1)
- Plk1 (1)
- Plus-end (1)
- Pneumococcal conjugate vaccine (1)
- Pneumocystis jirovecii (1)
- Polarity index (1)
- Police (1)
- Poliomyelitis (1)
- Polo-like kinase 3 (1)
- PolySUMOylation (1)
- Polyhexanide (1)
- Polymerase Chain Reaction (PCR) (1)
- Polyphenole (1)
- Polyps (1)
- Polysomnography (1)
- Polyzystisches Ovarsyndrom (1)
- Política de Saúde (1)
- Pooling (1)
- Poor solubility (1)
- Population-based screening (1)
- Porin regulation (1)
- Portal (1)
- Portugal (1)
- Posaconazole serum level (1)
- Position paper (1)
- Positron-emission tomography (1)
- Post surgery pain (1)
- Post treatment (1)
- Post-transplant (1)
- Posterior Cerebral (1)
- Postoperative infections (1)
- Postoperative nutritional management (1)
- Posttranslational modification (1)
- Posttraumatic stress disorder (1)
- Posttraumatische Belastungsstörung (1)
- Posture (1)
- Posture analysis (1)
- Potassium channel Kir2.1 (1)
- Poverty (1)
- Practical training (1)
- Practice (1)
- Practice-based research network (1)
- Praktikum (1)
- Praktische Fertigkeiten (1)
- Pre-economic effects (1)
- Pre-emptive immunotherapy (1)
- Pre-treatment drug resistance mutations (1)
- PreS1 deletion (1)
- Precision (1)
- Precision oncology (1)
- Preclinical (1)
- Preclinical drug development (1)
- Preclinical research (1)
- Precompetitive development (1)
- Predictive medicine (1)
- Predominant polarity (1)
- Preeclampsia (1)
- Prenatal ultrasonographic detection rate (1)
- Preoperative diagnostics (1)
- Preoperative radiochemotherapy (1)
- Prepontine (1)
- Pressure pain (1)
- Presynaptic vesicles (1)
- Preterm birth (1)
- Preventive medicine (1)
- Pre‐Ligand Assembly Domain (PLAD) (1)
- Primary Care Health Centre (1)
- Primary breast lymphoma (1)
- Primary cilium (1)
- Primary health care (1)
- Primary health care [MeSH] (1)
- Primary prophylaxis (1)
- Primary sclerosing cholangitis (1)
- Primärversorgung (1)
- Prisoners (1)
- Prisons (1)
- Probability density (1)
- Probability distribution (1)
- Produkte zur Desinfektion (1)
- Professions (1)
- Profiling Transthiolation Activity (1)
- Profilometry (1)
- Progesteron (1)
- Progesterone (1)
- Prognostic biomarker (1)
- Programming languages (1)
- Prospective randomized Analysis (1)
- Prostaglandin (1)
- Prostate Cancer (1)
- Prostate cancer cell lines (1)
- Prostate-specific membrane antigen (1)
- Prosthetic rehabilitation (1)
- Protease activity (1)
- Proteasomes (1)
- Protective factors (1)
- Protein Kinase Inhibitors (1)
- Protein Structure (1)
- Protein Translocation (1)
- Protein aggregates (1)
- Protein complex (1)
- Protein degradation (1)
- Protein domains (1)
- Protein kinase (1)
- Protein purify derivative (1)
- Protein tyrosine modification (1)
- Protein-Kinasen (1)
- Protein-Protein Interactions (1)
- Proteinkinase (1)
- Proteins (1)
- Proteostasis (1)
- Protestantism (1)
- Prothrombin complex concentrate (1)
- Protokoll-Compliance (1)
- Prototypes (1)
- Proximal humeral fracture (1)
- Präanalytik (1)
- Prädiktive Validität (1)
- Prävalenz (1)
- Prüfung (1)
- Prüfungen (1)
- Prüfungserfolg (1)
- Prüfungsfragen (1)
- Pseudo HE-images (1)
- Psoriasis (1)
- Psoriasis vulgaris (1)
- Psycho-oncology (1)
- Psychodynamic psychotherapy (1)
- Psychological stress (1)
- Psychometric evaluation (1)
- Psychometrics (1)
- Psychopathology (1)
- Psychophysiologie (1)
- Psychosocial (1)
- Public and occupational health (1)
- Publication (1)
- Publication output (1)
- Pulmonary artery pressure (1)
- Pulmonary disease, chronic obstructive (1)
- Pulmonary embolism (1)
- Pulmonary failure (1)
- Pulse contour analysis (1)
- Pulse pressure variation (1)
- Pulsed SILAC (1)
- Pupillometry (1)
- Pustulosis (1)
- Pyruvate (1)
- Pädiatrische Brandverletzung (1)
- QA/QC (1)
- QOL (1)
- Qb-Test (1)
- QbTest® (1)
- Qualitative research (1)
- Qualitative research [MeSH] (1)
- Quality indicators (1)
- Quality management (1)
- Quality of Teaching and Learning (1)
- Quality of health care [MeSH] (1)
- Quality, performance, safety and outcomes (1)
- Qualität (1)
- Qualitätsmanagement (1)
- Qualitätssicherung (1)
- Qualitätssicherung der Lehre (1)
- Quantitative research (1)
- Quantitative sensory testing (1)
- Quantitative trait (1)
- Quantitative trait loci (1)
- Questionnaire (1)
- Questionnaire - Psychometrics - Diagnostics (1)
- Quinine (1)
- Quinolinate phosphoribosyltransferase (1)
- Quinolinic acid (1)
- R (1)
- R programming language (1)
- R software (1)
- RAD001 (1)
- RBC (1)
- RBC-depletion (1)
- RBFOX1 (1)
- RCT (1)
- RD cells (1)
- RDoC (1)
- REM sleep (1)
- REMS (1)
- RH30 cells (1)
- RIP1 (1)
- RMS (1)
- RNA Biology (1)
- RNA extraction (1)
- RNA polymerase (1)
- RNA polymerase inhibitors (1)
- RNA processing (1)
- RNA processing machinery (1)
- RNA therapeutics (1)
- RNA therapy (1)
- RNA viruses (1)
- RNA, long noncoding (1)
- RNA-Interferenz (1)
- RNA-sequencing (1)
- RNA-templated DNA repair (1)
- RNActive (1)
- RNAi (1)
- RNAi and CRISPR screens (1)
- RNAseq analysis (1)
- RNF4 (1)
- ROS generation (1)
- ROS/RNS (1)
- ROS1 (1)
- RPE65 (1)
- RT-qPCR (1)
- RTS (1)
- RUFY (1)
- RULA (1)
- RUNX1/ETO (1)
- Rab proteins (1)
- Rab7 (1)
- Rac1 (1)
- Radial artery (1)
- Radiation exposure (1)
- Radiation induced diarrhoea (1)
- Radical cystectomy (1)
- Radical nephrectomy (1)
- Radiochemotherapy (1)
- Radiofrequency (1)
- Radiology and imaging (1)
- Radiyal arter (1)
- Rahmenbedingungen der Lehre (1)
- Rainfall (1)
- Raman spectroscopy (1)
- Ramón y Cajal (1)
- Random forest (1)
- Randomised controlled trial (1)
- Randomised trial (1)
- Randomized (1)
- Randomized controlled trials (1)
- Randomized trial (1)
- RapL (1)
- Rapamycin (1)
- Rapid diagnostic test (1)
- Rapid eye movement sleep behavior disorder (1)
- Rare Diseases (1)
- Rare disease (1)
- Ratewahrscheinlichkeit (1)
- Rational use (1)
- Re-exploration (1)
- Re-exposure (1)
- Re-injury (1)
- Readmission (1)
- Real-time phase contrast (1)
- Real-world data (1)
- Real-world evidence (1)
- RealTime (1)
- Rearing temperature (1)
- Recall rate (1)
- Receptor physiology (1)
- Reconstructed human epidermis (1)
- Reconstruction (1)
- Reconstructive surgical procedures (1)
- Recurrence (1)
- Recurrence rate (1)
- Red blood cells (1)
- Red yeast rice (1)
- Redox (1)
- Redox modification (1)
- Redox-sensitive GFP (1)
- Reference (1)
- Refractory ALL (1)
- Regenerative medicine (1)
- Regulatory T cells (1)
- Regulatory framework (1)
- Regulatory networks (1)
- Rehabilitation (1)
- Rehospitalization (1)
- Reintervention (1)
- Reisefieber (1)
- Rejection (1)
- Rekonstruktive chirurgische Verfahren (1)
- Relapsed ALL (1)
- Relaxometry (1)
- Release of mtDNA and mtRNA (1)
- Remission (1)
- Remote ischemic conditioning (1)
- Remote monitoring (1)
- Renal cancer (1)
- Renal function (1)
- Renal lesions (1)
- Renal replacement therapy (1)
- Repatriation of corpses (1)
- Reperfusion (1)
- Replication study (1)
- Repositioning drugs (1)
- Reproducibility (1)
- Reproduktionsmedizin (1)
- Research Article (1)
- Research trends (1)
- Reservoir function (1)
- Residential care (1)
- Residential facilities (1)
- Resin composites (1)
- Resource competition (1)
- Respimat® Soft Mist™ Inhaler (1)
- Respiratory Syncytial Virus (1)
- Respiratory infections (1)
- Respiratory signs and symptoms (1)
- Respiratory syncytial virus (1)
- Respiratory tract diseases (1)
- Response (1)
- Response criteria (1)
- Ressourcen (1)
- Restenosis (1)
- Resting state (1)
- Resting-state (1)
- Restricted posture (1)
- Resuscitation (1)
- Reticulon (1)
- Retina (1)
- Retinal degeneration (1)
- Retro-IDEAL (1)
- Retrospective studies (1)
- Return to play (1)
- Return to sports (1)
- Reverse transcription polymerase chain reaction (1)
- Review (1)
- Rezidivrate (1)
- Rheumatology (1)
- Rho GTPases (1)
- Rho/Rho-kinase (1)
- RhoA (1)
- RhoGTPases (1)
- Ribosomal S6 phosphorylation (1)
- Ribosomal translation (1)
- Ribosomes (1)
- Right hemisphere (1)
- Risk assessment (1)
- Risk factor (1)
- Risk factors (1)
- Risk prediction (1)
- Risk reduction (1)
- Risk stratification (1)
- Rivaroxaban (1)
- Robotic Radiosurgery (1)
- Robotic tracking (1)
- Roe deer (1)
- Rolandic Spikes (1)
- Roma women (1)
- Rora (1)
- Roughness (1)
- Round window membrane (1)
- Routinedaten (1)
- Roux-en-Y gastric bypass (1)
- Rtn3 (1)
- Ruijs-Aalfs syndrome (1)
- Rural area (1)
- Rush (1)
- Rush protocol (1)
- Rush-SIT (1)
- Ruxolitinib (1)
- Ryanodine (1)
- S. cerevisiae (1)
- S100 calcium‑binding protein B (1)
- S100b (1)
- S1P lyase (1)
- S1P1 receptor (1)
- S1P1–5 (1)
- S1PR1 (1)
- S1PR4 (1)
- SAGE (1)
- SAH close (1)
- SAMHD1 (1)
- SAMHD1 knockout mouse (1)
- SAMHD1 phosphorylation (1)
- SAP (1)
- SARS coronavirus (1)
- SARS-CoV (1)
- SAVI (1)
- SCA34 (1)
- SCA38 (1)
- SCCHN (1)
- SCMR (1)
- SCT (1)
- SDF-1 (1)
- SDH (1)
- SDS (1)
- SENP (1)
- SENP6 (1)
- SERS (1)
- SF-36 (1)
- SHH (1)
- SIADH (1)
- SILAC (1)
- SIRT1 (1)
- SKI II (1)
- SLC20A1 (1)
- SLP-76 (1)
- SMAD (1)
- SMAD signaling (1)
- SNP (1)
- SOCS (1)
- SOD (1)
- SOFA (1)
- SPARTAN (1)
- SPRTN (1)
- SPSS (1)
- SR protein (1)
- SR-BI (1)
- SRSF3 (1)
- SRSF7 (1)
- ST2L (1)
- STAMPE2 (1)
- STAT1 (1)
- STAT5 (1)
- STDP (1)
- STIR (1)
- SUMO (1)
- SUMO chains (1)
- SUMO1-3 (1)
- SUMOylation (1)
- SUN1 (1)
- SUN2 (1)
- SUV (1)
- SVR (1)
- SW480 Cell (1)
- SW480 cells (1)
- SWATH (1)
- Saccades (1)
- Saccadometry (1)
- Safety equipment (1)
- Safety learning (1)
- Salivary gland diseases (1)
- Salmonella choleraesuis (1)
- Salmonella infection (1)
- Salt inducible kinase 2 (SIK2) (1)
- Salvage therapy (1)
- Sarcomas (1)
- Sarcopenia (1)
- Sarkoidose (1)
- Sauerstoffpartialdruck (1)
- Scedosporium spp. (1)
- Scheimpflug imaging (1)
- School support (1)
- Science structure (1)
- Scientifi c competence (1)
- Scientific community (1)
- Scientific publishing (1)
- Scientometria (1)
- Scientometric analysis (1)
- Scientometrics (1)
- Scientometry (1)
- Sclerostin (1)
- Screening guidelines (1)
- Seattle heart failure model (1)
- Second stage of labor (1)
- Second-line treatment (1)
- Secondary injury cascades (1)
- Secondary prevention (1)
- Secretion (1)
- Seizure (1)
- Seizures (1)
- Selection bias (1)
- Selective autophagy (1)
- Selenium (1)
- Selenium administration in gynecologic radiation oncology (1)
- Selenoproteins (1)
- Self-assessment (1)
- Self-efficacy (1)
- Self-expandable metal stent (SEMS) (1)
- Self-expandable metal stents (1)
- Self-expandable metal stents complications (1)
- Self-management support (1)
- Self-myofascial release (1)
- Self-renewal (1)
- Self-report (1)
- Seltene Erkrankungen (1)
- Semicontinuous (1)
- Semitendinosus tendon autograft (1)
- Sensitivity (1)
- Sensorimotor processing (1)
- Sensorimotor training (1)
- Sensory Neuroscience (1)
- Sensory neuron (1)
- Sensory perception (1)
- Sensory systems (1)
- Sepsis-bundle (1)
- Septic shock (1)
- Sequence (1)
- Sequence alignment (1)
- Sequence motif analysis (1)
- Sequential (1)
- Seribantumab (1)
- Serine proteases (1)
- Seroconverter (1)
- Seroepidemiology (1)
- Seroprevalence (1)
- Serotype 3 (1)
- Serum (1)
- Serum Susceptibility (1)
- Severe Acute Respiratory Syndrome (1)
- Severe bacterial infection (1)
- Severe blood loss (1)
- Severe malaria (1)
- Severity of illness index (1)
- Sex (1)
- Sexual Dysfunctions (1)
- Sexual child abuse (1)
- Sexual violence (1)
- Sexualmedizin (1)
- Sexuelle Dysfunktionen (1)
- Sexuelle Gewalt (1)
- Sexuelle Revolution (1)
- Sexueller Kindesmissbrauch (1)
- Shannon index (1)
- Sharpin (1)
- Sholl analysis (1)
- Shone’s complex (1)
- Short bowel syndrome (1)
- Shoulder joint (1)
- Shunt (1)
- Sickle Cell Disease (1)
- Signal Transduction (1)
- Signal transduction (1)
- Signaling ROS (1)
- Signaling pathway (1)
- Silicosis (1)
- Silver in situ hybridization (1)
- Simulation and modeling (1)
- Simulation komplexer Systeme (1)
- Simulation training (1)
- Simultaneous (1)
- Single-Molecule Localization Microscopy (SMLM) (1)
- Single-cell RNA-seq (1)
- Single-cell RNA-sequencing (1)
- Sistemas de Saúde (1)
- Skeletal muscle (1)
- Skills training (1)
- Skin fibroblast (1)
- Skin irritation test (1)
- Skin manifestation (1)
- Skin morphology (1)
- Skp (1)
- Slc11a2 (1)
- Slc25a37 (1)
- Sleep deprivation (1)
- Smac mimetic (1)
- Small bowel (1)
- Small bowel atresia (1)
- Small bowel endoscopy (1)
- Small molecules (1)
- Small- and medium-sized enterprises (1)
- Small-cell lung cancer (1)
- Smart nebulizer (1)
- Smoking habits (1)
- Smooth muscle (1)
- Smooth muscle cell (1)
- Snakebite (1)
- Social Media (1)
- Social communication (1)
- Social epidemiology (1)
- Social health determinants (1)
- Social information processing (1)
- Social phobia (1)
- Social research (1)
- Social sciences (1)
- Social skills training (1)
- Social support (1)
- Socio-economic analysis (1)
- Soft skills (1)
- Soft tissue infection (1)
- Soft-tissue sarcoma (1)
- Software tool (1)
- Software tools (1)
- Solidworks 2015 (1)
- SoloSTAR (1)
- Somatization (1)
- Sonication (1)
- Source reconstruction (1)
- Sozialpsychiatrischer Dienst (1)
- Spa water (1)
- Spanish National Health System (1)
- Species identification (1)
- Speciesidentification (1)
- Specimen preparation and treatment (1)
- Spectral library (1)
- Spectraldomain OCTA (1)
- Spectrin (1)
- Speech (1)
- Speech signal processing (1)
- Sphere Formation Assay (1)
- Sphingolipid (1)
- Sphingosine 1-phosphate (1)
- Sphingosine-1-phosphate (1)
- Spinal cord (1)
- Spine Register (1)
- Spine density (1)
- Spinocerebellar ataxia (1)
- Spirochetes (1)
- Splanchnic Hemodynamics (1)
- Spleen (1)
- Splenic dendritic cell (1)
- Splice variants (1)
- Spondyloarthritis (1)
- Spondylolisthesis (1)
- Spontaneous bacterial peritonitis (1)
- Sports (1)
- Spot sign (1)
- Squamous cell carcinoma (1)
- StUbL (1)
- Staatsexamen (1)
- Standard risk (1)
- Standardized operating procedures (1)
- Standards of care (1)
- Standardverfahren (1)
- Staphylococcus aureus (1)
- Starvation (1)
- Statistical methods (1)
- Status epilepticus (1)
- Stavudine (1)
- Steatosis (1)
- Stenosis (1)
- Stenotrophomonas maltophilia (1)
- Stentoplasty (1)
- Sterblichkeit (1)
- Stereotactic radiosurgery (1)
- Steroid (1)
- Stilbene (1)
- Stimulation experiments (1)
- Stimulus-secretion coupling (1)
- Stoma (1)
- Stress (1)
- Stress and resilience (1)
- Stress resilience (1)
- Striatum (1)
- Stringed bow player (1)
- Stroke prevention (1)
- Stroke volume variation (1)
- Stromal cell (1)
- Structural MRI (1)
- Structural genomics (1)
- Structured reporting (1)
- Strukturwandel der Sexualität (1)
- Students (1)
- Studiendauer (1)
- Studium mit Kind (1)
- Störfaktoren (1)
- Sub-segmentation (1)
- Subacute cerebellar degeneration (1)
- Subarachnoid Hemorrhage (1)
- Subcutaneous (1)
- Subgroup identification (1)
- Subpopulation (1)
- Substances for disinfection (1)
- Subterranean (1)
- Sudden cardiac death (1)
- Suicidal behavior (1)
- Suicidal ideation (1)
- Suicidal thoughts (1)
- Sulfasalazine (1)
- Sulfhydryl-reactivity (1)
- Sulfur metabolism (1)
- Sumatra (1)
- Superimposition (1)
- Superinfection (1)
- Supplemental parenteral nutrition (1)
- Supplementation (1)
- Supraspinatus tendon (1)
- Supraventricular arrhythmias (1)
- Surface (1)
- Surgical ICU (1)
- Surgical risk (1)
- Surgical site occurrence (1)
- Surveillance (1)
- Surveys (1)
- Survival data (1)
- Sustainable Development (1)
- Sustained virological response (SVR) (1)
- Sweat osmolality (1)
- Sweat secretion rate (1)
- Swept-source OCTA (1)
- Switzerland (1)
- Sycamore (1)
- Syllables (1)
- Sympathicolysis (1)
- Symptome (1)
- Symptoms (1)
- Synapses (1)
- Synaptic dysfunction (1)
- Synaptopodin (1)
- Syncope (1)
- Syndrome des ovaires polykystiques (1)
- Synovial inflammation (1)
- Synovial sarcoma (1)
- Synthetic (1)
- Systematic review (1)
- Systemic inflammatory response (1)
- Systemic lupus erythematosus (1)
- Systemic treatment (1)
- Systems biology (1)
- Systems medicine (1)
- T Cells (1)
- T cell receptors (1)
- T cell/histiocyte rich large B cell lymphoma (1)
- T helper 17 cells (1)
- T-ALL (1)
- T-DM1 (1)
- T-cell homeostasis (1)
- T-cell homing (1)
- T-cell niche (1)
- T-cell receptor (1)
- T-cell targeting (1)
- T-cells (1)
- T-lymphocytes (1)
- T-tubule system (1)
- T1 (1)
- T1 and T2 mapping (1)
- T1 mapping (1)
- T84 colon carcinoma cells (1)
- TACE (1)
- TALE-homdomain protein (1)
- TAPSE (1)
- TAVI (1)
- TAVR (1)
- TAX1BP1 (1)
- TBK1 (1)
- TC stenosis (1)
- TCR signaling cascade (1)
- TEER (1)
- TEM (1)
- TEVAR (1)
- TG-186 (1)
- TG-43 (1)
- TGF-beta (1)
- TGF-β (1)
- TGF-β1 (1)
- THV (1)
- TIA-1 (1)
- TIC10 (1)
- TILs (1)
- TIM23 (1)
- TIMP2 (1)
- TL AOSIS (1)
- TLR (1)
- TLR2/6 (1)
- TLR7 (1)
- TLR8 (1)
- TMC435 (1)
- TMEM126B (1)
- TMS (1)
- TMS-EEG (1)
- TMT (1)
- TNF (1)
- TNF inhibitors (1)
- TNF-α (1)
- TNFR1 (1)
- TOR inhibitor (1)
- TOR1A (1)
- TP53 (1)
- TP53 mutation status (1)
- TP53-induced glycolysis and apoptosis regulator (1)
- TPR (1)
- TRAPP (1)
- TRIM25 (1)
- TRPA1 (1)
- TSC (1)
- TSC-associated neuropsychiatric disorders (1)
- TSC22D3 (1)
- TVT (1)
- TWINKLE (1)
- Tabakkonsum (1)
- Tagging (1)
- Tailored medicine (1)
- Tailored therapy (1)
- Tamponade (1)
- Targeted therapies (1)
- Targeted tumor therapy (1)
- Tas2r126 (1)
- Tas2r135 (1)
- Tas2r143 (1)
- Tattoo (1)
- Tau (1)
- Tau acetylation (1)
- Tax effect (1)
- Taxane (1)
- Taxonomy (1)
- Tea (1)
- Teaching and Learning conditions (1)
- Technicians (1)
- Technique (1)
- Telemedicine (1)
- Telomere length (1)
- Telomeres (1)
- Temozolomide (1)
- Temporal lobe epilepsy (1)
- Temsirolimus (1)
- Tendon incontinence repair (1)
- Tendon transplantation (1)
- Term birth (1)
- Testosterone (1)
- Tet-inducible system (1)
- Texture analysis (1)
- Tfrc (1)
- Tgfβ (1)
- Th1 polarization (1)
- Theft (1)
- Theorie der Sexualität (1)
- Therapeutics (1)
- Therapy response (1)
- Thermal injury (1)
- Thermal spring water (1)
- Thermische Verletzung (1)
- Thermodilution (1)
- Thermoplasma (1)
- Thiol redox modification (1)
- Three-dimensional back scan (1)
- Three-dimensional echocardiography (1)
- Thrombosis/hypercoagulable states (1)
- Thrombotic microangiopathy (1)
- Thrombotic thrombocytopenic purpura (1)
- Thromboxane (1)
- Thymocytes (1)
- Thymus (1)
- Thyroid (1)
- Thyroid disease (1)
- Tick (1)
- Tick-Borne diseases (1)
- Tick-borne encephalitis (1)
- Ticks (1)
- Time in therapeutic range (TTR) (1)
- Time optimization (1)
- Time series (1)
- Time to treatment failure (1)
- Timing (1)
- Tinnitus (1)
- Tissue microarray (TMA) (1)
- Tissue stiffness (1)
- Toll-like receptor (TLR) 6 (1)
- Toll-like receptors (1)
- Tomography (1)
- Tonsil (1)
- Tools and ressources (1)
- Tooth transplantation (1)
- Topoisomerase (1)
- Total colonoscopy (1)
- Total hip replacement (1)
- Total operating room time (1)
- Toxicology (1)
- Tozasertib (1)
- Tracheal Intubation (1)
- Tranexamic acid (1)
- Transcatheter Aortic Valve Implantation (1)
- Transcatheter based aortic valve implantation (1)
- Transcription (1)
- Transcriptional control (1)
- Transcriptome (1)
- Transcriptome analysis (1)
- Transcriptome microarray (1)
- Transduction (1)
- Transesophageal echocardiography (1)
- Transfer model (1)
- Transferases (1)
- Transformation (1)
- Transgender (1)
- Transgenic SK-2 mice (1)
- Transient (1)
- Transient elastography (1)
- Transient ischemic attack (1)
- Transition invariant (1)
- Transitional cell carcinoma (1)
- Translation initiation (1)
- Translational (1)
- Transmembrane communication (1)
- Transplantation (1)
- Transportation (1)
- Trastuzumab (1)
- Trauma surgery (1)
- Traumatic brain injury (1)
- Travellers (1)
- Treatment modification (1)
- Treatment protocol (1)
- Trees (1)
- Treg cell (1)
- Triamcinolone acetonide (1)
- Trichuris suis ova (1)
- Triple negative (1)
- Triple therapy (1)
- Triple-negative breast cancer (1)
- Trk (1)
- TrkC (1)
- Tropenmedizin (1)
- Troponin (1)
- Trousseau’s syndrome (1)
- Trueness (1)
- Tubers (1)
- Tularemia (1)
- Tumor growth (1)
- Tumor heterogeneity (1)
- Tumor infiltrating lymphocytes (1)
- Tumor interstitial fluid pressure (1)
- Tumor obstruction (1)
- Tumor suppressor protein (1)
- Tumor volume (1)
- Tumormarker (1)
- Tumorsphere Formation (1)
- Tumour biomarkers (1)
- Tumour immunology (1)
- Turkish (1)
- Tween20 (1)
- Twist (1)
- Two-hit hypothesis (1)
- Type 2 Diabetes mellitus (1)
- Type 2 diabetes (1)
- Tyrosine kinase inhibitor (1)
- Tyrosine kinase inhibitor mTOR inhibition (1)
- Tyrosine kinases (1)
- U-87MG (1)
- UDP-glucose ceramide glycosyltransferase (1)
- UGCG (1)
- ULBP4 (1)
- UPPS (1)
- USP9X (1)
- UVA (1)
- UWB diagnostics (1)
- Ubiquitin (1)
- Ubiquitin Ligase (1)
- Ubiquitin kinase PINK1 (1)
- Ubiquitylation (1)
- Ultra microscopy (1)
- Ultra-rush protocol (1)
- Ultrasonic nebulizer (1)
- Ultrasound imaging (1)
- Umbilical cord (1)
- Underfeeding (1)
- Undergraduate medical education (1)
- Undergraduate training (1)
- Undergraduates (1)
- Unilateral hip osteoarthritis (1)
- United States (1)
- União Européia (1)
- Unterdruckwundtherapie (1)
- Upper body posture (1)
- Upper respiratory tract infection (1)
- Urban (1)
- Ureter (1)
- Urethral cancer (1)
- Urothelial cancer (1)
- Urothelial carcinoma (1)
- Urothelial cells (1)
- Urticaria (1)
- Usutu virus (1)
- Uveal melanoma (1)
- V4 (1)
- VARGADO (1)
- VASP (1)
- VBM (1)
- VE-cadherin (1)
- VEGF receptors (1)
- VEGFA (1)
- VEGFR (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- VHH (1)
- VIP (1)
- VIP1 (1)
- VIS (1)
- VISTA (1)
- VLA4 (1)
- VPA-analogues (1)
- VPAC1 (1)
- VRE (1)
- VX680 (1)
- Vaccination breakthrough (1)
- Vaccine (1)
- Vaccine breakthrough (1)
- Vacuoles (1)
- Vaginal breech delivery (1)
- Vaginal delivery (1)
- Validierungsstudie (1)
- Validity (1)
- Value-added effect (1)
- Variant histology (1)
- Vascular biology (1)
- Vascular emergencies (1)
- Vascular endothelial growth factor A (1)
- Vascular endothelial growth factor receptor 2 (1)
- Vascular permeability (1)
- Vasculogenesis (1)
- Vector mosquito (1)
- Vector-borne infections (1)
- Vein (1)
- Veino-lymphatic separation (1)
- Vemurafenib (1)
- Venetoclax (1)
- VeroE6‐eGFP cells (1)
- Versorgungsforschung (1)
- Versorgungsstrukturen (1)
- Vertebral augmentation (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Vertigo (1)
- Veränderungsmanagement (1)
- Vespid venom allergy (1)
- Victimization (1)
- Video-oculography (1)
- Videolaryngoscopy (1)
- Vincristine (1)
- VirB (1)
- Viral Load (1)
- Viral core (1)
- Viral infection (1)
- Viral replication (1)
- Virchow-Robin Spaces (1)
- Virological Failure (1)
- Virological Response (1)
- Virological failure (1)
- Virotherapy (1)
- Virtual implant planning (1)
- Visual impairments (1)
- Visual quality (1)
- Visual system (1)
- Vitamin (1)
- Vitamin K antagonists (1)
- Vitreous opacity (1)
- Vitreous samples (1)
- Voltage attenuation (1)
- Volume overload (1)
- Volumetric analysis (1)
- Volumetric indexes (1)
- Voriconazole (1)
- Vorkenntnisse (1)
- Vorklinik (1)
- Voxel-based morphometry (1)
- WNT (1)
- WRNIP1 (1)
- WT1 (1)
- WYE-354 (1)
- Wait and see (1)
- Wakefulness (1)
- Water chemistry (1)
- Weak bases (1)
- Wearable cardioverter‐defibrillator (1)
- Web 2.0 (1)
- Weight loss (1)
- West Nile fever (1)
- West Nile neuroinvasive disease (1)
- West Nile virus (1)
- Westphal-Paradigm (1)
- White blood cells (1)
- Whole genome association (1)
- Willensfreiheit (1)
- Wilms tumor (1)
- Wing morphometry (1)
- Wnt (1)
- WoMo score (1)
- Women in medicine (1)
- Women in science (1)
- Work shadowing (1)
- Workplace (1)
- Workplace ergonomics (1)
- Wound healing potential (1)
- X-ray Crystallography (1)
- X-ray crystallography (1)
- XL probe (1)
- Xenorhabdus (1)
- YB-1 (1)
- YK-4-279 (1)
- YM155 (1)
- YWHAE (1)
- YWHAZ (1)
- Yarrowia lipolytica (1)
- Yarrowia lipolytica mitochondrial genome complex I NADH: ubiquinoneoxidoreductase (1)
- Yellow fluorescent protein (1)
- Zebrafish (1)
- Zellbiologie (1)
- Zellulärer Transport (1)
- Zervixverkürzung (1)
- Zika (1)
- Zika fever (1)
- Zika vaccine (1)
- Zirconia (1)
- Zoopotentation (1)
- Zooprophylaxis (1)
- Zulassung zum Medizinstudium (1)
- Zulassungskriterien (1)
- Zwangseinweisungen (1)
- a disintegrin and metalloprotease 10 (ADAM10) (1)
- abdominal imaging (1)
- abemaciclib (1)
- ablation (1)
- ablation techniques (1)
- abnormal tumor vasculature (1)
- abuso (1)
- academic (1)
- academic medicine (1)
- acceptable change limit (1)
- accident (1)
- accidental falls [MeSH] (1)
- accidents (1)
- acetylation (1)
- acetylcholine binding protein (1)
- acetylcholine receptors (1)
- acetylcholinesterase (1)
- acetylcholinesterase (AChE) inhibition (1)
- acetylcholinesterase inhibition (1)
- acid dentine lysate (1)
- acid sphingomyelinase (ASMase; Smpd1) (1)
- acneiform skin toxicity (1)
- acoustic radiation force impulse imaging (1)
- acquired drug resistance (1)
- actin cytoskeleton (1)
- actin dynamics (1)
- action sounds (1)
- action-effect association (1)
- activation receptors (1)
- active/deactive transition (1)
- activities of daily life (1)
- activity-based benefits (1)
- actography (1)
- acupuncture (1)
- acute and chronic graft versus host disease (a/c GVHD) (1)
- acute attacks (1)
- acute cholecystitis (1)
- acute chronic inflammation (1)
- acute coronary syndromes (1)
- acute decompensation of cirrhosis (1)
- acute exacerbations of COPD (1)
- acute inflammation (1)
- acute leukemia (1)
- acute liver failure (1)
- acute liver injury (1)
- acute lung injury (ALI) (1)
- acute lymphatic leukemia (1)
- acute lymphoblastic leukaemia (1)
- acute myeloid leukemia (AML) (1)
- acute respiratory distress syndrome (1)
- acute-on-chronic liver failure (ACLF) (1)
- acute‐on‐chronic liver failure (1)
- adaptation plan (1)
- adaptive cardiac remodelling (1)
- adaptive immune escape (1)
- adaptive immunity (1)
- adeno-associated virus (1)
- adenocarcinoma (1)
- adenomatous polyposis (1)
- adenosine receptors (1)
- adeno‐associated virus (1)
- adipocytes (1)
- adiponectin (1)
- adipose tissue (1)
- adipose tissue-derived stem cell (1)
- adipose-derived stem cells (1)
- adipose-derived stem cells (ASCs) (1)
- adiposity (1)
- adjustment disorder (1)
- adjuvant chemotherapy (1)
- adjuvant radiotherapy (1)
- admission criteria (1)
- adolescence (1)
- adolescentes (1)
- adolescents’ health (1)
- adoptive cell therapy (1)
- adoptive immunotherapy (1)
- adrenal insuffciency (1)
- adrenoceptors (1)
- adult and elderly patients (1)
- adult attention deficit/hyperactivity disorder (adult ADHD) (1)
- adult congenital heart disease (1)
- adult neurogenesis (1)
- advance directive (1)
- advanced breast cancer (1)
- advanced glycation end products (1)
- adverse effects (1)
- adverse events (1)
- aerobic exercise (1)
- aerodynamics (1)
- aerosol (1)
- aesthetics (1)
- affective disorder (1)
- affective disorders (1)
- affinity purification (1)
- affordance (1)
- aftercare structures (1)
- aged [MesH] (1)
- aggressiveness (1)
- agonists (1)
- air pollution (1)
- air pouch (1)
- airborne bacteria (1)
- airway (1)
- airway remodeling (1)
- alcohol dehydrogenase (ADH) (1)
- alcohol metabolism (1)
- alcohol use disorder (1)
- alcoholic liver disease (1)
- alcoholic liver injury (1)
- aliphatic halogenated hydrocarbons (1)
- alkaloid (1)
- all-ceramic (1)
- alleles (1)
- allergen immunotherapy (1)
- allergic rhinitis (1)
- allergy (1)
- alloHSCT (1)
- allocation (1)
- allogeneic (1)
- allogeneic hematopoietic stem cell transplantation (1)
- allogeneic hematopoietic stem cell transplantation (aHSCT) (1)
- allogeneic transplantation (1)
- allosteric inhibition (1)
- allosteric regulation (1)
- alpha band (1)
- alpha peak (1)
- alpha-synuclein (1)
- alpharetroviral vector (1)
- alpinia zerumbet (1)
- alternative 3′ end processing (1)
- alternative oxidase (1)
- alveolar macrophages (1)
- alzheimer disease (1)
- ambiguity (1)
- amblyopia (1)
- ameloblastoma (1)
- amino acid PET (1)
- amino acids (1)
- amlexanox (1)
- amoeboid (1)
- amoxicillin/metronidazole (1)
- amphiregulin (1)
- amygdala (1)
- amyloid beta-peptides (1)
- amyotrophic lateral sclerosis (ALS) (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- anal carcinoma (1)
- analgesia based sedation (1)
- anaphylactic reactions (1)
- anaplastic large cell lymphoma (1)
- anastomotic leakage (1)
- anatomy (1)
- anatomy and histology (1)
- anemia (1)
- anesthesiology (1)
- angio-immunogenic switch (1)
- angiography (1)
- angioplasty (1)
- angiopoietin-2 (1)
- angiopoietin-like 3 (ANGPTL3) (1)
- angiopoietins (1)
- angiostasis (1)
- animal host (1)
- animal model (1)
- anisotropy (1)
- annual bleeding rate (1)
- anorexia nervosa (1)
- anoxygenic phototrophic sulfur bacteria (1)
- antenatal characteristics (1)
- antenatalne značilnosti (1)
- anterior chamber depth changes (1)
- anti-GD2 immunotherapy (1)
- anti-cancer therapy (1)
- anti-chronic myeloid leukemia (1)
- anti-citrullinated protein antibodies (1)
- anti-diabetes (1)
- anti-epileptic drug (1)
- anti-inflammatory (1)
- anti-inflammatory agents (1)
- anti-inflammatory effects (1)
- anti-retroviral agents (1)
- anti-skin aging (1)
- anti-tumor activity (1)
- antibiotic (1)
- antibiotic treatment (1)
- antibody (1)
- antibody tests (1)
- anticancer agents (1)
- anticholinergic burden (1)
- anticoagulants (1)
- anticoagulation (1)
- anticonvulsant (1)
- anticonvulsant activity (1)
- antidepressants (1)
- antiepileptic drug (1)
- antifibrotic therapy (1)
- antifungal activity (1)
- antifungal combination therapy (1)
- antifungal host response (1)
- antifungal management (1)
- antifungal prophylaxis (1)
- antifungal therapy (1)
- antigen (1)
- antigenic variation (1)
- antigens of infectious origin (1)
- antihormone therapy (1)
- antimicrobial activity (1)
- antioxidant (1)
- antioxidant activity (1)
- antioxidant defense (1)
- antiproliferative activity (1)
- antireflux surgery (1)
- antiresorptive agents (1)
- antiseizure (1)
- antisense oligonucleotides (1)
- antisynthetase antibodies (1)
- antisynthetase syndrome (1)
- antitumor immunity (1)
- antiviral drugs (1)
- antiviral peptide (1)
- anxiety (1)
- apical junction (1)
- apigenin (1)
- apixaban (1)
- apparent diffusion constant (1)
- apparent motion (1)
- apps (1)
- aprotinin (1)
- aptamer (1)
- aquaporin 1 (1)
- aquaporin-4 (AQP4) antibody (1)
- arachidonate 15-lipoxygenase (1)
- arachidonic acid (1)
- archaea (1)
- archaeosomes (1)
- architecture (1)
- arm (1)
- aromatics (1)
- arsenic trioxide (1)
- arterial hypertension (1)
- artery (1)
- artesunate (ART) (1)
- articulatory motor cortex (1)
- artificial neural networks (1)
- aspirin (1)
- assay development (1)
- assessment (1)
- associative memory (1)
- asthma phenotypes (1)
- astrocyte (1)
- astrocyte heterogeneity (1)
- astroglia (1)
- asymmetric hearing (1)
- asymptomatic (1)
- ataxia score (1)
- athletes (1)
- athletic training (1)
- atopy (1)
- atrial septostomy (1)
- atrophy (1)
- attachment loss (1)
- attention deficit hyperactivity disorder (1)
- attention modulation (1)
- attention-deficit/hyperactivity disorder (1)
- attention-deficit/hyperactivitydisorder (1)
- attractiveness (1)
- auditory cortex (1)
- auditory development (1)
- auditory language processing (1)
- auditory prediction (1)
- auditory system (1)
- augmentation materials (1)
- authentication (1)
- authorship (1)
- autism (1)
- autistic disorder (1)
- auto-structure (1)
- autoantibodies (1)
- autoantigen (1)
- autograft (1)
- autoimmune encephalomyelitis (1)
- autoimmune polyglandular syndrome type 2 (1)
- autoimmune thyroiditis (1)
- automated patch-clamp (1)
- automatic environmental tobacco smoke emitter (1)
- automation (1)
- autophagic cell death (1)
- autopsy (1)
- autoreactivity (1)
- autovaccine (1)
- avelumab (1)
- aviscumine (1)
- axon (1)
- azaindole (1)
- b-cell lymphomas (1)
- back pain (1)
- back scan (1)
- bacteria (1)
- bacterial translocation (1)
- bacterium (1)
- baicalein (1)
- balanced state (1)
- balloon pulmonary angioplasty (1)
- baroreflex (1)
- barriers to implementation (1)
- basal cell carcinoma (1)
- basal insulin (1)
- basic leucine zipper transcription factor ATF-like (1)
- basic mechanisms (1)
- basonuclin 2 (1)
- beads (1)
- beam quality correction factors (1)
- behavioral adverse events (1)
- behavioral performance (1)
- belimumab (1)
- bendamustine (1)
- berotralstat (1)
- beta band (1)
- beta blockade (1)
- betamethasone dipropionate (1)
- beta‐trace protein (1)
- bibliometric analysis (1)
- bicuspid aortic valve (1)
- biglycan (1)
- bile duct stenosis (1)
- biliary cirrhosis (1)
- binary search procedure (1)
- binaural cochlear implants (1)
- binding (1)
- bio imaging (1)
- bio-absorbable mesh (1)
- bioacoustics (1)
- bioactive phospholipids (1)
- bioactive phytochemicals (1)
- bioactivity (1)
- biobank (1)
- biochanin A (1)
- biochemical recurrence (1)
- biochemistry (1)
- bioenergetics (1)
- biofilm (1)
- biokompatibilni materijali (1)
- biological maturation (1)
- biological mesh (1)
- biological transport (1)
- biological treatments (1)
- biologically inspired computing (1)
- biologicals (1)
- bioluminescence (1)
- biomarker study (1)
- biomechanics (1)
- biopsy naïve (1)
- bipolar disorders (1)
- birch pollen allergoid (1)
- bistable (1)
- bladder cancer (1)
- bladder cancer (BCa) (1)
- bladder dose (1)
- bladder exstrophy-epispadias complex (1)
- blastic plasmacytoid dendritic cell neoplasm (1)
- blended learning (1)
- bleomycin (1)
- blood consumption (1)
- blood donor (1)
- blood flow recovery (1)
- blood hiv rna (1)
- blood loss (1)
- blood safety (1)
- blood transfusion (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- blow flies (1)
- blow fly (1)
- bmal1 (1)
- body dysmorphic disorder (1)
- body plethysmography (1)
- body posture (1)
- bone (1)
- bone chips (1)
- bone damage (1)
- bone loss (1)
- bone marrow (1)
- bone marrow derived mononuclear cells (1)
- bone marrow metastasis (1)
- bone marrow microenvironment (1)
- bone marrow mononuclear cells (1)
- bone metastasis (1)
- bone morphogenetic protein-2 (1)
- bone morphogenetic proteins (BMPs) (1)
- bone regeneration (1)
- bone substitute material (1)
- bone substitutes (1)
- bone tissue regeneration (1)
- bone-marrow (1)
- bone‐screw (1)
- bone–implant interface (1)
- borrelia mayonii (1)
- bortezomib (1)
- bottom-up (1)
- brachytherapy imaging methods (1)
- brain anatomy (1)
- brain function (1)
- brain injury (1)
- brain metastasis (1)
- brain networks (1)
- brain oscillations (1)
- brain phosphorylome (1)
- brain structure (1)
- brain tumor (1)
- brainmass (1)
- brainsize (1)
- branched-chain amino acids (BCAA) (1)
- breakpoint cluster region (1)
- breast cancer diagnosis (1)
- breast cancer systemic therapy (1)
- breast cancer treatment (1)
- breech (1)
- broad-range qPCR (1)
- broadly neutralizing antibodies (1)
- bronchial allergen challenge (1)
- bronchial allergen provocation (1)
- bronchiolitis obliterans syndrome (1)
- bronchodilator (1)
- buccal mucosa (1)
- buccal mucosal graft urethroplasty (1)
- bulimia nervosa (1)
- bullying (1)
- bundle (1)
- butyrylcholinesterase (1)
- c-kit (1)
- c1orf124 (1)
- cBioPortal (1)
- cFLIP (1)
- cGAS-STING (1)
- cHL (1)
- cIAP1 (1)
- cIAP1 BIR (1)
- cIAP1/2 (1)
- cadherin (1)
- calbindin (1)
- calcification score (1)
- calcipotriol (1)
- calcium handling (1)
- calcium-independent phospholipase A2β (1)
- calcium-sensor (1)
- callous-unemotional traits (1)
- caloric restriction (1)
- calprotectin (1)
- calretinin-knock out (1)
- cancer and drug vulnerabilities (1)
- cancer care (1)
- cancer care providers (1)
- cancer cell malignancy (1)
- cancer cell metabolism (1)
- cancer cells (1)
- cancer drug (1)
- cancer immunobiology (1)
- cancer patients (1)
- cancer screening (1)
- cancer therapy (1)
- cancer-associated fibroblasts (1)
- cancer-specific survival (1)
- candidate genes (1)
- candidemia (1)
- cannabidiol (1)
- cannabinoid receptor type 1 (1)
- cannabinoids (1)
- cannabis (1)
- canonical (1)
- canonical/non-canonical (1)
- cap-dependent translation (1)
- car indoor (1)
- carbapenem resistance (1)
- carbapenem-resistant Gram-negative bacteria (CRGN) (1)
- carbon oxides (COx) (1)
- carbon tetrachloride (1)
- carboxyfluorescein (1)
- carcinoma (1)
- cardiac I/R injury (1)
- cardiac arrest (1)
- cardiac events (1)
- cardiac ischaemia‐reperfusion (1)
- cardiac magnetic (1)
- cardiac myocytes (1)
- cardiac rehabilitation (1)
- cardiomegaly (1)
- cardiomyopathy (1)
- cardiovascular diseases (1)
- cardiovascular magnetic resonance (1)
- cardiovascular pharmacology (1)
- cardiovascular precision medicine (1)
- cardiovascular risk factors (1)
- career promotion (1)
- caregivers (1)
- carnitine supplementation (1)
- carotid (1)
- carpal tunnel syndrome (1)
- carrion (1)
- cartilage oligomeric matrix protein (1)
- cartilage trauma (1)
- case reports (1)
- case study (1)
- case-control study (1)
- caspase 8 (1)
- caspase-1 (1)
- cataract surgery (1)
- catheter (1)
- catheter removal (1)
- catheterization/diagnostic interventional (1)
- causality assessment (1)
- cd4 count determination procedure (1)
- cdk (1)
- cdk2/cyclin A (1)
- ceRNA (1)
- celery (1)
- celiac desease (1)
- cell adhesion (1)
- cell and focal adhesion (1)
- cell cycle (1)
- cell cycle arrest (1)
- cell cycling (1)
- cell fate (1)
- cell fusion (1)
- cell growth (1)
- cell identity (1)
- cell line (1)
- cell salvage (1)
- cell signaling (1)
- cell survival (1)
- cell survival mechanisms (1)
- cell transplantation (1)
- cellular immunology (1)
- cellular reaction (1)
- cellular response (1)
- cellular signalling (1)
- cellular therapy (1)
- centenarians (1)
- central nervous system (1)
- central nervous system infection (1)
- centrifugation (1)
- ceramide synthase (CERS2/CERS1) (1)
- cerclage (1)
- cerebellar mutism (1)
- cerebello-dentato-thalamo-cortical pathway (1)
- cerebral infarct (1)
- cerebral radiation necrosis (1)
- cerebrovascular disease (1)
- ceritinib (1)
- cervical shortening (1)
- cervical spine (1)
- cervico-thoracic junction (1)
- cetuximab-bevacizumab therapy sequence (1)
- ch14.18/CHO (1)
- chamomile (1)
- changes immune activation (1)
- chaperones (1)
- characterization (1)
- charged particles (1)
- checklist (1)
- checkpoint inhibition (1)
- checkpoint proteins (1)
- chelation therapy (1)
- chemical-induced proximity (1)
- chemoattractant (1)
- chemoconvulsant (1)
- chemoembolization (1)
- chemogenomic set (1)
- chemokine (1)
- chemokine receptor 4 (1)
- chemokine receptors (1)
- chemokines (1)
- chemokines: CYP2D6 model (1)
- chemoprevention (1)
- chemosensory cells (1)
- chemotaxis (1)
- chemotherapeutic drug resistance (1)
- chemotherapeutics (1)
- chemotherapeutics-treated (1)
- chemotherapy regimen (1)
- chemotherapy-resistance (1)
- chest injury (1)
- child abuse and neglect (1)
- child maltreatment (1)
- child psychiatry (1)
- childhood (1)
- childhood abuse (1)
- childhood cancer (1)
- children and adolescents (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- chinese medicine (1)
- chloroplasts (1)
- cholangiocarcinoma (1)
- cholecystectomy (1)
- cholestasis (1)
- cholinesterase (1)
- chondrocyte (1)
- chondrocytes (1)
- chromatin immunoprecipitation (1)
- chromosomal breaks (1)
- chromosomal instability (1)
- chromosomal integration (1)
- chromosomal translocations (1)
- chromosome alignment (1)
- chromosome instability (1)
- chromosome segregation (1)
- chronic care (1)
- chronic colitis (1)
- chronic coronary artery disease (1)
- chronic granulomatous disease (1)
- chronic hepatitis C (1)
- chronic illness (1)
- chronic infection (1)
- chronic inflammation (1)
- chronic kidney disease (CKD) (1)
- chronic liver disease (1)
- chronic liver disease (CLD) (1)
- chronic metabolic acidosis (1)
- chronic myeloid leukemia (CML) (1)
- chronic total occlusion (1)
- chronic viral hepatitis (1)
- chronische Niereninsuffizienz (1)
- chronische metabolische Azidose (1)
- chronobiology (1)
- chronotype (1)
- cigarette smoke (1)
- cigarette strength (1)
- cigarettes (1)
- cigarillos (1)
- cilia (1)
- circadian variation (1)
- circular RNA (1)
- circulating miRNA (1)
- circulation (1)
- cisplatin sensitivity (1)
- citizen science (1)
- claims data (1)
- classical conditioning (1)
- classification of bone defects (1)
- clean room (1)
- clear or almost clear skin (1)
- clinical (1)
- clinical cases (1)
- clinical competency (1)
- clinical features (1)
- clinical history (1)
- clinical immunology (1)
- clinical management (1)
- clinical pathways (1)
- clinical practice (1)
- clinical relevance (1)
- clinical tool (1)
- clinical trials (1)
- clinically important restrictions and symptoms (1)
- clinico-biological indices (1)
- cloacae (1)
- cloacal malformation (1)
- clonal dominance (1)
- clonal hematopoiesis (1)
- clopidogrel (1)
- cluster of differentiation 4 (CD4) (1)
- cluster-randomized controlled trial (1)
- clusteranalysis (1)
- co-crystallization (1)
- co-infection (1)
- coaching (1)
- coauthor ship (1)
- cocaine (1)
- coffee (1)
- cognitive control (1)
- cognitive decline (1)
- cognitive deficits (1)
- cognitive fluency (1)
- cognitive functions (1)
- cognitive models (1)
- cognitive states (1)
- cognitively stimulating leisure activities (1)
- cohlear implant (1)
- cohort study (1)
- cold induced pain (1)
- cold tolerance (1)
- colitis (1)
- collaborative feedback (1)
- collagen I (1)
- collagen VI (1)
- collagen adhesion (1)
- collagen degradation marker (1)
- collagen type I (1)
- collagen-based biomaterial (1)
- collagen-based matrix (1)
- collateral growth (1)
- collateral sprouting (1)
- collective dynamics (1)
- colloid (1)
- colon (1)
- colon cancer cells (1)
- colon carcinoma (1)
- colonization (1)
- colorectal cancer (CRC) (1)
- colorectal cancer liver metastases (CRLM) (1)
- column chromatography (1)
- combination (1)
- combination immunotherapy (1)
- combination therapies (1)
- combination treatment (1)
- combined immunodeficiency (1)
- common genetic variation (1)
- common neighbor (1)
- common variant (1)
- common variants (1)
- communication/social competencies (1)
- community violence exposure (1)
- comorbidities (1)
- comorbidity (1)
- compaction (1)
- comparative pathology (1)
- comparative study (1)
- competitive peptide (1)
- complement dependent cytotoxicity (1)
- complement; patients (1)
- complementary information (1)
- complementary psychosocial care (1)
- complex I deficiency (1)
- complex systems (1)
- complexity theory (1)
- complexome profiling (1)
- comprehensive care (1)
- computational biology (1)
- computational functional genomics (1)
- computational intelligence (1)
- computational modeling (1)
- computational models (1)
- computational neuroimaging (1)
- computational neuroscience (1)
- computational techniques (1)
- computer tomography (1)
- computer vision (1)
- computer-assisted (1)
- computer-assisted drug therapy (1)
- computerized programs (1)
- concentric (1)
- concordance (1)
- concurrent (1)
- concurrent TMS--fMRI (1)
- conditioning (1)
- conduit (1)
- cone-beam computed tomography (CBCT) (1)
- cone-beam computer tomography (1)
- confidence (1)
- confinement (1)
- congenic mice (1)
- congenital deafness (1)
- congruency (1)
- connectional fingerprint (1)
- connective tissue (1)
- connective tissue graft (1)
- conotoxin (1)
- consciousness (1)
- consensus (1)
- consolidation treatment (1)
- contact heat evoked potentials (CHEPS) (1)
- contact lens solution (1)
- continuing education (1)
- continuing medical education (1)
- continuous glucose monitoring (1)
- contralateral delay activity (1)
- controlled nuclear import (1)
- conventional laparoscopic (1)
- conventional/traditional transarterial chemoembolization (cTACE) (1)
- conversation skills (1)
- convolution neural network (1)
- convulsive seizures (1)
- cooling deactivation (1)
- cooling period (1)
- coordination (1)
- copeptin (1)
- coping (1)
- copy number polymorphism (1)
- cord clamping (1)
- corneas (1)
- corona virus (1)
- coronary (1)
- coronary artery bypass surgery (1)
- coronary calcium (1)
- coronary computed-tomography angiography (CCTA) (1)
- coronary disease (1)
- coronary plaques (1)
- coronavirus disease 2019 (1)
- corpus callosum (1)
- correction of incidence rate (1)
- correction of mortality rate (1)
- correlation (1)
- corrosion (1)
- cortex, gray matter (1)
- cortical folding (1)
- cortical layers and areas (1)
- cortical malformation (1)
- cortical network (1)
- cortical networks (1)
- cortical slices (1)
- cortical thickness (1)
- corticomuscular coherence (CMC) (1)
- cost-effective (1)
- cost-of-illness (1)
- costimulation (1)
- costs (1)
- coupling (1)
- courting behavior (1)
- cranberry (1)
- crestal bone loss (1)
- crime scene (1)
- crista junction (1)
- cristae (1)
- critical care unit (1)
- critical ill patients (1)
- critical periods (1)
- critical size defect (1)
- critically ill patients (1)
- cross-border (1)
- cross-communication (1)
- cross-modal (1)
- cross-modal plasticity (1)
- cross-sectional study (1)
- crowns (1)
- cryogenic electron microscopy (1)
- cryopreservation (1)
- cryotherapy (1)
- crystalloid (1)
- cultural and social transformation of sexuality (1)
- cumulative dose (1)
- curriculum (1)
- cutaneous T cell lymphoma (1)
- cuticular hydrocarbons (1)
- cyclic depsipeptide (1)
- cyclin D1 (1)
- cyclins (1)
- cyclooxygenase 1 (COX-1) (1)
- cyclooxygenase 2 (COX-2) (1)
- cyclophilin A (1)
- cyclophosphamide (1)
- cyclosporine (1)
- cys-loop receptor (1)
- cystatin C (1)
- cytarabin (1)
- cytarabine dose (1)
- cytokine (1)
- cytokine gene expression (1)
- cytokine release syndrome (1)
- cytokine, angiogenesis (1)
- cytoskeleton (1)
- cytotoxic immunotherapy (1)
- dNTP pools (1)
- dabigatran (1)
- daily activity protocols (1)
- damage associated molecular pattern (1)
- damage-associated molecular pattern (1)
- dapagliflozin (1)
- data modeling (1)
- data quality (1)
- data quality check (1)
- day clinic (1)
- deaf white cat (1)
- death (1)
- death receptor (1)
- debridement (1)
- decision aids (1)
- decision support systems (1)
- decision-making (1)
- declaration of tobacco ingredients (1)
- decomposition (1)
- deconvolution (1)
- decorin (1)
- decorrelation (1)
- dedifferentiation (1)
- deep mutational scanning (1)
- deep neural network (1)
- deep sedation (1)
- defect configuration (1)
- delay (1)
- delayed auditory feedback (1)
- delayed cholecystectomy (1)
- delayed wound healing (1)
- deletion 5q (1)
- delirium (1)
- delta-9-tetrahydrocannabinol (1)
- dendrite (1)
- dendritic cell–tumor cell fusion (1)
- dendritic inhibition (1)
- denervation (1)
- density equalizing mapping (1)
- dental abutment (1)
- dental assistant (1)
- dental emergency treatment (1)
- dental health professional (1)
- dentin adhesives (1)
- dentistry (1)
- dentoalveolar surgery (1)
- depolymerization (1)
- depressive symptoms (1)
- depressive symptoms clusters (1)
- deprivation (1)
- dermatology (1)
- dermatomes (1)
- desensitization (1)
- desmoplastic small round cell tumor (1)
- desmoplastic stroma (1)
- deswelling (1)
- deubiquitinating enzyme (1)
- deubiquitinating enzymes (1)
- devastated bladder outlet (1)
- device handling (1)
- dexamethasone (1)
- diabetes therapy (1)
- diabetic macular edema (1)
- diabetic nephropathy (1)
- diabetic neuropathy (1)
- diagnostic algorithm (1)
- diagnostic biomarkers (1)
- diagnostic method (1)
- diagnostic test (1)
- diagnostics (1)
- dialysis (1)
- diarrhoeal disease (1)
- diastolic function (1)
- diclofenac (1)
- diet (1)
- differentiated thyroid carcinoma (1)
- diffuse large B cell lymphoma (1)
- diffuse low-grade glioma (1)
- diffusion MRI (1)
- diffusion microstructure (1)
- diffusion tensor imaging (DTI) (1)
- digestive tract (1)
- digital age determination (1)
- digital didactics (1)
- digital pathology (1)
- digitale Didaktik (1)
- dihydroceramides (1)
- dimethylfumarate (1)
- dipeptide (1)
- diplopia (1)
- direct antiviral (1)
- direct antiviral agents (1)
- direct-acting antivirals (DAAs) (1)
- directed disulfide bond formation (1)
- directed forgetting (1)
- directly acting antiviral agents (1)
- disasters (1)
- discoidin domain-containing receptor (1)
- discomfort/pain (1)
- discontinuous dose dependency (1)
- disease modelling (1)
- disease progression (1)
- disease-free survival (1)
- disease-modifying antirheumatic drugs (1)
- disease-modifying therapy (1)
- dislocation (1)
- disposable insulin pens (1)
- disruptive behaviour disorder (1)
- dissemination (1)
- dissimilatory sulfite reductase (1)
- distal pronephric outlet obstruction (1)
- distance learning (1)
- distraction (1)
- distributed computation (1)
- diuretics (1)
- diurnal (1)
- docetaxel (1)
- docking studies (1)
- dog study (1)
- donor deferral (1)
- donor recruitment (1)
- donor retention (1)
- dopamine (1)
- doppler (1)
- dorsal auditory stream (1)
- dose response curve (1)
- dosimetry (1)
- dosing accuracy (1)
- double inversion recovery (DIR) (1)
- double orifice mitral valve (1)
- doublecortin (1)
- doxycycline (1)
- drilling tool design (1)
- drug delivery (1)
- drug hepatotoxicity (1)
- drug interaction (1)
- drug metabolism and distribution (1)
- drug resistance and invasiveness (1)
- drug screening (1)
- drug targets (1)
- drug therapy (1)
- drug-coated balloon (1)
- drug-eluting balloon (1)
- drug-eluting beads TACE (DEB-TACE) (1)
- drug-induced liver injury (DILI) (1)
- druggable genome (1)
- drugs (1)
- drug‐resistant epilepsy (1)
- dsr genes (1)
- dual antiplatelet therapy (1)
- dual bronchodilators (1)
- dynamic 18F-FDG PET/CT (1)
- dynamic connectivity (1)
- dynamic stimuli (1)
- dysbiosis (1)
- dysferlin (1)
- dysferlinopathy (1)
- dyssynchrony analysis (1)
- e-Health (1)
- e-scooter (1)
- eNOS (1)
- eNPP2 (1)
- ePTFE membrane (1)
- early cholecystectomy (1)
- early continence (1)
- early epilepsy (1)
- early infection (1)
- early loss (1)
- early myocardial damage (EMD) (1)
- early recognition (1)
- early tumor stages (1)
- eating disorders (1)
- eccentric (1)
- economic burden (1)
- economy (1)
- ectopic pregnancy (1)
- edema (1)
- editorials (1)
- edoxaban (1)
- educational cases (1)
- educational measurement (1)
- educational settings (1)
- educational technology (1)
- educational theory (1)
- effect mechanism (1)
- effective lens position (1)
- effectiveness (1)
- eight disorders (1)
- ejection fraction (EF) (1)
- electric and acustic stymulation (1)
- electric scooter (1)
- electrical stimulation (1)
- electroconvulsive therapy (1)
- electroencephalography (EEG), EEG reference choices, event-related potentials (ERP), independent component analysis (ICA), pain research, contact heat evoked potentials (CHEPS) (1)
- electromagnetic navigation bronchoscopy (EMN, ENB) (1)
- electrophiles (1)
- elite athlete (1)
- eltrombopag (1)
- embodiment (1)
- embolization (1)
- emergence (1)
- emergency care (1)
- emergent self-organizing maps (1)
- emotion (1)
- emotional climate (1)
- emotional information processing (1)
- empagliflozin (1)
- empowerment (1)
- emulsion diffusion (1)
- encoding strategies (1)
- end of life care (1)
- endocarditis (1)
- endogenous clock (1)
- endometrial cancer (1)
- endometriosis (1)
- endophytes (1)
- endoscopic retrograde cholangiopancreatography (1)
- endoscopy (1)
- endothelial activation (1)
- endothelial barrier (1)
- endothelial function (1)
- endothelial nitric-oxide synthase (1)
- endothelial receptor expression (1)
- endothelial to mesenchymal transition (1)
- endothelin (1)
- endothelin receptor type A antagonist (1)
- endothelium (1)
- endotoxemia (1)
- endotoxins (1)
- enforced viral replication (1)
- english (1)
- enterovirus (1)
- entomological evidence (1)
- envelope technique (1)
- environment (1)
- eosinophil cationic protein (1)
- eosinophilic cholangitis (1)
- eosinophils (1)
- epidemics (1)
- epidermal growth factor (1)
- epidermal growth factor receptor (1)
- epidermis (1)
- epididymitis (1)
- epigenetic memory (1)
- epigenome (1)
- epigenomics (1)
- epileptic encephalopathies (1)
- epileptic encephalopathy (1)
- epiregulin (1)
- epithelial cells (1)
- epithelial mesenchymal transition (1)
- epithelial‐mesenchymal transition (1)
- epitope mapping (1)
- erectile dysfunction (1)
- ergometry (1)
- ergonomics (1)
- erosions (1)
- erythropoietin (1)
- erythropoietin (EPO) (1)
- escape mutations (1)
- esterification (1)
- ethical trade-off (1)
- ethyl pyruvate (1)
- eutheria (1)
- euthymic (1)
- evaluation practice (1)
- event logs (1)
- event-based (1)
- event-related potential (1)
- event-related potentials (ERP) (1)
- evoked response (1)
- evolution (1)
- ex vivo expansion (1)
- ex vivo model (1)
- ex vivo stimulation (1)
- ex-Gaussian analysis (1)
- examination success (1)
- excess fluid volume (1)
- excitability (1)
- executive control (1)
- executive function (1)
- exercise on prescription (1)
- exercise physiology (1)
- exercise testing (1)
- exercise training (1)
- exome sequencing (1)
- experimental human pain models (1)
- expert review (1)
- explainable AI (1)
- exponential model (1)
- exposure (1)
- expressed emotion (1)
- expression studies (1)
- extensive surgery (1)
- extensively drug-resistant (1)
- external fixation (1)
- external joint moments (1)
- extracellular chromatin (1)
- extracellular vesicles (1)
- extracting solvents (1)
- extraction socket healing (1)
- extremity (1)
- eye movement (1)
- eye tracking (1)
- eye-tracking (1)
- face (1)
- face inversion effect (1)
- face-name association task (1)
- facial EMG (1)
- facial emotion recognition (1)
- facial expressions of emotion (1)
- facial muscle activity (1)
- facial nerve functional outcome (1)
- facial prosthesis (1)
- factor IX (1)
- factor VIII (1)
- factor VIII (FVIII) (1)
- falls (1)
- false memory (1)
- familial colorectal cancer (1)
- familial infantile epilepsy (1)
- familiengerechte Hochschule (1)
- family medicine (1)
- family-friendly universities (1)
- fat (1)
- fatty acid elongase (Elovl1/4/5) (1)
- fatty acids (1)
- fear conditioning (1)
- fear extinction (1)
- fear generalization (1)
- fear learning (1)
- feeder cells (1)
- feeding (1)
- female health (1)
- female subjects (1)
- femoropopliteal segment (1)
- ferret (1)
- ferric carboxymaltose (1)
- fetal weight estimation (1)
- fiber orientations (1)
- fibre tracking (1)
- fibrin (1)
- fibrinolysis (1)
- fibroblast (1)
- fibrocytes (1)
- fibrogenesis (1)
- fibromodulin (1)
- fibronectin (1)
- fibrosarcoma (1)
- fibrotest (1)
- fidaxomicin (1)
- finger tapping (1)
- fingolimod (1)
- first-line chemotherapy (1)
- fitness (1)
- fixation (1)
- fixed partial dentures (1)
- fizička aktivnost; (1)
- flavivirus entry factor (1)
- fluid (1)
- fluid shear stress (1)
- fluocinolone acetonide (1)
- fluorescent dye (1)
- fluorine (1)
- focal adhesion kinase (1)
- focal cortical dysplasia (FCD) (1)
- focal seizures (1)
- focal therapy (1)
- follow-up (1)
- forensics (1)
- formalin-fixed and paraffin-embedded tissue (FFPE) (1)
- formalin-fixed paraffin-embedded (FFPE) samples (1)
- fourth (1)
- fractional anisotropy (1)
- free gingival graft (1)
- free leptin index (FLI) (1)
- freeze avoidance (1)
- fresh frozen plasma (1)
- frontal cortex (1)
- frontotemporal lobar degeneration (1)
- full-contour crown restorations (1)
- full-contour zirconia (1)
- fully human (1)
- fumonisin B1 (1)
- function, sorting (1)
- functional MRI (1)
- functional imaging (1)
- functional magnetic resonance imaging (fMRI) (1)
- fundoplication (1)
- fungal pathogens (1)
- fungi (1)
- fungus (1)
- funktionelle Bildgebung (1)
- furcation involvement (1)
- further education (1)
- fusion (1)
- gRNA library (1)
- gadobutrol (1)
- gadolinium (1)
- gadolinium enhancing lesion (1)
- gadolinium‐based contrast agent (1)
- galactomannan (1)
- gallbladder cancer (1)
- gallbladder cancer xenografts (1)
- gallstone disease (1)
- galunisertib monohydrate (LY2157299) (1)
- gap junction protein alpha 4-genotype (1)
- gas chromatography-mass spectrometry (1)
- gastric (1)
- gastric surgery (1)
- gastro-oesophageal junction cancer (1)
- gastroesophageal reflux (1)
- gastrointestinal tract (1)
- gel spacer injection (1)
- gender difference (1)
- gender dysphoria (1)
- gender equality (1)
- gender equality plan (1)
- gender studies (1)
- gender-affirming hormone therapy (1)
- gene delivery (1)
- gene expression analysis (1)
- gene expression profiling (1)
- gene expression profiling (GEP) (1)
- gene signature (1)
- gene vectors (1)
- general anaesthesia (1)
- general practitioner (1)
- generic preparedness (1)
- genes (1)
- genetic diversity (1)
- genetic generalized epilepsy (1)
- genetic markers (1)
- genetic phenotypes (1)
- genetic polymorphisms (1)
- genetic predisposition (1)
- genetic rearrangements (1)
- genetics and genomics (1)
- gene×environment interactions (1)
- genome (1)
- genome editing (1)
- genome-wide (1)
- genome-wide association study (1)
- genomic classifiers (1)
- genotype (1)
- genotype determination (1)
- geriatric medicine (1)
- germ cell tumors (1)
- germinal center (1)
- gland extracts (1)
- glecaprevir (1)
- glial activation (1)
- glial fibrillary acidic protein (1)
- glioblastoma (GBM) (1)
- glioblastoma stem-like cells (1)
- glioma-associated oncogene homolog (1)
- gliomas (1)
- gliomatosis cerebri growth pattern (1)
- global diversity (1)
- global mapping (1)
- global warming (1)
- glucocorticoid (1)
- glucocorticoids (1)
- glucosamine (1)
- glucose (1)
- glutamate metabolism (1)
- glutamine (1)
- glycation (1)
- glycolysis (1)
- glycosaminoglycan (1)
- gold nanoparticles (1)
- good manufacturing practice (1)
- gossypol (1)
- governance (1)
- graft (1)
- graft perfusion (1)
- graft rejection (1)
- graft-versus host (1)
- graft-versus-host disease (1)
- graft-versus-tumor effect (1)
- gram-negative bacteria (1)
- granulocyte (1)
- granulocytecolony stimulating factor (1)
- granulocytemacrophage colony-stimulating factor (1)
- granuloma (1)
- granulomas (1)
- granulomatous inflammation (1)
- gray matter (1)
- gray matter changes (1)
- gray‐white matter blurring (1)
- green fluorescent protein (1)
- green tea extract (1)
- grey matter volume (1)
- grinding (1)
- grounded theory (1)
- growth hormone (1)
- guanidine alkaloid (1)
- guessing likelihood (1)
- guidance (1)
- guinea pig (1)
- gut microbiota (1)
- gyrification (1)
- h-index (1)
- hMOF/KAT8 (1)
- habituation (1)
- haematologic malignancies (1)
- haemophilia (1)
- haemophilia A (1)
- haemophilic arthropathy (1)
- haemostasis (1)
- hair cell (1)
- hand area (1)
- hanging donors (1)
- haplo-identical (1)
- haploidentical (1)
- harassment (1)
- harmine (1)
- head and neck neoplasms (1)
- head and neck squamous cell carcinoma (1)
- head to head (1)
- head zones (1)
- head-and-neck cancer (1)
- head-to-head (1)
- headache (1)
- health apps (1)
- health care (1)
- health care personnel (1)
- health economics (1)
- health insurance data (1)
- health literacy (1)
- health related quality of life (1)
- health services accessibility (1)
- health services research (1)
- healthcare (1)
- healthcare personnel (1)
- healthcare professional (1)
- healthcare systems (1)
- healthcare worker (1)
- healthcare workers (1)
- healthy subjects (1)
- health‐related quality of life (1)
- hearing loss (1)
- hearing nerve (1)
- heart (1)
- heart rate variability (1)
- heat (1)
- heat stress (1)
- hedgehog (1)
- hedgehog signaling pathway (1)
- helminths (1)
- hemadsorption (1)
- hemagglutination (1)
- hematoma (1)
- hematopoietic cell transplantation (1)
- hematopoietic cells (1)
- hematopoietic stem cell mobilization (1)
- hematopoietic stress (1)
- hemiplegic migraine (1)
- hemispherotomy (1)
- hemodynamic (1)
- hemodynamic instability (1)
- hemophilia A (1)
- hemorrhage (1)
- hemorrhagic transformation (1)
- hepatic fibrosis (1)
- hepatic osteodystrophy (1)
- hepatic phenotype (1)
- hepatic steatosis (1)
- hepatic tumor (1)
- hepatitis B virus (1)
- hepatitis E (1)
- hepatitis E virus (1)
- hepatitis c (1)
- hepatoblastoma (1)
- hepatocellular carcinoma (HCC) (1)
- hepatocyte transplantation (1)
- hepatocytes (1)
- hepatotoxicity (1)
- herb induced liver injury (HILI) (1)
- herbal drug (1)
- herbs (1)
- hereditary angioedema, (1)
- hereditary tumor syndromes (1)
- hernia to the cord (1)
- herpes simplex virus (1)
- heterogeneity of plasticity effects (1)
- hexosamine biosynthetic pathway (1)
- hiPSC (1)
- hierarchy (1)
- high molecular weight plasticizer (1)
- high surgical risk (1)
- high throughput (1)
- high-dimensional data sets (1)
- high-dose chemotherapy (1)
- high-dose-rate interstitial brachytherapy (1)
- high-energy photon and proton radiation (1)
- high-intensity focused ultrasound ablation (1)
- high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (1)
- high-pitch (1)
- high-throughput nucleotide sequencing (1)
- high-throughput sequencing (1)
- higher education (1)
- higher education pedagogy (1)
- highly parallel recordings (1)
- high‐mobility group box‐1 (HMGB1) (1)
- hip joint (1)
- hippocampal neuronal cell line (1)
- hippocampal sclerosis (1)
- hippocampal volume (1)
- histamine (1)
- histological technic (1)
- histomorphometry (1)
- histone deacetylase (1)
- histone deacetylase 5 (1)
- histone deacetylases (HDACs) (1)
- histone modification (1)
- histoplasmosis (1)
- history (1)
- history of medicine (1)
- history taking (1)
- hiv (1)
- home care services (1)
- home visit (1)
- homeostatic synaptic scaling (1)
- homing (1)
- homoarginine (1)
- homologna transplantacija (1)
- hormonal therapy (1)
- hormone (1)
- hormones (1)
- hospital (1)
- hospital exemption (1)
- hospitalization (1)
- host cell interaction (1)
- host cell response (1)
- host immune response (1)
- host response (1)
- host-directed therapies (1)
- host-pathogen interaction (1)
- host-targeting antivirals (1)
- hostpathogen interaction (1)
- hotspot loci (1)
- house dust mite allergy (1)
- household chaos (1)
- huCAR19 (1)
- human Natural Killer cell (1)
- human antigen R (HuR) (1)
- human brain (1)
- human decellularized dermis (1)
- human erythroid leukemia (HEL) (1)
- human experimental pain (1)
- human genomics (1)
- human gingival fibroblasts (1)
- human immunodeficiency virus (1)
- human intracranial recordings (1)
- human knockout model (1)
- human lymph node (1)
- human natural killer cell (1)
- human papilloma virus (1)
- human renal proximal tubular epithelial cells (1)
- human resources (1)
- human sera (1)
- human skin graft (1)
- humanized mice (1)
- humanized mouse (1)
- humanized mouse model (1)
- humans (1)
- humectant agents (1)
- humoral factors (1)
- hybrid (1)
- hydrocephalus (1)
- hydroxyapatite crystals (1)
- hydroxyurea (1)
- hygienic hand disinfection (1)
- hygienische Händedesinfektion (1)
- hymenoptera (1)
- hyperalgesia (1)
- hyperammonemia (1)
- hyperarousal (1)
- hyperbaric oxygen treatment (1)
- hyperlipidemia (1)
- hypertension (1)
- hypertension and anti-hypertensive treatment (1)
- hypertension, pulmonary (1)
- hypertonic (1)
- hypoglycaemia (1)
- hyponatremia (1)
- hypoparathyroidism (1)
- hypophosphataemia (1)
- hypothalamus (1)
- hypothermia (1)
- hypoxia-induced cell death (1)
- hypoxia-inducible factor (1)
- hysteresis (1)
- i-AAA protease (1)
- iCBT (1)
- iCLIP (1)
- iDrug induced liver injury (1)
- idiopathic dystonia (1)
- idiopathic pulmonary fibrosis (1)
- idiosyncratic DILI (1)
- idiosyncratic drug-induced liver injury (1)
- ifenprodil (1)
- ignition (1)
- illness experiences (1)
- image analysis (1)
- image distortion (1)
- image-based risk modelling (1)
- imiquimod (1)
- imitation (1)
- immune (1)
- immune checkpoint inhibitors (1)
- immune deficiency (1)
- immune dysregulation (1)
- immune function (1)
- immune landscape (1)
- immune microenvironment (1)
- immune modulation (1)
- immune responses (1)
- immune surveillance of cancer (1)
- immune therapy (1)
- immune tolerance (1)
- immune-checkpoint inhibition (1)
- immune-mediated inflammatory diseases (1)
- immune-modulating therapy (1)
- immunization (1)
- immunocompromised patient (1)
- immunoglobulin superfamily (1)
- immunologic (1)
- immunological research (1)
- immunology and infectious diseases (1)
- immunomagnetic (1)
- immunoprecipitation (1)
- immunostaining (1)
- immunosuppressants (1)
- immunosuppression (1)
- immunosuppressive agent (1)
- immunosuppressive drug (1)
- impact factor (1)
- implant (1)
- implant movement (1)
- implant stability (1)
- implant survival (1)
- implanto-prosthetic therapy (1)
- imported malaria (1)
- improvement in quality of life (1)
- in silico simulation (1)
- in situ gene correction (1)
- in situ hybridization (1)
- in situ vaccine (1)
- in vivo micro‐CT (1)
- in vivo model of critical size defects (1)
- in-cabin exposure (1)
- incisional hernia (1)
- indacaterol/glycopyrronium (1)
- independent component analysis (ICA) (1)
- indication (1)
- individual moulds (1)
- individualized solutions (1)
- individualized therapy (1)
- indomethacin (1)
- indoor air pollution (1)
- inducible gene expression (1)
- inducible nitric oxide synthase (1)
- induction chemotherapy (1)
- infant (1)
- infants (1)
- infection eradication (1)
- infection model (1)
- infections: pneumonia, TB, viral (1)
- infectious disease (1)
- infectious diseases (1)
- infectivity (1)
- inflammatory arthritis (1)
- inflammatory cytokines (1)
- inflammatory markers (1)
- influenza (1)
- influenza pandemic (1)
- influenza vaccination (1)
- influenza vaccine (1)
- infomax (1)
- information decomposition (1)
- information needs (1)
- information storage (1)
- information transfer (1)
- inhalation flow profiles (1)
- inhaled steroids (1)
- inhaler (1)
- inheritance (1)
- inhibition (1)
- inhibition of DNA-binding (1)
- inhibitor of apoptosis protein family (1)
- inhibitors (1)
- injury (1)
- innate and adaptive immune response (1)
- innate immune system (1)
- innate lymphoid cells (1)
- inner ear therapy (1)
- inpatient hospital admissions (1)
- insect herbivory (1)
- insecticide (1)
- insertable cardiac monitor (1)
- insertion (1)
- insomnia (1)
- instructional interventions (1)
- insulitis (1)
- integrate and fire (1)
- integrated stress response (1)
- intensive care (1)
- intensive care unit (1)
- inter-assay precision (1)
- interactome (1)
- interaural time difference (1)
- interference (1)
- interferon regulatory factor 9 (IRF9) (1)
- interferon-free (1)
- interferon-free antiviral treatment (1)
- interferon-γ (1)
- interferons (1)
- interleukin-1 (1)
- interleukin-10 (1)
- interleukin-1β (1)
- interleukin-23 receptor (1)
- interleukin-6 (1)
- internal ribosomal entry site (IRES) (1)
- internal time (1)
- international (1)
- internet (1)
- internet- and mobile-based intervention (1)
- internet-based cognitive behavioral therapy (1)
- internet-based treatment (1)
- interneurons (1)
- interscalene brachial plexus block (1)
- interstitial brachytherapy (1)
- interstitial lung disease (1)
- intervention (1)
- intervention study (1)
- interventional radiology (1)
- intervertebral disc (1)
- intervertebral disc (IVD) (1)
- intervertebral disc degeneration (1)
- intestinal barrier (1)
- intestinal graft-versushost disease (1)
- intestinal obstruction (1)
- intoxication (1)
- intra-arterial chemotherapy (1)
- intraarterial therapy (1)
- intracellular trafficking (1)
- intracerebral haemorrhage (1)
- intracerebral hemorrhage (1)
- intracranial hemorrhage (1)
- intraperitoneal therapy (1)
- intratumoral (1)
- intraventricular chemotherapy (1)
- intravital microscopy (1)
- intrinsic DILI (1)
- intrinsic apoptosis (1)
- intrinsic drug resistance (1)
- intronic ORF (1)
- invasive growth (1)
- invasive mold infection (1)
- inverse dynamics (1)
- involuntary hospitalization (1)
- in vivo (1)
- ion channel (1)
- ionomycin (1)
- ionotropic glutamate receptors (1)
- irbesartan (1)
- irinotecan-loaded drug-eluting beads TACE (DEBIRI-TACE) (1)
- iron chelation (1)
- iron chelator (1)
- iron chelators (1)
- iron deficiency (1)
- iron homeostasis (1)
- iron metabolism (1)
- iron overload versus deprivation (1)
- iron supplements (1)
- irritable bowel syndrome (1)
- ischaemia (1)
- ischemia (1)
- ischemic stroke (1)
- ischemic type biliary lesions (1)
- isocaloric ketogenic diet (1)
- isogenic (1)
- isomeric antagonists (1)
- isovaleric acidaemia (1)
- isradipine (1)
- isušenje (1)
- itraconazole (1)
- ixekizumab (1)
- joint bleeding (1)
- joint contact forces (1)
- joint loading (1)
- joint moments (1)
- junctional adhesion molecule (1)
- juvenile brain lesion (1)
- juvenile myoclonic epilepsy (1)
- kallikrein inhibitor (1)
- kavalactones (1)
- keratinized mucosa (1)
- keratinocytes (1)
- keratoplasty (1)
- ketamine (1)
- ketogenic (1)
- ketogenic diet (1)
- ketone body (1)
- kidney disease (1)
- kidney formation (1)
- kidney function (1)
- kinesin (1)
- kinetic fingerprint (1)
- klinische Kompetenz (1)
- klinische Studie (1)
- knee joint (1)
- knockout mice (1)
- knockout mouse (1)
- kommunikative/soziale Kompetenzen (1)
- konduit (1)
- koroner arter baypas cerrahisi (1)
- kutane Larva migrans (1)
- kynureninase (1)
- kynurenine (1)
- kyphosis (1)
- l-DOPA (1)
- laceration (1)
- lacosamide (1)
- lactate (1)
- lactate dehydrogenase (1)
- laminin (1)
- laminins (1)
- lamotrigine (1)
- language (1)
- laser (1)
- laser based cell manipulation (1)
- laser microdissection (1)
- laser-capture microdissection (1)
- late lumen loss (1)
- late-life depression (1)
- latent class analysis (1)
- latent tuberculosis infection (1)
- layer 1 (1)
- layer-specificity (1)
- learning (1)
- learning curve (1)
- learning strategies (1)
- left ventricular function (1)
- left ventricular non-compaction (1)
- left ventricular trabeculation (1)
- leg alignment (1)
- legal gender reassignment (1)
- lenalidomide (1)
- length of study (1)
- lentiviral vector (1)
- leptin (1)
- leptin, leptin receptor (sOB-R) (1)
- leptomeningeal disease (1)
- leptomeningeal metastases (1)
- lethal toxin (1)
- leukapheresis (1)
- leukemia initiating cell (1)
- leukemia; solid tumors (1)
- leukocytosis (1)
- leukodystrophy (1)
- leukotriene (1)
- life cycle (1)
- life span (1)
- lifelong learning (1)
- lifespan (1)
- ligelizumab (1)
- light microscopy (1)
- light transmission aggregometry (1)
- limb girdle muscular dystrophy type 2B (LGMD2B) (1)
- liminality (1)
- linoleic acid metabolites (1)
- lipid mediator (1)
- lipid metabolism (1)
- lipid raft (1)
- lipid signaling (1)
- lipid signalling (1)
- lipid-protein interaction (1)
- lipidomic analysis (1)
- lipidomics (1)
- lipids (1)
- lipids inflammatory pain (1)
- lipiodol (1)
- lipopolyplex (1)
- lipopolysaccharide (1)
- liposomes (1)
- liquid PRF (1)
- liquid-PRF (1)
- live cell imaging (1)
- liver abscess (1)
- liver adaption (1)
- liver cancer (1)
- liver cell lines (1)
- liver damage (1)
- liver diseases (1)
- liver immunology (1)
- liver metabolism (1)
- liver transplantation center (1)
- livermetastases of colorectal cancer (1)
- living will (1)
- local anesthetic (1)
- local field potential (1)
- local inflammation (1)
- local radiotherapy (1)
- lockdown (1)
- locomotor rhythm (1)
- locoregional chemotherapy (1)
- long essay questions (1)
- long essey questions (1)
- long non-coding RNA (1)
- long noncoding RNAs (1)
- long reads (1)
- long-acting muscarinic antagonist (1)
- long-acting β2-agonists (1)
- long-term depression (1)
- long-term distress (1)
- long-term follow-up (1)
- long-term infection (1)
- long-term infusion (1)
- long-term outcome (1)
- long-term potentiation (1)
- longitudinal follow-up after epilepsy surgery (1)
- longitudinal relaxation time T1 (1)
- longitudinally extensive transverse myelitis (1)
- loss (1)
- loss of signal (1)
- low birth weight infant (1)
- low doses (1)
- low speed centrifugation concept (1)
- low-back pain (1)
- low-cost medication (1)
- low-density lipoprotein cholesterol (1)
- low-dose imaging (1)
- low-dose radiation therapy (1)
- low-risk (1)
- lower extremity arterial disease (1)
- lower urinary tract obstruction (1)
- lumican (1)
- lung (1)
- lung disease (1)
- lung disease phenotype (1)
- lung remodeling (1)
- lung transplantation (1)
- luteolin (1)
- lymph nodes (1)
- lymphangiogenesis (1)
- lymphocyte (1)
- lymphocytes (1)
- lymphoma pathogenesis (1)
- lysosomes (1)
- l‐arginine:glycine amidinotransferase (1)
- mGluR3 (1)
- mGluR5 (1)
- mPGES-1 (1)
- mRNA (1)
- mRNA active cancer immunotherapy (1)
- mRNA and protein expression (1)
- mRNA decay (1)
- mRNA export (1)
- mRNA stability (1)
- mRNA vaccine (1)
- mTOR inhibition (1)
- mTOR inhibitor (1)
- mTOR inhibitors (1)
- mTORC (1)
- macula (1)
- macular hole (1)
- magentoencephalography (MEG) (1)
- magnetic field gradient (1)
- magnetic resonance imaging of the brain (1)
- magnetoencephalography (MEG) (1)
- maintenance therapy (1)
- major adverse cardiac events (1)
- major adverse cardiovascular events (1)
- major depression (1)
- major depression (MD) (1)
- major depressive disorder (1)
- major depressive disorder (MDD) (1)
- malaria elimination (1)
- malignancy (1)
- malignant glioma (1)
- mammals (1)
- mammary cancer (1)
- mammary carcinoma (1)
- mammary carcinomas (1)
- mandatory reporting system (1)
- mantle cell lymphoma (1)
- marathon (1)
- maraton (1)
- markovianity (1)
- maspin (1)
- mass spectrometry-based proteomics (1)
- massive parallel sequencing (1)
- massive weight loss (1)
- maternal care (1)
- maternal tobacco smoke (1)
- matrikine (1)
- matrix metalloproteinase (1)
- matrix metalloproteinases (1)
- maturation (1)
- mature T-cell lymphoma (1)
- mean diffusivity (1)
- measure development/validation (1)
- mechanical stimuli (1)
- mechanism of action (1)
- mechanistic target of rapamycin (mTOR) (1)
- mechanobactericidal surfaces (1)
- medial prefrontal cortex (1)
- medial thigh lift (1)
- medical and health research (1)
- medical error (1)
- medical history (1)
- medical illustration (1)
- medical informatics initiative (1)
- medical psychologoy (1)
- medical school (1)
- medical studies admission (1)
- medical teacher (1)
- medical teaching (1)
- medication (1)
- medication reconciliation (1)
- medication review (1)
- medications (1)
- medulloblastoma (1)
- medulloblastoma resection (1)
- memantine (1)
- membrane (1)
- membrane potential (1)
- membrane protein (1)
- membrane protein complex (1)
- membrane repair (1)
- membrane structure (1)
- memebrane (1)
- memory and learning tests (1)
- memory performance (1)
- mental health (1)
- mental health services (1)
- menthol (1)
- mentoring (1)
- men’s (1)
- merkel cell carcinoma (1)
- mesenchymal (1)
- mesenchymal stem cell (1)
- mesenchymal stromal cell (1)
- meta-analysis (1)
- metabolic cancer therapy (1)
- metabolic reprogramming (1)
- metabolic syndromes (1)
- metabolites (1)
- metalloprotease (1)
- metamorphosis (1)
- metaplasticity (1)
- metastability (1)
- metastasis-directed radiotherapy (1)
- metastates (1)
- metastatic cancer (1)
- metastatic colorectal cancer (1)
- metastatic melanoma stage IV (1)
- metastatic urethral cancer (1)
- meter (1)
- methotrexate (1)
- methylation profiling (1)
- methylglyoxal (1)
- methyltransferases (1)
- miR (1)
- miR-122 (1)
- miR-143-3p (1)
- miR-181 (1)
- miR-21 (1)
- miR-375 (1)
- miRNA let-7e (1)
- miRNA-17–92 (1)
- micelles (1)
- micro CT (1)
- microRNAs (1)
- microcirculation (1)
- microdeletions (1)
- microkeratome (1)
- microlesions (1)
- microplasmin (1)
- microsaccades (1)
- microsatellite instability (1)
- microsomal ethanol-oxidizing system (MEOS) (1)
- microsurgical treatment (1)
- microtubular cytoskeleton (1)
- microtubule disruptors (1)
- microtubule dynamics (1)
- microtubule-targeting agents (1)
- microwave breast imaging (1)
- midkine (1)
- migrants (1)
- migration and invasion (1)
- mindfulness (1)
- mini gastric bypass (1)
- minimal clinically important difference (1)
- minimally invasive cardiac surgery (1)
- mino acid metabolism (first pass) (1)
- mir-148a (1)
- mismatch repair (1)
- mitochondrial bioenergetics and glycolysis (1)
- mitochondrial dynamics (1)
- mitochondrial dysfunction (1)
- mitogen-activated protein kinase (1)
- mitogenic effects (1)
- mitomycin C (1)
- mitostatin (1)
- mitotic arrest (1)
- mitotic kinases (1)
- mixed micelles (1)
- mobile air quality study (1)
- mobile phone apps (1)
- mobile tongue cancer (1)
- mobilization (1)
- model curriculum (1)
- model psychosis (1)
- moisturing cream (1)
- molecular characteristics (1)
- molecular diagnosis (1)
- molecular diagnostics (1)
- molecular dynamics (1)
- molecular dynamics simulation (1)
- molecular identification (1)
- molecular marker (1)
- molecular pathology (1)
- molecular targeted drugs (1)
- molecular targeting (1)
- molecular therapy (1)
- molecular tumor board (1)
- molecular typing (1)
- momilactone A (1)
- momilactone B (1)
- monitoring (1)
- monkey (1)
- monkeys (1)
- monoamine oxidase A (1)
- monoclonal antibody (1)
- monocrotaline (1)
- monocyte chemotactic protein 1 (MCP-1) (1)
- monogenic disorders (1)
- mononuclear cell (1)
- montelukast (1)
- morbidity (1)
- morphological filtering (1)
- morphometry (1)
- motifs (1)
- motion analysis (1)
- motion capture (1)
- motor control (1)
- motor cortex (1)
- motor neuron disease (1)
- motor task (1)
- motor-evoked potential (1)
- mountain (1)
- mouse models (1)
- movement disorders (1)
- movement pattern (1)
- movement profile (1)
- mpMRI (1)
- mtor (1)
- mucormycete (1)
- mucormycetes (1)
- mucosal inflammation (1)
- mucositis (1)
- multi-drug resistance (1)
- multidisciplinary pain treatment (1)
- multidrug-resistant Gram-negative bacteria (MRGN) (1)
- multifocal (1)
- multimedia (1)
- multimodal complex treatment (1)
- multimorbidity [MeSH] (1)
- multiple choice question (1)
- multiple choice questions (1)
- multiple chronic conditions (1)
- multiple myeloma (1)
- multiple trauma (1)
- multiplex immunofluorescence (1)
- multiresistente Gram-negativen Stäbchenbakterien (MRGN) (1)
- multisensory (1)
- multisensory integration (1)
- multisite cooperation (1)
- multiunit activity (1)
- murine model (1)
- muscle (1)
- muscle disease (1)
- muscular dystrophies (1)
- muscular dystrophy (1)
- musculoskeletal modeling (1)
- musculoskeletal pain (1)
- musician (1)
- mutated neoantigens (1)
- mutational antigenic profiling (1)
- mutations (1)
- mutually exclusive mutations (1)
- mycophenolate mofetil [MMF] (1)
- myeloid cells (1)
- myeloperoxidase (1)
- myocardial infarction (1)
- myocardial injury (1)
- myocardial perfusion (1)
- myocarditis (1)
- myocardium (1)
- myocyte enhancer factor 2 (1)
- myoferlin (1)
- myogenic tone (1)
- myogenic vasoconstriction (1)
- myositis (1)
- myotonia congenita (1)
- nadomjesci za kost (1)
- nadp (1)
- naked haplo (1)
- nanobodies (1)
- nanoparticle (1)
- nanostructures (1)
- narrative content analysis (1)
- narrative economics (1)
- narrative medicine (1)
- natriuretic peptide (1)
- natural compounds (1)
- natural cytotoxicity (1)
- natural killer T cells (1)
- natural killer cell cultivation (1)
- natural killer cell cytotoxicity (1)
- natural killer cell expansion (1)
- natural killer cell therapy (1)
- natural sciences (1)
- naturalistic sample (1)
- necrosis (1)
- needle displacement (1)
- needs assessment (1)
- negative symptoms (1)
- neglect (1)
- negligencia (1)
- nematophin (1)
- neoadjuvant treatment (1)
- neocortex development (1)
- neocortical circuits (1)
- neoepitopes (1)
- neonatal intensive care unit (1)
- neonatal septic shock (1)
- neonates (1)
- neonatology (1)
- neosexual revolution (1)
- neosexualities (1)
- neovascularization, physiologic (1)
- nerve growth factor (NGF) (1)
- nerve injury (1)
- nerve-sparing (1)
- network (1)
- network neuroscience (1)
- network topology (1)
- networks (1)
- neural adaptation (1)
- neural computation (1)
- neural development (1)
- neural dynamics (1)
- neural systems (1)
- neurale Stammzellen (1)
- neuraminidase inhibitor (1)
- neuro-ophthalmological examination (1)
- neurobiology (1)
- neuroblastoma regression (1)
- neurocognition (1)
- neurodegenerative diseases (1)
- neurodevelopmental (1)
- neurodevelopmental disorders (1)
- neuroendocrine (1)
- neurofibrillary pathology (1)
- neuroinflammation (1)
- neuroinformatics (1)
- neurological diseases (1)
- neurological emergencies (1)
- neurological impairment (1)
- neurological outcome (1)
- neuronal avalanches (1)
- neuronal maturation (1)
- neuronale Netzwerke (1)
- neuronale Vorläuferzellen (1)
- neurons (1)
- neurooncology (1)
- neuropathological diagnosis (1)
- neuropathy (1)
- neuropilin-1 (1)
- neuroprotection (1)
- neuropsychiatric disorders (1)
- neuropsychological impairment (1)
- neuropsychology (1)
- neurosurgery (1)
- neurotrophins (1)
- neurovascular bundle preservation (1)
- neutral ceramidase (Asah2) (1)
- neutral sphingomyelinase (Smpd3) (1)
- neutralization (1)
- neutralizing antibodies (1)
- neutropenia (1)
- new miRNA functions (1)
- newborn infant (1)
- newborn screening (1)
- next-generation sequencing (1)
- nicotinic acetylcholine receptors (1)
- nintedanib (1)
- nitro-fatty acids (1)
- nitrogen dioxide (1)
- nitrogen oxides (NOx) (1)
- niños (1)
- nocardia (1)
- nocardiosis (1)
- nociception (1)
- nodular lymphocyte predominant Hodgkin lymphoma (1)
- nodular sclerosis (1)
- noise intervention measures (1)
- non - pharmacological anti-infective measures (1)
- non-Poissonian (1)
- non-ST-segment elevation acute coronary syndrome (1)
- non-canonical (1)
- non-classical adhesion molecule (1)
- non-communicable disease (1)
- non-communicable diseases (1)
- non-homologous end joining (1)
- non-invasive brain stimulation (1)
- non-invasive fibrosis assessment (1)
- non-linear dynamics (1)
- non-malignant hematological diseases (1)
- non-receptor tyrosine kinase (nRTK) (1)
- non-sensory bias (1)
- non-sexual (1)
- non-small cell lung cancer (1)
- non-small-cell lung cancer (1)
- non-spatial processing (1)
- nonalcoholic fatty liver disease (1)
- nonalcoholic steatohepatitis (1)
- noncoding RNA (1)
- noninterventional (1)
- nonnucleoside polymerase inhibitor (1)
- nonrandom connectivity (1)
- nonviral gene delivery (1)
- non‐selective beta‐blocker (1)
- non‑Hodgkin's lymphoma (1)
- novel H1N1 influenza (1)
- novel psychoactive substance (1)
- nuclear envelope (1)
- nuclear hormone receptor (1)
- nuclear import (1)
- nuclear pore complex (1)
- nuclear translocation (1)
- nucleotide analogue (1)
- nucleotide metabolism (1)
- nucleus accumbens (1)
- nursery school students (1)
- nursery students (1)
- nurses (1)
- nutrient deprivation (1)
- obese (1)
- objecitvity (1)
- object perception (1)
- object tracking (1)
- observational cohort study (1)
- occupational factors (1)
- occupational stress (1)
- ocriplasmin (1)
- off-pump surgery (1)
- offene Fragen (1)
- offset times (1)
- oksidacioni stres (1)
- older patients (1)
- older people (1)
- oligodendrocyte (1)
- oligomerization (1)
- olivo-ponto-cerebellar atrophy (OPCA) (1)
- omalizumab (1)
- omphalocele (1)
- oncogenes (1)
- oncological gastrectomy (1)
- oncological outcome (1)
- oncolytic virotherapy (1)
- oncomodulation (1)
- one anastomosis gastric bypass (1)
- one health (1)
- online information processing (1)
- online learning (1)
- online reasoning patterns (1)
- online survey (1)
- online teaching (1)
- open-source (1)
- operative (1)
- optical coherence tomography (1)
- optical imaging (1)
- oral and maxillofacial surgery (1)
- oral anticoagulation (1)
- oral cancer (1)
- oral enzyme combination (1)
- oral kallikrein inhibitor (1)
- oral squamous cell carcinoma (1)
- organ dysfunction (1)
- organ failure (1)
- organ of Corti (1)
- organisation of health services (1)
- organizational development (1)
- organophosphate flame retardants (OFR) (1)
- organotypic slice cultures (1)
- orientation (1)
- orientation selectivity (1)
- orthodeoxia (1)
- orthodontic mini‐implant (1)
- orthodontist (1)
- orthopaedic surgery (1)
- orthopic liver transplantation (1)
- oscillation (1)
- oscillator (1)
- oseltamivir (1)
- osteogenic sarcoma cells (1)
- osteoimmunological changes (1)
- osteopenia (1)
- osteoporosis treatment (1)
- osteotomy (1)
- ostium (1)
- otoferlin (1)
- ouabain (1)
- outcome parameter (1)
- oval split ring resonator (1)
- ovary (1)
- overall survival (OS) (1)
- overreaching markers (1)
- own-face perception (1)
- oxLDL (1)
- oxidised lipids (1)
- oxygen (1)
- oxygen metabolism (1)
- p14 (1)
- p16 (1)
- p21 phosphorylation (1)
- p21 stability (1)
- p21-activated kinase 2 (1)
- p22phox (1)
- p38 (1)
- p44/42 MAPK (1)
- p53 activator (1)
- p62 (1)
- p67phox (1)
- p73 (1)
- p75 (1)
- p97 (1)
- pCREB (1)
- pSMAD2 (1)
- pacemaker implantation (1)
- pack-years (PY) (1)
- paclitaxel sensitization (1)
- paediatric (1)
- paediatric nephrology (1)
- pain genetics (1)
- pain management (1)
- pain medication (1)
- pain questionnaire (1)
- pain research (1)
- pain target (1)
- pain, dorsal root ganglia (1)
- paired continuous theta burst stimulation (1)
- palbociclib (1)
- palmitoylation (1)
- pancreatic surgery (1)
- pandemic preparedness (1)
- papilloma (1)
- parameter estimation (1)
- parasite identity (1)
- parathormone (PTH) (1)
- parenting (1)
- parenting students (1)
- paricalcitol (1)
- parietal cortex (1)
- parkinson’s disease (1)
- parsley (1)
- participation (1)
- particle size distribution (1)
- particulate matter (PM) (1)
- passive immunization (1)
- passive reading paradigm (1)
- passive smoke (1)
- patency (1)
- patent (1)
- patent foramen ovale (1)
- pathogenesis (1)
- pathology (1)
- patient and public involvement (1)
- patient centered care (1)
- patient perspective (1)
- patient preference (1)
- patient preferences (1)
- patient questionnaire (1)
- patient study (1)
- patient-derived xenograft (1)
- patient-reported outcome measure (1)
- patient-reported outcomes (1)
- patients (1)
- patients' experience (1)
- patient‐centred outcomes (1)
- patient’s desires (1)
- patient’s perspective (1)
- pattern (1)
- patterns of progression (1)
- paxilline (1)
- pazopanib (1)
- peanut allergy (1)
- pediatric (1)
- pediatric cancer (1)
- pediatric epilepsy (1)
- pediatric eye screening (1)
- pediatric patients (1)
- pediatrics (1)
- pedicle screws (1)
- peficitinib (1)
- peg-interferon lambda (1)
- peginterferon (1)
- peginterferon-α (1)
- pelvic injury (1)
- pelvic ring fracture (1)
- pentafluorothio group (1)
- pentose phosphate pathway (1)
- perceptual memory (1)
- perceptual organization (1)
- perforin (1)
- performance assessment (1)
- performance evaluation (1)
- performance-based funding allocation (1)
- perfusion-weighted imaging (1)
- peri-implantitis (1)
- pericardial empyema (1)
- pericarditis (1)
- pericytes (1)
- perinasal skin cancer (1)
- perinatal HIV infection (1)
- perineurium (1)
- perio-prosthetic joint infection (1)
- periodontal disease progression (1)
- periodontal diseases (1)
- periodontal probing, (1)
- periodontal risk assessment (1)
- periodontal risk calculator (1)
- perioperative ischemia (1)
- perioperative mortality (1)
- perioperative outcome (1)
- perioperative period (1)
- peripheral arterial disease (1)
- peripheral blood mononuclear cells (1)
- peripheral blood stem cell transplant (1)
- peripheral nerve (1)
- peripheral vascular diseases (1)
- perirenal (1)
- peritoneal carcinomatosis (1)
- peri‐implant lesions (1)
- peri‐implant probing (1)
- peri‐implantitis therapy (1)
- persistent atrial fibrillation (1)
- persisting pain (1)
- person-oriented approach (1)
- personalised therapy (1)
- personalized oncology (1)
- pertuzumab (1)
- pervasive developmental disorders (1)
- pessary (1)
- pet rabbit (1)
- phage (1)
- phage display (1)
- phage therapy (1)
- phagocytes (1)
- pharmacist (1)
- pharmacoepidemiology (1)
- pharmacogenetics (1)
- pharmacogenomics (1)
- pharmacologic vitreolysis (1)
- pharmacology (1)
- phase 2 clinical trials (1)
- phase 3 study (1)
- phase II trial (1)
- phase III (1)
- phase coupling (1)
- phase-1 (1)
- phenolics (1)
- phenotype (1)
- phenotype/genotype relation (1)
- phenotypic screening (1)
- phenotypic spectrum (1)
- phenylephrine (1)
- phonological processing (1)
- phosphatases (1)
- phosphatidylinositols (1)
- phosphorus (1)
- phosphorylation (1)
- photoaging (1)
- photodynamic therapy (1)
- phylogenetic analysis (1)
- physical activity counseling (1)
- physical activity promotion (1)
- physical activity recommendations (1)
- physiotherapy (1)
- pibrentasvir (1)
- pictilisib (1)
- pig (1)
- pigs (1)
- pilot study (1)
- pineal (1)
- piperidone (1)
- pirinixic acid (1)
- pirinixic acid derivative (1)
- pitch perception (1)
- pivalate (1)
- pivoloyl (1)
- pixantrone (1)
- placement (1)
- plant growth (1)
- plant resistance (1)
- plant-insect interactions (1)
- plaque psoriasis (1)
- plasma membrane MICA (1)
- plasma-derived factor VIII concentrate, prophylaxis (1)
- plasminogen (1)
- plastic (1)
- platelet (1)
- platelet aggregation (1)
- platelet count (1)
- platelet lysate (1)
- platelet rich plasma (1)
- platform switching (1)
- platform-switched (1)
- platypnea (1)
- pleiotropin (1)
- pleomorphic xanthoastrocytoma (1)
- pleuropericarditis (1)
- plus-tip (1)
- pneumocystis carinii (1)
- pneumocystis pneumonia (1)
- pneumonia (1)
- podocytes (1)
- poetry (1)
- point shear wave elastography (1)
- pol g (1)
- polarization (1)
- polishing (1)
- pollen allergy (1)
- polo-like kinase (1)
- polo-like kinase 3 (1)
- poly(I:C) (1)
- poly-L-lysine (1)
- polyamines/metabolism (1)
- polycyclic aromatic hydrocarbon (1)
- polycystic kidney (1)
- polydipsia (1)
- polyethylenimine (1)
- polylactic acid (PLA) (1)
- polylactide (1)
- polyomavirus (1)
- polyomavirus (MCPyV) (1)
- polypharmacology (1)
- polyphenols (1)
- polysomnography (1)
- polysorbate 20 (1)
- polyuria (1)
- poor condition subarachnoid hemorrhage (1)
- popliteal artery (1)
- population-based (1)
- population-based surveillance (1)
- porcine (1)
- portosystemic shunt (1)
- posaconazole (1)
- post hoc study (1)
- post-liver transplantation management (1)
- post-translational modifications (PTMs) (1)
- post-transplantation lymphoproliferative disease (1)
- post-traumatic (1)
- post-traumatic osteoarthritis (1)
- posterior fossa masses (1)
- posterior parietal cortex (1)
- posterior vitreous detachment (1)
- postmortem interval (1)
- postnatal neurogenesis (1)
- postoperative delirium (1)
- posttranslational modification (1)
- posttransnational modification (1)
- posttraumatic inflammation (1)
- post‐traumatic stress disorder (1)
- potassium channels (1)
- power dynamics (1)
- ppi1 (1)
- practical exercises (1)
- pranlukast (1)
- pre-clinical models (1)
- pre-emptive allogeneic hematopoietic stem cell transplantation (1)
- pre-school asthma (1)
- preclinical (1)
- preclinical semesters (1)
- preconditioning (1)
- prediabetes (1)
- predialysis (1)
- prediction model (1)
- predictive biomarkers (1)
- predictive timing (1)
- predictive validity (1)
- pregnant (1)
- premature infant (1)
- premature transcript termination (1)
- premotor cortex (1)
- preoperative anaemia management (1)
- preoperative assessment (1)
- preoperative preparation (1)
- preparation (1)
- preprocedure prophylaxis (1)
- preschool asthma (1)
- preschool children (1)
- preschool health examination (1)
- presenilin (PS)/gamma-secretase activity (1)
- pressure (1)
- pressure cycling technology (1)
- pressure ulcer treatment (1)
- pressurized intraperitoneal aerosol chemotherapy (PIPAC) (1)
- preterm (1)
- pretreatment (1)
- prevalence of hysterectomy (1)
- prevent smoking (1)
- preventive medicine (1)
- primary biliary cirrhosis (1)
- primary biliary diseases (1)
- primary brain tumors (1)
- primary healthcare (1)
- primary immunodeficiency (PID) (1)
- primary motor cortex (1)
- primary motor cortex (M1) (1)
- primary mouse proximal tubular cells (1)
- primary prostate cancer (1)
- primary tubular cells (1)
- prior knowledge (1)
- proactive aggression (1)
- proanthocyanidin (1)
- procedural safety (1)
- process mining (1)
- productivity (1)
- progenitor (1)
- progeria (1)
- progesterone (1)
- progestin (1)
- prognosis research (1)
- prognostic biomarker (1)
- prognostic factor (1)
- programmed cell death (1)
- programmed cell death ligand 1 (1)
- programmed cell death protein 1 (1)
- progranulin (1)
- progression-free survival (PFS) (1)
- progressive myoclonus epilepsy (1)
- progressive neoplastic disease (1)
- proinflammatory microenvironment (1)
- promotion index (1)
- pronephric development (1)
- prophylactic vaccine (1)
- propofol anesthesia (1)
- proprotein convertase subtilisin/kexin type 9 inhibition (1)
- prospective memory (1)
- prospective studies (1)
- prostaglandin E2 (1)
- prostate and breast cancer cell lines (1)
- prostate brachytherapy (1)
- prostate cancer cells (1)
- prostate volume (1)
- prostate-specific antigen (1)
- prostatic cancer (1)
- proteases (1)
- protein C (1)
- protein kinase D (1)
- protein kinases (1)
- protein phosphatase 1 (PP1) inhibition/activation (1)
- protein phosphorylation (1)
- protein stability (1)
- protein tagging (1)
- protein transduction (1)
- protein/lentiviral transduction (1)
- protein–protein interactions (1)
- proteoglycans (1)
- proteostasis (1)
- proto-oncogene proteins c-akt (1)
- protocol compliance (1)
- proton density (1)
- proton pump inhibitors (1)
- proximal tubule cells (1)
- pruritus (1)
- pseudoexfoliative syndrome (1)
- psoriatic (1)
- psychiatric disorders (1)
- psychiatry (1)
- psycho-oncology (1)
- psychological (1)
- psychological distress (1)
- psychological model (1)
- psychological questionnaires (1)
- psychometric properties (1)
- psychometrics (1)
- psychosocial adjustment (1)
- psychosocial stress (1)
- psychotherapy (1)
- pteridine (1)
- public health department (1)
- public health. (1)
- public mental health (1)
- publication (1)
- pulmonary arterial hypertension (1)
- pulmonary endarterectomy (1)
- pulmonary inflammation (1)
- pulmonary nocardiosis (1)
- pulse labeling (1)
- pulse-spreading harmonic complex (1)
- pupil dilation (1)
- pupillary reactivity (1)
- putrescine/metabolism (1)
- pyramidal cell (1)
- qPCR (1)
- qRT-PCR (1)
- qRT-PCR detection (1)
- quality control (1)
- quality indicators (1)
- quality management (1)
- quality of care (1)
- quality of health care (1)
- quantification (1)
- quantitative T1 mapping (1)
- quantitative T1‐difference maps (1)
- quantitative mass spectrometry (1)
- quantitative proteomics (1)
- quantitative sensory testing (1)
- quantum biology (1)
- quantum neurobiology (1)
- rRNA (1)
- racket sports (1)
- radiation damage response (1)
- radiation oncology (1)
- radiation theraphy (1)
- radiation therapy (1)
- radiation-induced leukemia (1)
- radical oxygen species (1)
- radical prostatecomy (1)
- radical scavenging chemicals (1)
- radiofrequency (1)
- radiofrequency ablation (1)
- radioimmunotherapy (1)
- radioimmunotherpay (1)
- radiological (1)
- radiomic (1)
- radionuclide imaging (1)
- radioresponse (1)
- radiotherapy resistance (1)
- radixin (1)
- radon therapy (1)
- randomised controlled trial (1)
- randomized (1)
- randomized controlled trial (1)
- rare disease (1)
- rare disesases (1)
- rare variant (1)
- rare variants (1)
- rat femur defect (1)
- rat model (1)
- rct (1)
- re-emerging virus (1)
- re-transplantation (1)
- reactivation (1)
- reactive aggression (1)
- reactive oxygen species (ROS) (1)
- readmission rates (1)
- reaktivne vrste kiseonika (1)
- real-world (1)
- real-world evidence (1)
- receptor (1)
- receptor for advanced glycation end product (RAGE) (1)
- receptor tyrosine kinase (1)
- recertification (1)
- recombinant vesicular stomatitis virus‐Zaire ebolavirus (1)
- recommendation (1)
- recurrence (1)
- recurrent chromosomal translocations (1)
- recurrent laryngeal nerve palsy (1)
- recurrent mutations (1)
- recurrent optic neuritis (1)
- red blood cells (1)
- redox (1)
- redox signalling (1)
- redox-linked proton translocation (1)
- redundancy (1)
- redundant information (1)
- referred pain (1)
- reflexes (1)
- refractory aGvHD (1)
- registry for primary immunodeficiency (1)
- regorafenib (1)
- regorafenib csf concentration (1)
- regulation (1)
- regulatory T cell (1)
- regulatory T cells (1)
- relapsing fever (1)
- relapsing–remitting (1)
- relaxation (1)
- relaxometry (1)
- reliable change index (1)
- remifentanil (1)
- remission (1)
- remote ischemic preconditioning (1)
- remote monitoring (1)
- removal (1)
- renal failure (1)
- renal impairment (1)
- renal ischemia reperfusion injury (1)
- renal tubular cells (1)
- renal tubular epithelial cells (1)
- renin-angiotensin system (1)
- reorganization (1)
- repeat DMEK (1)
- repeat biopsy (1)
- repeated (1)
- reperfusion injury (1)
- repetition suppression (RS) (1)
- repetitive firing (1)
- repetitive transcranial magnetic stimulation (1)
- reproduction biology (1)
- repsonse process patterns (1)
- requirements analysis (1)
- research consortium (1)
- research in academic medicine (1)
- resective surgery (1)
- reserve substance (1)
- reservoir computing (1)
- resilience (1)
- resistance-associated substitutions (RAS) (1)
- resolution (1)
- resonance (1)
- resource utilization (1)
- respiratory complex I (1)
- respiratory disease (1)
- respiratory failure (1)
- restenosis (1)
- resting EEG (1)
- resting-state functional connectivity (1)
- resting‐state (1)
- restless legs syndrome (1)
- restrictive atrial communication (1)
- resuscitation (1)
- resveratrol (1)
- retina (1)
- retinal degeneration (1)
- retinal detachment (1)
- retinoic acid-related orphan receptor gamma t (1)
- retrospective (1)
- retrospective trial (1)
- retuximab (1)
- revalidation (1)
- reverse transcription (1)
- rhabdomyosarcomas (1)
- rheumatoid (1)
- rhodocetin-αβ (1)
- rhyme (1)
- rhythm (1)
- rhythmic aptitude (1)
- rhythms (1)
- ribociclib (1)
- ribosome-inactivating protein (1)
- rice husk (1)
- ridge preservation (1)
- right heart catheter (1)
- right ventricular function (1)
- riociguat (1)
- risk assessment (1)
- risk communication (1)
- risk factor progression (1)
- risk genes (1)
- risk management (1)
- risk score (1)
- rivaroxaban (1)
- robotic heart surgery (1)
- robotik kalp cerrahis (1)
- rolipram (1)
- romske ženske (1)
- root coverage (1)
- rosacea (1)
- rosetting T cells (1)
- roughness (1)
- rub-in technique (1)
- running (1)
- running wheel (1)
- rural health program (1)
- sCD163 (1)
- sCD206 (1)
- sE-cadherin (1)
- saliva (1)
- salvage radiotherapy (1)
- salvage therapy (1)
- sarcoma (1)
- sarcopenia (1)
- scaffold size (1)
- scaffolding proteins (1)
- scavenger receptor (1)
- schizophrenia spectrum (1)
- sciatic nerve (1)
- sciatic nerve injury (1)
- sclerosing cholangitis (1)
- sclerostin (1)
- scoping review (1)
- screening routine (1)
- screening test (1)
- screw augmentation (1)
- screw loosening (1)
- second mitochondria-derived activator of caspases mimetic (1)
- secondary cancer (1)
- secondary data analysis (1)
- secondary hyperparathyroidism (sHPT) (1)
- secondary schools (1)
- seed germination (1)
- segmentation (1)
- selectin (1)
- selection (1)
- selective attention (1)
- selective autophagy (1)
- selective autophagy receptor (1)
- selective mutism, (1)
- self-administration (1)
- self-citation (1)
- self-esteem (1)
- self-management support (1)
- self-organisation (1)
- self-organized criticality (1)
- self-schema (1)
- selfish genetic element (1)
- self‐expanding (1)
- semen (1)
- sensitization (1)
- sensorimotor exercise training (1)
- sensory deprivation (1)
- sensory neurons (1)
- sensory processing (1)
- sequential ALK-inhibitor therapy (1)
- serine palmitoyltransferase 2 (Sptlc2) (1)
- serology (1)
- serositis (1)
- serotonin (1)
- serum (1)
- serum albumin deficiency (1)
- serum concentrations (1)
- severe acute respiratory syndrome coronavirus (1)
- severe asthma (1)
- severe congenital neutropenia (1)
- severe uncontrolled asthma (1)
- severe vitamin D deficiency (1)
- sexual revolution (1)
- sexually transmitted diseases (1)
- sexually transmitted infection (1)
- sex‑determining region Y-box 11 (1)
- sham (1)
- shedding (1)
- shell ginger (1)
- shock (1)
- shock filter (1)
- short linear motifs (SLiMs) (1)
- short tandem repeats (1)
- short-chain ceramide (1)
- short-term prophylaxis (1)
- shortage of family doctors (1)
- shortening of treatment (1)
- shrinkage (1)
- siRNA delivery (1)
- siRNA/RNAi (1)
- sialitis (1)
- sickle cell anemia (1)
- signal transducer and activator of transcription (1)
- signal transducer and activator of transcription 3 (1)
- signal transducer and activator of transcription-1 (1)
- signalosome (1)
- silence interfering RNA (1)
- silicone device (1)
- silk fibroin (1)
- simeprevir (1)
- single best choice question (1)
- single choice questions (1)
- single nucleotide polymorphism (1)
- single-port cholecystectomy (1)
- single‐photon emission (1)
- sinus rhythm (1)
- sirtuin1 (1)
- sirtuins (1)
- six-step technique (1)
- size of cigarettes (1)
- skill mix (1)
- skills shortage (1)
- skin conductance (1)
- skin inflammation (1)
- skin involvement (1)
- sleep apnea (1)
- sleepiness (1)
- slow-wave rhythms (1)
- slowing (1)
- smac mimetic (1)
- small compounds (1)
- small leucine-rich proteoglycan (1)
- small molecule inhibitor (1)
- small molecules (1)
- small-angle neutron scattering (1)
- smoking in pregnancy (1)
- social cognitive (1)
- social determinants (1)
- social isolation (1)
- social psychiatry (1)
- socioeconomic status (1)
- sodium bituminosulfonate (1)
- sodium channels (1)
- sofosbuvir (1)
- soft drinks (1)
- soft skills (1)
- soft tissue sarcoma (STS) (1)
- solid tumors (1)
- solitary pulmonary nodule (1)
- soluble epoxide hydrolase (1)
- soluble tumor necrosis factor receptor (1)
- solvent (1)
- solvent displacement (1)
- somatic mutations (1)
- somatoform disorder (1)
- somatostatin interneurons (1)
- sonic hedgehog (1)
- sonic hedgehog signaling (1)
- sonidegib (1)
- sound analyses (1)
- sound-induced flash illusion (1)
- sox genes (1)
- spatial (1)
- spatial interactions (1)
- spatial processing (1)
- species differences (1)
- spectral activity (1)
- spectrin (1)
- spectroscopy (1)
- speech rhythm (1)
- speech segmentation (1)
- spermidine (1)
- sphinganine 1-phosphate (1)
- sphingolipid metabolism (1)
- sphingolipid sphingosine-1-phosphate (1)
- sphingosine 1-phoshate (1)
- sphingosine 1-phosphate antagonistst/inhibitors (1)
- sphingosine 1-phosphate metabolism (1)
- sphingosine 1-phosphate receptor (1)
- sphingosine 1-phosphate signaling (1)
- sphingosine kinase (1)
- sphingosine kinase 1 (1)
- sphingosine-1-phosphate receptor (1)
- sphingosine-1-phosphate receptor 5 (1)
- spider toxin (1)
- spike train (1)
- spike train analysis (1)
- spike-in SILAC (1)
- spike-timing dependent plasticity (1)
- spike-timing dependent-like plasticity (1)
- spinal fusion (1)
- spindle assembly (1)
- spindle mispositioning (1)
- spine (1)
- spinster homology protein 2 (Spns2) (1)
- spiral ganglion (1)
- spiral ganglion cell (1)
- spiral ganglion cells (1)
- spirochete (1)
- spirometry (1)
- spontaneous portosystemic shunt (1)
- sport (1)
- sports (1)
- squamous cell carcinoma (1)
- squamous cell carcinoma of head and neck (1)
- staff capacity (1)
- staff fluctuation (1)
- stage (1)
- stage II/III colorectal cancer (1)
- standard value (1)
- standardization (1)
- standardized regression-based change norms (1)
- starvation (1)
- state exams (1)
- statedependence (1)
- statistical parametric mapping (1)
- steatosis (1)
- stellate reticulum (1)
- stem cell niche (1)
- stem cell therapy (1)
- stem cells (1)
- stem/progenitor cell expansion (1)
- stenosis (1)
- stenosis quantification (1)
- stent (1)
- stereoselectivity (1)
- stereotactic (1)
- sterile abscess (1)
- sterile α motif (SAM) (1)
- steroid control of aging (1)
- steroid-resistant aGvHD (1)
- sterol regulatory element binding protein-2 (1)
- stimulation (1)
- stimulus coding (1)
- stiripentol (1)
- stopping rule (1)
- stratification (1)
- strength (1)
- strength and conditioning mesocycle (1)
- strength training (1)
- stretching (1)
- stroke prevention (1)
- stromal-derived factor 1 (1)
- structural biology and molecular biophysics (1)
- structural covariance (1)
- structural equation modeling (1)
- structural plasticity (1)
- structure (1)
- structure–activity relationships (1)
- studentisches Lernverhalten (1)
- study protocol (1)
- subcutaneous fat (1)
- subcutaneous immunotherapy (1)
- subject selection (1)
- subjunctivity (1)
- sublingual immunotherapy (1)
- substance abuse disorder (1)
- subventricular zone (1)
- subventricular zone (SVZ) (1)
- success rate (1)
- succession (1)
- suicidality (1)
- suicide (1)
- sulfasalazine (1)
- sulfur dioxide (1)
- sulfur globules (1)
- superficial femoral artery (1)
- superiority (1)
- supervised machine-learning (1)
- supervision (1)
- supervisión (1)
- suplementacija (1)
- supplementary motor area (1)
- supplementary motor area (SMA) (1)
- supplementation (1)
- support vector machines (1)
- suprapubic catheter (1)
- surface marker reversion (1)
- surface-based morphometry (1)
- surfactant (1)
- surgical margin (1)
- surveillance (1)
- survey (1)
- sympathetic nervous system (1)
- sympathicus (1)
- symptoms (1)
- synapse (1)
- synaptic plasticity (1)
- synaptic signaling (1)
- syncope (1)
- synergistic interaction (1)
- synovial fibroblast (1)
- synoviocyte (1)
- synovium (1)
- syntax (1)
- synuclein (1)
- systematic biopsy (1)
- systematisches Review (1)
- systemic antibiotics (1)
- systemic inflammation (1)
- systemic lupus erythematosus (1)
- systemic sclerosis (1)
- szentiamide (1)
- t(6;9) (1)
- t-distributed stochastic neighbor embedding (1)
- tDCS (1)
- tRNA (1)
- tacrolimus (1)
- tailored treatment schedule (1)
- talent development (1)
- talent identification (1)
- tandem mass spectrometry (1)
- target variability (1)
- targeted biopsy (1)
- targeting (1)
- task set (1)
- task-switching training (1)
- tea (1)
- teach-the-teacher (1)
- teacher training (1)
- teacher's training (1)
- teachers' training (1)
- teaching competencies (1)
- teaching skills (1)
- tear (1)
- tehnika dekalcifikacije (1)
- telmisartan (1)
- temporal correlations (1)
- temsirolimus-resistance (1)
- terapia cognitivo conductual enfocada en trauma (1)
- teratoma (1)
- terebridae venom (1)
- terminology (1)
- test protocol (1)
- testicular cancer (1)
- testing (1)
- testis (1)
- testosterone (1)
- tetracycline (1)
- tetraether lipid (1)
- tetrahydrobiopterin (1)
- tetrahydrocannabinol (1)
- thalassemia (1)
- thalidomide (1)
- the allen institute for brain science (1)
- the small molecule inhibitor MRIA9 (1)
- theory of sexuality (1)
- theranostics (1)
- therapeutics (1)
- therapy at the end of life (1)
- thiazolidine and perhydrothiazine derivatives of aldophosphamide and I-aldophosphamide (1)
- thighplasty (1)
- thioredoxin (1)
- thiosulfate oxidation (1)
- third (1)
- thoracolumbar spine injury classification system (1)
- thoracolumbar trauma (1)
- three point bending test (1)
- three-dimensional analysis (1)
- three‐dimensional analysis (1)
- thrombocyte dysfunction (1)
- thrombocyte function (1)
- thrombocytopenia (1)
- thrombocytosis (1)
- thrombolysis (tPA) (1)
- thrombopenia (1)
- thrombopietin receptor agonist (1)
- thrombosis (1)
- thrombospondin-4 (1)
- thrombotic microangiopathy (1)
- thrombotic thrombocytopenic purpura (1)
- thyroglobulin mRNA (1)
- thyroid cancer (1)
- thyroid nodule (1)
- thyroid resection (1)
- thyroid surgery (1)
- tick (1)
- time-lapse imaging (1)
- tiotropium (1)
- tissue at risk (1)
- tissue engineering (1)
- tissue mechanics (1)
- tissue slice co-cultures (1)
- titanium (1)
- titanium particles (1)
- tobacco cessation (1)
- tobacco control (1)
- tobacco products (1)
- tobacco taxation (1)
- toc64 (1)
- tolerability (1)
- tolerance (1)
- toll-like receptors (1)
- tolvaptan (1)
- tomography (1)
- tongue edema (1)
- tooth (1)
- tooth autotransplantation (1)
- tooth transplantation (1)
- tooth wear (1)
- top-down (1)
- top-down processing (1)
- topical agent (1)
- topographic maps (1)
- top–down (1)
- total body score (1)
- total events (1)
- total flavonoids (1)
- total joint arthroplasty (TJA) (1)
- total phenols (1)
- toxic hemisphere syndrome (1)
- toxin B (1)
- tpileptogenesis (1)
- tracheobronchomalacia (1)
- tracking (1)
- tractography (1)
- traffic accident (1)
- traffic emissions (1)
- trafficking (1)
- training effects (1)
- training program (1)
- training transfer (1)
- trans-Golgi network (1)
- transapical aortic valve replacement (1)
- transarterial chemoembolization (TACE) (1)
- transbronchial biopsy (TBB) (1)
- transcatheter aortic valve replacement (1)
- transcatheter aortic valve replacement (TAVR) (1)
- transcatheter aortic valve replacement (TAVR), aortic valve stenosis (AS) (1)
- transcatheter closure (1)
- transcranial alternating current stimulation (tACS) (1)
- transcription factor (1)
- transcription factors (1)
- transcriptional profiling (1)
- transcriptional regulation of autophagy (1)
- transcriptome analysis (1)
- transcriptomics (1)
- transdifferentiation (1)
- transfemoral (1)
- transfer (1)
- transforming growth factor beta (1)
- transforming growth factor beta (TGF-β) (1)
- transforming growth factor-β (1)
- transgelin (1)
- transgenically augmented CAR NK cell (1)
- transient interactions (1)
- transient receptor potential channels (1)
- transient virtual lesion (1)
- transition (1)
- transjugular intrahepatic portosystemic shunt (TIPS) (1)
- transjugular portosystemic intrahepatic (1)
- transketolase-like protein 1 (1)
- translation (1)
- translational cancer research (1)
- translational medical research (1)
- translational medicine (1)
- translational reseach (1)
- translocation partner genes (1)
- translocon (1)
- transmission and vector control (1)
- transmission routes (1)
- transmitted founder virus (1)
- transportation (1)
- transposition (1)
- transrectal prostate biopsy (1)
- transsexualism (1)
- transurethral catheter (1)
- transverse axis (1)
- traumafocused cognitive behavioural therapy (1)
- traumatic brain injury (1)
- traumatic brain injury (TBI) (1)
- treatment choice (1)
- treatment preference (1)
- treatment-related changes (1)
- treatment-resistant (1)
- trehalose (1)
- triathlon (1)
- tricalcium phosphate (1)
- trichostatin A (1)
- trigeminal pain (1)
- triple therapy (1)
- trochee (1)
- trophiclevel (1)
- trophoblastic cell lines (1)
- trophoblasts (1)
- tropical marine sponges (1)
- troponin (1)
- trust (1)
- trustworthy AI (1)
- tryptophan (1)
- tuberculosis epidemiology (1)
- tuberous sclerosis complex (1)
- tubular regeneration (1)
- tuft cells (1)
- tumor (1)
- tumor adhesion (1)
- tumor cell proliferation (1)
- tumor dissemination (1)
- tumor growth in xenografts (1)
- tumor immune escape (1)
- tumor immune evasion (1)
- tumor invasion (1)
- tumor metabolism (1)
- tumor microenviroment (1)
- tumor microenvironment (TME) (1)
- tumor migration (1)
- tumor necrosis factor converting enzyme (1)
- tumor necrosis factor receptor superfamily member 9 (1)
- tumor pain (1)
- tumor proliferation (1)
- tumor response (1)
- tumor stroma (1)
- tumor weight (1)
- tumor xenograft (1)
- tumor-infiltrating-lymphocytes (1)
- tumor-specific antigen expressing dendritic cells (1)
- tumor‐associated macrophages (1)
- tumour (1)
- tumour growth (1)
- tumour immunology (1)
- tumour microenvironment (1)
- tumour-infiltrating lymphocytes (1)
- two-tissue compartment model (1)
- type 1 diabetes (1)
- type B (1)
- type I interferon (1)
- type I interferons (1)
- type I interferons (IFNs) (1)
- type-1-diabetes (1)
- tyrosinase inhibitor (1)
- tyrosine kinase inhibitors (1)
- tyrosine kinase inhibitors. (1)
- ubiquitin coat (1)
- ubiquitin receptor (1)
- ubiquitin-binding zinc finger (1)
- ulcerative colitis (1)
- ultra-high field MRI (1)
- unanticipated (1)
- uncertainty (1)
- understudied kinase (1)
- unfolded protein response (1)
- unguided (1)
- unilateral hip osteoarthritis (1)
- unique information (1)
- university hospitals (1)
- upper gastrointestinal cancer (1)
- urachal cancer (1)
- urethral stricture (1)
- urethroplasty (1)
- urinary diversion (1)
- urinary tract development (1)
- ursodeoxycholic acid (1)
- uterine cervical cancer (1)
- vaccination rates (1)
- vaccine acceptance (1)
- vaccine trial (1)
- vacuuming (1)
- vadimezan (1)
- validation studies (1)
- value frameworks (1)
- vancomycin (1)
- variability (1)
- vascular (1)
- vascular calcification (1)
- vascular complications (1)
- vascular disease (1)
- vascular disrupting agents (1)
- vascular dysfunction and inflammation (1)
- vascular endothelial growth factor (1)
- vascular endothelial growth factor receptor (1)
- vascular endothelial growth factor receptor 2 (1)
- vascular remodeling (1)
- vascular smooth muscle (1)
- vascular smooth muscle cells (1)
- vascular surgery (1)
- vasculogenic mimicry (1)
- vasoconstriction (1)
- vasodilation (1)
- vasopressin (1)
- vector-borne disease (1)
- velpatasvir (1)
- veneering porcelain (1)
- ventilation modes (1)
- ventral striatum (1)
- ventricular zone (VZ) (1)
- ventriculoperitoneal shunt (1)
- venturesomeness (1)
- versican (VCAN) (1)
- vertebrates (1)
- vertebroplasty (1)
- verzweigtkettige Aminosäuren (1)
- vesicovaginal septum (1)
- vesicular glutamate transporter 2 (1)
- vessel density (1)
- vessel-associated mural cells (1)
- vestibular schwannoma (1)
- viability (1)
- videos (1)
- vigilance (1)
- vincristine (1)
- violence (1)
- viral gene transfer (1)
- viral infection (1)
- viral tracing (1)
- viral vectors (1)
- virological failure (1)
- virulence (1)
- virus (1)
- virus-like particles (1)
- viscero-cutaneous (1)
- vision (1)
- vismodegib (1)
- vismodegib (GDC-0449) (1)
- visual cortex (1)
- visual illusion (1)
- visual priming (1)
- visual short-term memory (1)
- visual system (1)
- visuo-spatial attention (1)
- visuospatial attention (1)
- vitamin D deficiency (1)
- vitamin D metabolites (1)
- vitamin D receptor (1)
- vitamin D supplementation (1)
- vitamin D target genes (1)
- vitamin D3 (1)
- vitamin Dmetabolism (1)
- vitreomacular traction (1)
- vitreous samples (1)
- vocal cord dysfunction (1)
- vocal cord palsy (1)
- voice (1)
- volatile organic compounds (VOC) (1)
- volatile sedation (1)
- voltage sensitive dye imaging (1)
- voluntary training (1)
- von Willebrand disease (1)
- von Willebrand diseases (1)
- voxel-based morphometry (1)
- voxilaprevir (1)
- waking state (1)
- water parameter (1)
- wax layer (1)
- wear (1)
- western blotting (1)
- wheezing (1)
- white matter changes (1)
- white-matter (1)
- whole abdominal radiotherapy (1)
- whole genome sequencing (1)
- whole slide image (1)
- whole-brain modeling (1)
- wild animals (1)
- wild boar carcass (1)
- willingness to participate (1)
- winter survival (1)
- within-host viral modeling (1)
- women (1)
- words (1)
- work ability (1)
- work productivity (1)
- work-life balance (1)
- workplace health promotion (1)
- wound complications (1)
- xenobiotics (1)
- xenophagy (1)
- yeast-two-hybrid (Y2H) (1)
- yellow fever virus (1)
- yellow fever virus tropism (1)
- yield optimization (1)
- young people (1)
- youth football (1)
- zafirlukast (1)
- zebrafish development (1)
- zirconia (1)
- zymosan (1)
- Übernahme von Innovationen (1)
- Übertragungswege (1)
- Überwachung (1)
- ß-D-glucan (1)
- ß-tricalciumphosphate (1)
- α-amylase inhibitor (1)
- α-mannosidosis (1)
- α-particles (1)
- α-synuclein (1)
- αvβ3 integrin (1)
- β-catenin (1)
- β-lactamases (1)
- γH2AX (1)
- γδT cell (1)
- γ‐H2AX (1)
- μ-opioid receptor regulation (1)
- π-clamp (1)
- гепатит С (1)
- правила прекращения лечения (1)
- противовирусные препараты прямого действия (ПППД) (1)
- сокращение лечения (1)
- устойчивый вирусологический ответ (УВО) (1)
- “gatekeeper” mutation T315I (1)
- flow cytometry (1)
Institute
- Medizin (3563) (remove)
Autophagy is the highly conserved catabolic process, which enables the survival of a cell under unfavorable environmental conditions. In a constantly changing environment, cells must be capable of dynamically oscillating between anabolism and catabolism in order to maintain cellular homeostasis. In this context, the activity of the mechanistic Target Of Rapamycin Complex 1 (mTORC1) is of major importance. As a central signaling node, it directly controls the process of macroautophagy and thus cellular metabolism. Thereby, the control of mTORC1 is equally crucial as the regulation of cellular homeostasis itself, whereby particular importance is attributed to amino acid sensory proteins. In this review, we describe the recent findings of macroautophagy and mTORC1 regulation by upstream amino acid stimuli in different subcellular localizations. We highlight in detail which proteins of the sensor complexes play a specific role in this regulation and point out additional non-canonical functions, e.g. in the regulation of macroautophagy, which have received little attention so far.
Hintergrund: In den vergangenen 10 Jahren wurden an verschiedenen Epilepsiezentren in Deutschland (Bochum, Erlangen, Greifswald, Berlin Brandenburg, Frankfurt Rhein-Main) Projekte entwickelt, die sich mit telemedizinischen Arzt-zu-Arzt-Anwendungen im Bereich der Epilepsieversorgung beschäftigen.
Ziel der Arbeit: Im Folgenden wird ein Überblick über die aktuell laufenden telemedizinischen Projekte in der Epilepsieversorgung in Deutschland gegeben.
Material und Methoden: Die Verantwortlichen der einzelnen Projekte stellen ihr Projekt anhand einer vorgegebenen Struktur dar.
Ergebnisse und Diskussion: In allen Projekten konnte gezeigt werden, dass eine technische Lösung für die telemedizinische Arzt-zu-Arzt Anwendung im Bereich Epileptologie geschaffen werden kann. Die dargestellten Projekte unterscheiden sich zum Teil hinsichtlich des Zieles und der Umsetzung, zum Teil zeigen sich Übereinstimmungen. Perspektivisches Ziel ist es, aus den Erfahrungen der einzelnen Projekte eine gemeinsame Strategie zur Förderung epileptologischer Telemedizin und ihrer Überführung in die Regelversorgung zu entwickeln.
Serum GFAP for stroke diagnosis in regions with limited access to brain imaging (BE FAST India)
(2021)
Introduction: Despite a high burden of stroke, access to rapid brain imaging is limited in many middle- and low-income countries. Previous studies have described the astroglial protein GFAP (glial fibrillary acidic protein) as a biomarker of intracerebral hemorrhage. The aim of this study was to test the diagnostic accuracy of GFAP for ruling out intracranial hemorrhage in a prospective cohort of Indian stroke patients. Patients and methods: This study was conducted in an Indian tertiary hospital (Christian Medical College, Ludhiana). Patients with symptoms suggestive of acute stroke admitted within 12 h of symptom onset were enrolled. Blood samples were collected at hospital admission. Single Molecule Array technology was used for determining serum GFAP concentrations. Results: A total number of 155 patients were included (70 intracranial hemorrhage, 75 ischemic stroke, 10 stroke mimics). GFAP serum concentrations were elevated in intracranial hemorrhage patients compared to ischemic stroke patients [median (interquartile range) 2.36 µg/L (0.61–7.16) vs. 0.18 µg/L (0.11–0.38), p < 0.001]. Stroke mimics patients had a median GFAP serum level of 0.14 µg/L (0.09–0.26). GFAP values below the cut-off of 0.33 µg/L (area under the curve 0.871) ruled out intracranial hemorrhage with a negative predictive value of 89.7%, (at a sensitivity for detecting intracranial hemorrhage of 90.0%). Discussion: The high negative predictive value of a GFAP test system allows ruling out patients with intracranial hemorrhage. Conclusion: In settings where immediate brain imaging is not available, this would enable to implement secondary prevention (e.g., aspirin) in suspected ischemic stroke patients as soon as possible.
Mitofusin 2 (MFN2) is a mitochondrial outer membrane GTPase, which modulates mitochondrial fusion and affects the interaction between endoplasmic reticulum and mitochondria. Here, we explored how MFN2 influences mitochondrial functions and inflammatory responses towards zymosan in primary human macrophages. A knockdown of MFN2 by small interfering RNA decreased mitochondrial respiration without attenuating mitochondrial membrane potential and reduced interactions between endoplasmic reticulum and mitochondria. A MFN2 deficiency potentiated zymosan-elicited inflammatory responses of human primary macrophages, such as expression and secretion of pro-inflammatory cytokines interleukin-1β, -6, -8 and tumor necrosis factor α, as well as induction of cyclooxygenase 2 and prostaglandin E2 synthesis. MFN2 silencing also increased zymosan-induced nuclear factor kappa-light-chain-enhancer of activated B cells and mitogen-activated protein kinases inflammatory signal transduction, without affecting mitochondrial reactive oxygen species production. Mechanistic studies revealed that MFN2 deficiency enhanced the toll-like receptor 2-dependent branch of zymosan-triggered responses upstream of inhibitor of κB kinase. This was associated with elevated, cytosolic expression of interleukin-1 receptor-associated kinase 4 in MFN2-deficient cells. Our data suggest pro-inflammatory effects of MFN2 deficiency in human macrophages.
The purpose of this narrative review is to discuss and highlight recently published studies regarding the surgical management of patients suffering from prostate cancer treatment complications. Focus will be put on the recalcitrant and more complex cases which might lead to urinary diversion as a definite, last resort treatment. It is in the nature of every treatment, that complications will occur and be bothersome for both patients and physicians. A small percentage of patients following prostate cancer treatment (radical prostatectomy, radiation therapy, or other focal therapies) will suffer side effects and thus, will experience a loss of quality of life. These side effects can persist for months and even years. Often, conservative management strategies fail resulting in recalcitrant recurrences. Prostate cancer patients with “end-stage bladder,” “devastated outlet,” or a history of multiple failed interventions, are fortunately rare, but can be highly challenging for both patients and Urologists. In a state of multiple previous surgical procedures and an immense psychological strain for the patient, urinary diversion can offer a definite, last resort surgical solution for this small group of patients. Ideally, they should be transferred to centers with experience in this field and a careful patient selection is needed. As these cases are highly complex, a multidisciplinary approach is often necessary in order to guarantee an improvement of quality of life.
Clinical data on antifungal combination therapy are limited, in particular in the pediatric setting. We analyzed real-life data collected in two major pediatric cancer centers over a period of 4 years. Patients were identified in an observational study on children with acute leukemia and lymphoma or undergoing hematopoietic cell transplantation. Out of 438 patients, 19 patients received 21 episodes of antifungal combination therapy. Therapy was mostly started for sepsis (n = 5) or clinical deterioration with pulmonary infiltrates (n = 10), and less often for periorbital swelling with suspected mold infection (n = 2), clinical deterioration and new skin lesions, secondary antifungal prophylaxis, a persistently elevated galactomannan index, or as pre-emptive treatment (n = 1 each). Diagnostics revealed proven, probable, and possible invasive fungal disease in two, seven and four episodes, respectively. Most regimens included caspofungin (n = 19), and treatment was initiated as first line therapy in 10 episodes. The median duration was 13 days (4–46 days). Nine of the 13 patients with proven, probable, or possible invasive fungal disease survived, which was comparable to patients receiving antifungal monotherapy. Our analysis demonstrates that combination therapy has mainly been prescribed in selected immunocompromised patients with clinical deterioration due to suspected invasive fungal disease or those with sepsis, and is well tolerated. Future studies need to better characterize clinical settings in which patients may benefit from antifungal combination therapy.
Chronic intestinal failure (CIF) is a rare but feared complication of Crohn’s disease. Depending on the remaining length of the small intestine, the affected intestinal segment, and the residual bowel function, CIF can result in a wide spectrum of symptoms, from single micronutrient malabsorption to complete intestinal failure. Management of CIF has improved significantly in recent years. Advances in home-based parenteral nutrition, in particular, have translated into increased survival and improved quality of life. Nevertheless, 60% of patients are permanently reliant on parenteral nutrition. Encouraging results with new drugs such as teduglutide have added a new dimension to CIF therapy. The outcomes of patients with CIF could be greatly improved by more effective prevention, understanding, and treatment. In complex cases, the care of patients with CIF requires a multidisciplinary approach involving not only physicians but also dietitians and nurses to provide optimal intestinal rehabilitation, nutritional support, and an improved quality of life. Here, we summarize current literature on CIF and short bowel syndrome, encompassing epidemiology, pathophysiology, and advances in surgical and medical management, and elucidate advances in the understanding and therapy of CIF-related complications such as catheter-related bloodstream infections and intestinal failure-associated liver disease.
Climate change and variability affect virtually everyone and every region of the world but the effects are nowhere more prominent than in mountain regions and people living therein. The Hindu Kush Himalayan (HKH) region is a vast expanse encompassing 18% of the world’s mountainous area. Sprawling over 4.3 million km2, the HKH region occupies areas of eight countries namely Nepal, Bhutan, Afghanistan, Bangladesh, China, India, Myanmar, and Pakistan. The HKH region is warming at a rate higher than the global average and precipitation has also increased significantly over the last 6 decades along with increased frequency and intensity of some extreme events. Changes in temperature and precipitation have affected and will like to affect the climate-dependent sectors such as hydrology, agriculture, biodiversity, and human health. This paper aims to document how climate change has impacted and will impact, health and well-being of the people in the HKH region and offers adaptation and mitigation measures to reduce the impacts of climate change on health and well-being of the people. In the HKH region, climate change boosts infectious diseases, non-communicable diseases (NCDs), malnutrition, and injuries. Hence, climate change adaptation and mitigation measures are needed urgently to safeguard vulnerable populations residing in the HKH region.
The kidneys play a vital role in the basic physiological functions of the body. Kidney dysfunction impairs these physiological functions and can lead to a wide range of diseases. Damage to the kidney cells can be caused by a variety of ischemic, toxic or immunological complaints that lead to inflammation and cell death, which can lead to organ damage and, ultimately, complete failure. Although the mechanisms underlying acute kidney injury (AKI) and chronic kidney disease (CKD) are quite distinct, clinical evidence suggests that the two conditions are inextricably interconnected [1]. AKI and CKD, regardless of the underlying cause, have inflammation and activation of the immune system as the common underlying mechanisms. Inflammation, a process aimed, in principle, at detecting and fighting harmful pathogens, is, therefore, a major pathogenic mechanism for both AKI and CKD [1]. While the kidney has the remarkable ability to regenerate after an acute injury and can recover completely, depending on the type of kidney lesion, the options for clinical interventions are currently limited to fluid management and extracorporeal kidney support. However, persistent chronic inflammation can trigger renal fibrosis and chronic kidney disease. The investigation of the molecular mechanisms involved in each individual injury is currently insufficiently understood.
We report here that RUFY4, a newly characterized member of the ‘RUN and FYVE domain-containing’ family of proteins previously associated with autophagy enhancement, is highly expressed in alveolar macrophages (AM). We show that RUFY4 interacts with mitochondria upon stimulation by microbial-associated molecular patterns of AM and dendritic cells. RUFY4 interaction with mitochondria and other organelles is dependent on a previously uncharacterized OmpH domain located immediately upstream of its C-terminal FYVE domain. Further, we demonstrate that rufy4 messenger RNA can be translated from an alternative translation initiation codon, giving rise to a N-terminally truncated form of the molecule lacking most of its RUN domain and with enhanced potential for its interaction with mitochondria. Our observations point towards a role of RUFY4 in selective mitochondria clearance in activated phagocytes.
The heterogeneity and complexity of glycosylation hinder the depth of site-specific glycoproteomics analysis. High-field asymmetric-waveform ion-mobility spectrometry (FAIMS) has been shown to improve the scope of bottom-up proteomics. The benefits of FAIMS for quantitative N-glycoproteomics have not been investigated yet. In this work, we optimized FAIMS settings for N-glycopeptide identification, with or without the tandem mass tag (TMT) label. The optimized FAIMS approach significantly increased the identification of site-specific N-glycopeptides derived from the purified immunoglobulin M (IgM) protein or human lymphoma cells. We explored in detail the changes in FAIMS mobility caused by N-glycopeptides with different characteristics, including TMT labeling, charge state, glycan type, peptide sequence, glycan size, and precursor m/z. Importantly, FAIMS also improved multiplexed N-glycopeptide quantification, both with the standard MS2 acquisition method and with our recently developed Glyco-SPS-MS3 method. The combination of FAIMS and Glyco-SPS-MS3 methods provided the highest quantitative accuracy and precision. Our results demonstrate the advantages of FAIMS for improved mass spectrometry-based qualitative and quantitative N-glycoproteomics.
Background: Secukinumab [an interleukin (IL)‐17A inhibitor] has demonstrated significantly higher efficacy vs. etanercept (a tumour necrosis factor inhibitor) and ustekinumab (an IL‐12/23 inhibitor) in patients with moderate‐to‐severe plaque psoriasis.
Objectives: To report 52‐week results from a prespecified analysis of patients with active psoriatic arthritis (PsA) having concomitant moderate‐to‐severe plaque psoriasis from the head‐to‐head EXCEED monotherapy study comparing secukinumab with adalimumab.
Methods: Patients were randomized to receive secukinumab 300 mg via subcutaneous injection at baseline, week 1–4, and then every 4 weeks until week 48 or adalimumab 40 mg via subcutaneous injection every 2 weeks from baseline until week 50. Assessments in patients with concomitant moderate‐to‐severe psoriasis, defined as having affected body surface area > 10% or Psoriasis Area and Severity Index (PASI) ≥ 10 at baseline, included musculoskeletal, skin and quality‐of‐life outcomes. Missing data were handled using multiple imputation.
Results: Of the 853 patients [secukinumab (N = 426), adalimumab (N = 427)], 211 (24·7%) had concomitant moderate‐to‐severe psoriasis [secukinumab (N = 110, 25·8%), adalimumab (N = 101, 23·7%)]. Up to week 50, 5·5% of patients discontinued secukinumab vs.17·8% in the adalimumab group. The proportion of patients who achieved American College of Rheumatology (ACR) 20 response was 76·4% with secukinumab vs. 68·3% with adalimumab (P = 0·175), PASI 100 response was 39·1% vs. 23·8% (P = 0·013), and simultaneous improvement in ACR 50 and PASI 100 response at week 52 was 28·2% vs. 17·7%, respectively (P = 0·06). Secukinumab demonstrated consistently higher responses vs. adalimumab across skin endpoints.
Conclusions: This prespecified analysis in PsA patients with concomitant moderate‐to‐severe plaque psoriasis in the EXCEED study provides further evidence that IL‐17 inhibitors offer a comprehensive biological treatment to manage the concomitant features of psoriasis and PsA.
Pathogens possess the ability to adapt and survive in some host species but not in others–an ecological trait known as host tropism. Transmitted through ticks and carried mainly by mammals and birds, the Lyme disease (LD) bacterium is a well-suited model to study such tropism. Three main causative agents of LD, Borrelia burgdorferi, B. afzelii, and B. garinii, vary in host ranges through mechanisms eluding characterization. By feeding ticks infected with different Borrelia species, utilizing feeding chambers and live mice and quail, we found species-level differences in bacterial transmission. These differences localize on the tick blood meal, and specifically complement, a defense in vertebrate blood, and a polymorphic bacterial protein, CspA, which inactivates complement by binding to a host complement inhibitor, Factor H (FH). CspA selectively confers bacterial transmission to vertebrates that produce FH capable of allele-specific recognition. CspA is the only member of the Pfam54 gene family to exhibit host-specific FH-binding. Phylogenetic analyses revealed convergent evolution as the driver of such uniqueness, and that FH-binding likely emerged during the last glacial maximum. Our results identify a determinant of host tropism in Lyme disease infection, thus defining an evolutionary mechanism that shapes host-pathogen associations.
Under natural conditions, the visual system often sees a given input repeatedly. This provides an opportunity to optimize processing of the repeated stimuli. Stimulus repetition has been shown to strongly modulate neuronal-gamma band synchronization, yet crucial questions remained open. Here we used magnetoencephalography in 30 human subjects and find that gamma decreases across ≈10 repetitions and then increases across further repetitions, revealing plastic changes of the activated neuronal circuits. Crucially, increases induced by one stimulus did not affect responses to other stimuli, demonstrating stimulus specificity. Changes partially persisted when the inducing stimulus was repeated after 25 minutes of intervening stimuli. They were strongest in early visual cortex and increased interareal feedforward influences. Our results suggest that early visual cortex gamma synchronization enables adaptive neuronal processing of recurring stimuli. These and previously reported changes might be due to an interaction of oscillatory dynamics with established synaptic plasticity mechanisms.
Niemann-Pick type C (NPC) disease, a lysosomal storage disorder caused by defective NPC1/NPC2 function, results in the accumulation of cholesterol and glycosphingolipids in lysosomes of affected organs, such as liver and brain. Moreover, increase of mitochondrial cholesterol (mchol) content and impaired mitochondrial function and GSH depletion contribute to NPC disease. However, the underlying mechanism of mchol accumulation in NPC disease remains unknown. As STARD1 is crucial in intramitochondrial cholesterol trafficking and acid ceramidase (ACDase) has been shown to regulate STARD1, we explored the functional relationship between ACDase and STARD1 in NPC disease. Liver and brain of Npc1−/− mice presented a significant increase in mchol levels and STARD1 expression. U18666A, an amphiphilic sterol that inhibits lysosomal cholesterol efflux, increased mchol levels in hepatocytes from Stard1f/f mice but not Stard1ΔHep mice. We dissociate the induction of STARD1 expression from endoplasmic reticulum stress, and establish an inverse relationship between ACDase and STARD1 expression and LRH-1 levels. Hepatocytes from Npc1+/+ mice treated with U18666A exhibited increased mchol accumulation, STARD1 upregulation and decreased ACDase expression, effects that were reversed by cholesterol extraction with 2-hydroxypropyl-β-cyclodextrin. Moreover, transfection of fibroblasts from NPC patients with ACDase, decreased STARD1 expression and mchol accumulation, resulting in increased mitochondrial GSH levels, improved mitochondrial functional performance, decreased oxidative stress and protected NPC fibroblasts against oxidative stress-mediated cell death. Our results demonstrate a cholesterol-dependent inverse relationship between ACDase and STARD1 and provide a novel approach to target the accumulation of cholesterol in mitochondria in NPC disease.
The conventional approach of looking down a microscope to perform microsurgical procedures is associated with occupational injuries, anti-ergonomic postures, and increased tremor and fatigue, all of which predispose microsurgeons to early retirement. Recently, three-dimensional (3D) visualization of real-time microscope magnification has been developed as an alternative. Despite its commercial availability, no supermicrosurgical procedures have been reported using this technology to date. Lymphovenous anastomoses (LVAs) often require suturing vessels with diameters of 0.2–0.8 mm, thus representing the ultimate microsurgical challenge. After performing the first documented LVA procedure using 3D-augmented visualization in our unit and gaining experience with this technique, we conducted an anonymized in-house survey among microsurgeons who had used this approach. The participants considered that 3D visualization for supermicrosurgery was equivalent in terms of handling, optical detail, depth resolution, and safety to conventional binocular magnification. This survey revealed that team communication, resident education, and ergonomics were superior using 3D digital hybrid visualization. Postoperative muscle fatigue, tremor, and pain were also reduced. The major drawbacks of the 3D visualization microscopic systems are the associated costs, required space, and difficulty of visualizing the lymphatic contrast used.
Purpose: To compare swept-source (SS) versus spectral-domain (SD) optical coherence tomography angiography (OCTA) for the detection of macular neovascularization (MNV).
Methods: In this prospective cohort study, 72 eyes of 54 patients with subretinal hyperreflective material (SHRM) and/or pigment epithelial detachment (PED) on OCT possibly corresponding to MNV in at least one eye were included. OCTA scans were acquired using two devices, the PLEX Elite 9000 SS-OCTA and the Spectralis SD-OCTA. Fluorescein angiography (FA) was used as reference. Two graders independently evaluated en face OCTA images using a preset slab as well as a manually modified slab, followed by a combination of en face and cross-sectional OCTA.
Results: Sensitivity (specificity) for the automated slabs was 51.7% (93.0%) for SS-OCTA versus 58.6% (95.3%) for SD-OCTA. Manual modification of segmentation increased sensitivity to 79.3% for SS-OCTA but not for SD-OCTA (58.6%). The combination of en face OCTA with cross-sectional OCTA reached highest sensitivity values (SS-OCTA: 82.8%, SD-OCTA: 86.2%), and lowest number of cases with discrepancies between SS-OCTA and SD-OCTA (4.2%). Fleiss kappa as measure of concordance between FA, SS-OCTA, and SD-OCTA was 0.56 for the automated slabs, 0.60 for the manual slabs, and 0.73 (good agreement) for the combination of en face OCTA with cross-sectional OCTA. Concordance to FA was moderate for the automated slabs and good for manual slabs and combination with cross-sectional OCTA of both devices.
Conclusion: Both devices reached comparable results regarding the detection of MNV on OCTA. Sensitivity for MNV detection and agreement between devices was best when evaluating a combination of en face and cross-sectional OCTA.
Background and Aims: Activation of the inflammasome NLRP3 (NOD-, LRR- and pyrin domain containing 3) contributes to the development of non-alcoholic fatty liver disease (NAFLD) and progression to non-alcoholic steatohepatitis (NASH). Therefore, this study explored the therapeutic effects of a novel and selective NLRP3 antagonist in a murine dietary model of NASH. Methods: Groups of 12-week-old ApoE-/- mice were fed ad lib for 7 weeks with a methionine/choline deficient (MCD) and western diet (WD). After 3 weeks of diet-induced injury, mice were injected i. p. with the NLRP3 antagonist IFM-514 (100 mg/kg body weight) or vehicle (0.5% carmellose) every day, 5 days/week for a further 4 weeks. Several markers of inflammation, fibrosis and steatosis were evaluated. Whole transcriptome sequencing and panel RNA expression analysis (NanoString) were performed. Results: IFM-514 inhibited IL-1β production in mice challenged with 20 mg/kg lipopolysaccharide, and in mouse and human inflammatory cells in vitro. IFM-514 inhibited hepatic inflammation in the in vivo non-alcoholic steatohepatitis model assessed by H&E staining and in the hepatic gene expression of inflammasome-related proinflammatory cytokines. This effect was associated with significant reduction in caspase-1 activation. Similarly, IFM-514 was efficacious in vivo in MDC-fed ApoE-/- mice, markedly reducing portal pressure, Sirius red staining and 4-hydroxyproline content compared to vehicle-treated mice. Moreover, IFM-514 significantly reduced hepatic steatosis in MCD-fed ApoE-/- mice, as evidenced by NAFLD scores, oil red O staining, hepatic triglycerides and gene expression. In WD treated animals, similar trends in inflammation and fibrosis were observed, although not sufficient IFM-514 levels were reached. Conclusion: Overall, IFM-514 reduced liver inflammation and fibrosis, with mild effects on liver steatosis in experimental murine NASH. Blocking of NLRP3 may be an attractive therapeutic approach for NASH patients.
Lockdown measures during the COVID-19 pandemic have led to reductions in physical activity (PA) worldwide. Leading public health organizations have recommended the use of online exercise classes (OEC) to compensate the loss of regular exercise classes. As of now, no data are available on the uptake of OEC and on users’ attitudes. The aim of the current online survey was to assess the use of and attitudes towards OEC in Germany. Respondents indicated awareness and use of OEC, and levels of agreement with statements on OEC. Frequency of awareness and use of OEC according to PA status were calculated with contingency tables and the Χ2 test. Differences between users and non-users were tested with the Student’s t-test and the Mann–Whitney U test. Data on attitudes are presented as percentages, and Spearman correlations were calculated between attitudes and activity status, frequency of use, educational attainment, age and body mass index. A total of 979 datasets were analyzed. Of the respondents, 681 were aware of and 180, 118 and 84 used them <1 per week, 1–2 per week and ≥3 per week, respectively. Significantly more active respondents were aware of and used OEC compared to less active respondents. All in all, regular OEC use was quite limited. OEC was differentially attractive to people according to PA status, frequency of use, BMI and age. Tailoring OEC to current non-users and adding motivational support might enhance the regular use of OEC.
GATA2 deficiency is a heterogeneous multi-system disorder characterized by a high risk of developing myelodysplastic syndrome (MDS) and myeloid leukemia. We analyzed the outcome of 65 patients reported to the registry of the European Working Group (EWOG) of MDS in childhood carrying a germline GATA2 mutation (GATA2mut) who had undergone hematopoietic stem cell transplantation (HSCT). At 5 years the probability of overall survival and disease-free survival (DFS) was 75% and 70%, respectively. Non-relapse mortality and relapse equally contributed to treatment failure. There was no evidence of increased incidence of graft-versus-host-disease or excessive rates of infections or organ toxicities. Advanced disease and monosomy 7 (−7) were associated with worse outcome. Patients with refractory cytopenia of childhood (RCC) and normal karyotype showed an excellent outcome (DFS 90%) compared to RCC and −7 (DFS 67%). Comparing outcome of GATA2mut with GATA2wt patients, there was no difference in DFS in patients with RCC and normal karyotype. The same was true for patients with −7 across morphological subtypes. We demonstrate that HSCT outcome is independent of GATA2 germline mutations in pediatric MDS suggesting the application of standard MDS algorithms and protocols. Our data support considering HSCT early in the course of GATA2 deficiency in young individuals.
Simple Summary
Seizures are among the most common symptoms of meningioma patients even after surgery. This study sought to identify risk factors for early and late seizures in meningioma patients and to evaluate a modified version of a score to predict postoperative seizures on an independent cohort. The data underline that there are distinct factors identifying patients with a high risk of postoperative seizures following meningioma surgery which has been already shown before. We could further show that the high proportion of 43% of postoperative seizures occur as late seizures which are more dangerous because they may happen out of hospital. The modified STAMPE2 score could predict postoperative seizures when reaching very high scores but was not generally transferable to our independent cohort.
Abstract
Seizures are among the most common symptoms of meningioma. This retrospective study sought to identify risk factors for early and late seizures in meningioma patients and to evaluate a modified STAMPE2 score. In 556 patients who underwent meningioma surgery, we correlated different risk factors with the occurrence of postoperative seizures. A modified STAMPE2 score was applied. Risk factors for preoperative seizures were edema (p = 0.039) and temporal location (p = 0.038). For postoperative seizures preoperative tumor size (p < 0.001), sensomotory deficit (p = 0.004) and sphenoid wing location (p = 0.032) were independent risk factors. In terms of postoperative status epilepticus; sphenoid wing location (p = 0.022), tumor volume (p = 0.045) and preoperative seizures (p < 0.001) were independent risk factors. Postoperative seizures lead to a KPS deterioration and thus an impaired quality of life (p < 0.001). Late seizures occurred in 43% of patients with postoperative seizures. The small sub-cohort of patients (2.7%) with a STAMPE2 score of more than six points had a significantly increased risk for seizures (p < 0.001, total risk 70%). We concluded that besides distinct risk factors, high scores of the modified STAMPE2 score could estimate the risk of postoperative seizures. However, it seems not transferable to our cohort
The aim of this study was to evaluate whether recurrent carpal tunnel syndrome (CTS) after complete and sufficient division of the transverse ligament really exists. Another goal was to analyze the underlying reasons for recurrent CTS operated on in our department. Over an observation period of eleven years, 156 patients underwent surgical intervention due to CTS. The records of each patient were analyzed with respect to baseline data (age, gender, affected hand), as were clinical signs and symptoms pre- and postoperatively. To assess long-term results, standardized telephone interviews were performed using a structured questionnaire in which the patients were questioned about persisting symptoms, if any. Of the 156 patients, 128 underwent first surgical intervention due to CTS in our department. In long-term follow-up, two-thirds of these patients had no symptoms at all; one-third of the patients described mild persisting numbness. None of the patients experienced a recurrence of CTS. The 28 patients who received their first operation outside of our department were operated on for recurrent CTS. The cause of recurrence was incomplete division of the distal part of the transverse carpal ligament in all cases. The results suggest that recurrent CTS after complete and sufficient division of the transverse ligament is very unlikely.
Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are clonal hematopoietic stem cell diseases leading to an insufficient formation of functional blood cells. Disease-immanent factors as insufficient erythropoiesis and treatment-related factors as recurrent treatment with red blood cell transfusions frequently lead to systemic iron overload in MDS and AML patients. In addition, alterations of function and expression of proteins associated with iron metabolism might are increasingly recognized to be pathogenetic factors and potential vulnerabilities of these diseases. Iron is known to be involved in multiple intracellular and extracellular processes. It is essential for cell metabolism as well as for cell proliferation and closely linked to the formation of reactive oxygen species. Therefore, iron can influence the course of clonal myeloid disorders, the leukemic environment and the occurrence as well as the defense of infections. Imbalances of iron homeostasis may induce cell death of normal but also of malignant cells. New potential treatment strategies utilizing the importance of the iron homeostasis include iron chelation, modulation of proteins involved in iron metabolism, induction of leukemic cell death via ferroptosis and exploitation of iron proteins for the delivery of antileukemic drugs.
Here, we provide a summary of some of the latest findings about the function, the prognostic impact and potential treatment strategies of iron in patients with MDS and AML.
Purpose: Amblyopia with eccentric fixation, especially when not diagnosed early, is a therapeutic challenge, as visual outcome is known to be poorer than in amblyopia with central fixation. Consequently, treatment after late diagnosis is often denied. Electronic monitoring of occlusion provides us the chance to gain first focussed insight into age-dependent dose response and treatment efficiency, as well as the shift of fixation in this rare group of paediatric patients. Methods: In our prospective pilot study, we examined amblyopes with eccentric fixation during 12 months of occlusion treatment. We evaluated their visual acuity, recorded patching duration using a TheraMon®-microsensor, and determined their fixation with a direct ophthalmoscope. Dose-response relationship and treatment efficiency were calculated. Results: The study included 12 participants with strabismic and combined amblyopia aged 2.9–12.4 years (mean 6.5). Median prescription of occlusion was 7.7 h/day (range 6.6–9.9) and median daily received occlusion was 5.2 h/day (range 0.7–9.7). At study end, median acuity gain was 0.6 log units (range 0–1.6) and residual interocular visual acuity difference (IOVAD) 0.3 log units (range 0–1.8). There was neither significant acuity gain nor reduction in IOVAD after the 6th month of treatment. Children younger than 4 years showed best response with lowest residual IOVAD at study end. Efficiency calculation showed an acuity gain of approximately one line from 100 h of patching in the first 2 months and half a line after 6 months. There was a significant decline of treatment efficiency with age (p = 0.01). Foveolar fixation was achieved after median 3 months (range 1–6). Three patients (> 6 years) did not gain central fixation. Conclusion: Eccentric fixation is a challenge to therapy success. Based on electronic monitoring, our study quantified for the first time the reduction of treatment efficiency with increasing age in amblyopes with eccentric fixation. Despite some improvement in patients up to 8 years, older patients showed significantly lower treatment efficiency. In younger patients with good adherence, despite poor initial acuity, central fixation and low residual IOVAD could be attained after median 3 months. Hence, the necessity of early diagnosis and intensive occlusion should be emphasized.
Pancreatic cancer (PC) still remains a major cause of cancer-related death worldwide and alternative treatments are urgently required. A common problem of PC is the development of resistance against apoptosis that limits therapeutic success. Here we demonstrate that the prototypical Smac mimetic BV6 cooperates with the stimulator of interferon (IFN) genes (STING) ligand 2′,3′-cyclic guanosine monophosphate–adenosine monophosphate (2′3′-cGAMP) to trigger necroptosis in apoptosis-deficient PC cells. Pharmacological inhibition of key components of necroptosis signaling, such as receptor-interacting protein 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like protein (MLKL), significantly rescues PC cells from 2′3′-cGAMP/BV6/zVAD.fmk-mediated cell death, suggesting the induction of necroptosis. Consistently, 2′3′-cGAMP/BV6 co-treatment promotes phosphorylation of MLKL. Furthermore, we show that 2′3′-cGAMP stimulates the production of type I IFNs, which cooperate with BV6 to trigger necroptosis in apoptosis-deficient settings. STING silencing via siRNA or CRISPR/Cas9-mediated gene knockout protects PC cells from 2′3′-cGAMP/BV6/zVAD.fmk-mediated cell death. Interestingly, we demonstrate that nuclear factor-κB (NF-κB), tumor necrosis factor-α (TNFα), and IFN-regulatory factor 1 (IRF1) signaling are involved in triggering 2′3′-cGAMP/BV6/zVAD.fmk-induced necroptosis. In conclusion, we show that activated STING and BV6 act together to exert antitumor effects on PC cells with important implications for the design of new PC treatment concepts.
Introduction: Prognosis of survivors from cardiac arrest is generally poor. Acute kidney injury (AKI) is a common finding in these patients. In general, AKI is well characterized as a marker of adverse outcome. In-hospital cardiac arrest (IHCA) represents a special subset of cardiac arrest scenarios with differential predisposing factors and courses after the event, compared to out-of-hospital resuscitations. Data about AKI in survivors after in-hospital cardiac arrest are scarce. Methods: In this study, we retrospectively analyzed patients after IHCA for incidence and risk factors of AKI and its prognostic impact on mortality. For inclusion in the analysis, patients had to survive at least 48 h after IHCA. Results: A total of 238 IHCA events with successful resuscitation and survival beyond 48 h after the initial event were recorded. Of those, 89.9% were patients of internal medicine, and 10.1% of patients from surgery, neurology or other departments. In 120/238 patients (50.4%), AKI was diagnosed. In 28 patients (23.3%), transient or permanent renal replacement therapy had to be initiated. Male gender, preexisting chronic kidney disease and a non-shockable first ECG rhythm during resuscitation were significantly associated with a higher incidence of AKI in IHCA-survivors. In-hospital mortality in survivors from IHCA without AKI was 29.7%, and 60.8% in patients after IHCA who developed AKI (p < 0.01 between groups). By multivariate analysis, AKI after IHCA persisted as an independent predictor of in-hospital mortality (HR 3.7 (95% CI 2.14–6.33, p ≤ 0.01)). Conclusion: In this cohort of survivors from IHCA, AKI is a frequent finding, with adverse impact on outcome. Therefore, therapeutic strategies to prevent AKI in post-IHCA patients are warranted.
Mitochondrial dysfunction may activate innate immunity, e.g. upon abnormal handling of mitochondrial DNA in TFAM mutants or in altered mitophagy. Recent reports showed that also deletion of mitochondrial matrix peptidase ClpP in mice triggers transcriptional upregulation of inflammatory factors. Here, we studied ClpP-null mouse brain at two ages and mouse embryonal fibroblasts, to identify which signaling pathways are responsible, employing mass spectrometry, subcellular fractionation, immunoblots, and reverse transcriptase polymerase chain reaction. Several mitochondrial unfolded protein response factors showed accumulation and altered migration in blue-native gels, prominently the co-chaperone DNAJA3. Its mitochondrial dysregulation increased also its extra-mitochondrial abundance in the nucleus, a relevant observation given that DNAJA3 modulates innate immunity. Similar observations were made for STAT1, a putative DNAJA3 interactor. Elevated expression was observed not only for the transcription factors Stat1/2, but also for two interferon-stimulated genes (Ifi44, Gbp3). Inflammatory responses were strongest for the RLR pattern recognition receptors (Ddx58, Ifih1, Oasl2, Trim25) and several cytosolic nucleic acid sensors (Ifit1, Ifit3, Oas1b, Ifi204, Mnda). The consistent dysregulation of these factors from an early age might influence also human Perrault syndrome, where ClpP loss-of-function leads to early infertility and deafness, with subsequent widespread neurodegeneration.
Mesial temporal lobe epilepsy (mTLE) is a common form of epilepsy and is characterized by recurrent spontaneous seizures originating from the temporal lobe. The majority of mTLE patients develop pharmacoresistance to available anti-epileptic drugs (AEDs) while exhibiting severe pathological changes that can include hippocampal atrophy, neuronal death, gliosis and chronic seizures. The molecular mechanisms leading to mTLE remain incompletely understood, but are known to include defects in post-transcriptional gene expression regulation, including in non-coding RNAs (ncRNAs). Circular RNAs (circRNAs) are a class of recently rediscovered ncRNAs with high levels of expression in the brain and proposed roles in diverse neuronal processes. To explore a potential role for circRNAs in epilepsy, RNA-sequencing (RNA-seq) was performed on hippocampal tissue from a rat perforant pathway stimulation (PPS) model of TLE at different post-stimulation time points. This analysis revealed 218 differentially expressed (DE) circRNAs. Remarkably, the majority of these circRNAs were changed at the time of the occurrence of the first spontaneous seizure (DOFS). The expression pattern of two circRNAs, circ_Arhgap4 and circ_Nav3, was further validated and linked to miR-6328 and miR-10b-3p target regulation, respectively. This is the first study to examine the regulation of circRNAs during the development of epilepsy. It reveals an intriguing link between circRNA deregulation and the transition of brain networks into the state of spontaneous seizure activity. Together, our results provide a molecular framework for further understanding the role and mechanism-of-action of circRNAs in TLE.
Doppler examination of the umbilical artery and the fetal middle cerebral artery is evaluated predominantly in pregnancies with fetuses in cephalic presentation and never has been elucidated in breech presentation. Evidence on the accuracy of fetal weight estimation in dependence of the fetal presentation is controversial. Nevertheless, clinical decisions including recommendations for a cesarean section or labor induction based on these examinations are applied to pregnancies with fetuses in breech presentation. The objective of this study was to investigate the influence of the fetal presentation on fetal weight estimation accuracy, umbilical artery and middle cerebral artery resistance indices (RI) in a prospective case control study. Ultrasound examinations in 305 uncomplicated term pregnancies (153 vertex presentations, 152 breech) were investigated. Non-parametric variables were compared using Pearson’s chi2 test and Wilcoxon chi2 test, depending on variable scaling. Fetal weight estimation accuracy was not significantly different between vertex presentation group (VP) (6.97%) and breech presentation group (BP) (7.96%, p = 0.099). Fetal head circumference measurements were significantly larger in BP (350 mm vs. 341 mm in VB, p > 0.0001) while abdominal circumferences were significantly smaller (VP: 338 mm, BP: 331 mm, p = 0.0039) and weight estimation was not significantly different. Umbilical artery RIs were not significantly different between VP (54.5) and BP (55.3, p = 0.354). Fetal middle cerebral artery RIs also showed no significant differences (VP: 71.2, BP: 70.7, p = 0.335). Our study shows that fetal Doppler (RI) and weight estimation ultrasound originally calibrated in cephalic pregnancies are applicable to pregnancies with fetuses in breech presentation.
Transcription factors can serve as links between tumor microenvironment signaling and oncogenesis. Interferon regulatory factor 9 (IRF9) is recruited and expressed upon interferon stimulation and is dependent on cofactors that exert in tumor-suppressing or oncogenic functions via the JAK-STAT pathway. IRF9 is frequently overexpressed in human lung cancer and is associated with decreased patient survival; however, the underlying mechanisms remain to be elucidated. Here, we used stably transduced lung adenocarcinoma cell lines (A549 and A427) to overexpress or knockdown IRF9. Overexpression led to increased oncogenic behavior in vitro, including enhanced proliferation and migration, whereas knockdown reduced these effects. These findings were confirmed in vivo using lung tumor xenografts in nude mice, and effects on both tumor growth and tumor mass were observed. Using RNA sequencing, we identified versican (VCAN) as a novel downstream target of IRF9. Indeed, IRF9 and VCAN expression levels were found to be correlated. We showed for the first time that IRF9 binds at a newly identified response element in the promoter region of VCAN to regulate its transcription. Using an siRNA approach, VCAN was found to enable the oncogenic properties (proliferation and migration) of IRF9 transduced cells, perhaps with CDKN1A involvement. The targeted inhibition of IRF9 in lung cancer could therefore be used as a new treatment option without multimodal interference in microenvironment JAK-STAT signaling.
Background: The Global Burden of Diseases Study 2017 predicted that chronic obstructive pulmonary disease (COPD) is the second leading cause of death, the fourth leading cause of premature death, and the third cause for DALYs lost in Nepal. However, data on the population-based prevalence of COPD in Nepal are very limited. This study aims to assess the prevalence of COPD and factors associated with the occurrence of COPD in Nepal.
Methods: From a nationally representative, population-based cross-sectional study on chronic non-communicable diseases, the prevalence of COPD and its associated factors was determined. Of 12,557 participants aged over 20 years, 8945 participants completed a questionnaire and spirometry. Eligible participants were also asked to answer a COPD diagnostic questionnaire for screening COPD cases, and if needed underwent pre-bronchodilator and post-bronchodilator spirometry. COPD was defined as a post-bronchodilator FEV1/FVC (forced expiratory volume in 1 s/forced vital capacity) ratio of < 0.70. Multivariate logistic regression was performed to identify factors associated with COPD. Sampling weights were used for all data analyses.
Results: The prevalence of COPD in Nepal was 11.7% (95% CI: 10.5% to 12.9 %), which increased with age, and higher in those with a low educational level, those who had smoked ≥ 50 pack-years, persons having a low body mass index (BMI), and residents of Karnali province. Multivariate analysis revealed that being aged 60 years and above, having a low BMI, low educational status, having smoked more than 50 pack-years, provincial distribution, and ethnicity were independent predictors of COPD.
Conclusion: COPD is a growing and serious public health issue in Nepal. Factor such as old age, cigarette smoking, low educational attainment, low BMI, ethnicity, and locality of residence (province-level variation) plays a vital role in the occurrence of COPD. Strategies aimed at targeting these risk factors through health promotion and education interventions are needed to decrease the burden of COPD.
The NADPH oxidase Nox4 is a hydrogen peroxide (H2O2)-producing enzyme, with the highest expression in the kidney. As the kidney is involved in volume and blood pressure control through sodium handling, we set out to determine the impact of a low sodium diet on these parameters in WT and Nox4-/- mice. Nox4 expression in the murine kidney was restricted to the proximal tubule. Nevertheless, low-sodium-induced weight loss and sodium sparing function was similar in WT and Nox4-/- mice, disputing an important function of renal Nox4 in sodium handling. In contrast, a low sodium diet resulted in a reduction in systolic blood pressure in Nox4-/- as compared to WT mice. This was associated with a selectively lower pressure to heart-rate ratio, as well as heart to body weight ratio. In general, a low sodium diet leads to activation of sympathetic tone and the renin angiotensin system, which subsequently increases peripheral resistance. Our observations suggest that the control by this system is attenuated in Nox4-/- mice, resulting in lower blood pressure in response to low sodium.
Patients with neuroendocrine tumors (NET) often go through a long phase between onset of symptoms and initial diagnosis. Assessment of time to diagnosis and pre-clinical pathway in patients with gastroenteropancreatic NET (GEP-NET) with regard to metastases and symptoms. Retrospective analysis of patients with GEP-NET at a tertiary referral center from 1984 to 2019; inclusion criteria: Patients ≥18 years, diagnosis of GEP-NET; statistical analysis using non-parametrical methods. Four hundred eighty-six patients with 488 tumors were identified; median age at first diagnosis (478/486, 8 unknown) was 59 years; 52.9% male patients. Pancreatic NET: 143/488 tumors; 29.3%; small intestinal NET: 145/488 tumors, 29.7%. 128/303 patients (42.2%) showed NET specific and 122/486 (25%) patients other tumor-specific symptoms. 222/279 patients had distant metastases at initial diagnosis (187/222 liver metastases). 154/488 (31.6%) of GEP-NET were incidental findings. Median time from tumor manifestation (e.g., symptoms related to NET) to initial diagnosis across all entities was 19.5 (95% CI: 12–28) days. No significant difference in patients with or without distant metastases (median 73 vs 105 days, P = .42). A large proportion of GEP-NET are incidental findings and only about half of all patients are symptomatic at the time of diagnosis. We did not find a significant influence of the presence of metastases on time to diagnosis, which shows a large variability with a median of <30 days.
Objective: To evaluate the prognostic impact of gastrointestinal involvement on the survival of children with Langerhans cell histiocytosis (GI-LCH) registered with the international clinical trials of the Histiocyte Society. Study design: This was a retrospective analysis of 2414 pediatric patients registered onto the consecutive trials DAL-HX 83, DAL-HX 90, LCH-I, LCH-II, and LCH-III. Results: Among the 1289 patients with single-system LCH, there was no single case confined to the GI tract; 114 of 1125 (10%) patients with multisystem LCH (MS-LCH) had GI-LCH at initial presentation. GI-LCH was significantly more common in children aged <2 years at diagnosis (13% vs 6% in those aged >2 years; P < .001) and in those with risk organ involvement (15% vs 6% in those without risk organ involvement; P < .001). The 5-year overall survival (OS) in patients without risk organ involvement was excellent irrespective of GI disease (98% vs 97% in patients with GI-LCH; P = .789). In patients with risk organ involvement, the 5-year OS was 51% in 70 patients with GI-LCH vs 72% in 394 patients without GI-LCH (P < .001). Conclusions: GI-LCH has an additive unfavorable prognostic impact in children with MS-LCH and risk organ involvement. The emerding need for more intensive or alternative treatments mandates prospective evaluation.
Introduction: Information on the long-term performance of biosynthetic meshes is scarce. This study analyses the performance of biosynthetic mesh (Phasix™) over 24 months.
Methods: A prospective, international European multi-center trial is described. Adult patients with a Ventral Hernia Working Group (VHWG) grade 3 incisional hernia larger than 10 cm2, scheduled for elective repair, were included. Biosynthetic mesh was placed in sublay position. Short-term outcomes included 3-month surgical site occurrences (SSO), and long-term outcomes comprised hernia recurrence, reoperation, and quality of life assessments until 24 months.
Results: Eighty-four patients were treated with biosynthetic mesh. Twenty-two patients (26.2%) developed 34 SSOs, of which 32 occurred within 3 months (primary endpoint). Eight patients (11.0%) developed a hernia recurrence. In 13 patients (15.5%), 14 reoperations took place, of which 6 were performed for hernia recurrence (42.9%), 3 for mesh infection (21.4%), and in 7 of which the mesh was explanted (50%). Compared to baseline, quality of life outcomes showed no significant difference after 24 months. Despite theoretical resorption, 10.7% of patients reported presence of mesh sensation in daily life 24 months after surgery.
Conclusion: After 2 years of follow-up, hernia repair with biosynthetic mesh shows manageable SSO rates and favorable recurrence rates in VHWG grade 3 patients. No statistically significant improvement in quality of life or reduction of pain was observed. Few patients report lasting presence of mesh sensation. Results of biosynthetic mesh after longer periods of follow-up on recurrences and remodeling will provide further valuable information to make clear recommendations.
Trial registration: Registered on clinicaltrials.gov (NCT02720042), March 25, 2016.
Introduction: Deep brain stimulation (DBS) has become a well-established treatment modality for a variety of conditions over the last decades. Multiple surgeries are an essential part in the postoperative course of DBS patients if nonrechargeable implanted pulse generators (IPGs) are applied. So far, the rate of subclinical infections in this field is unknown. In this prospective cohort study, we used sonication to evaluate possible microbial colonization of IPGs from replacement surgery. Methods: All consecutive patients undergoing IPG replacement between May 1, 2019 and November 15, 2020 were evaluated. The removed hardware was investigated using sonication to detect biofilm-associated bacteria. Demographic and clinical data were analyzed. Results: A total of 71 patients with a mean (±SD) of 64.5 ± 15.3 years were evaluated. In 23 of these (i.e., 32.4%) patients, a positive sonication culture was found. In total, 25 microorganisms were detected. The most common isolated microorganisms were Cutibacterium acnes (formerly known as Propionibacterium acnes) (68%) and coagulase-negative Staphylococci (28%). Within the follow-up period (5.2 ± 4.3 months), none of the patients developed a clinical manifest infection. Discussions/Conclusions: Bacterial colonization of IPGs without clinical signs of infection is common but does not lead to manifest infection. Further larger studies are warranted to clarify the impact of low-virulent pathogens in clinically asymptomatic patients.
Purpose: Amblyopia with eccentric fixation, especially when not diagnosed early, is a therapeutic challenge, as visual outcome is known to be poorer than in amblyopia with central fixation. Consequently, treatment after late diagnosis is often denied. Electronic monitoring of occlusion provides us the chance to gain first focussed insight into age-dependent dose response and treatment efficiency, as well as the shift of fixation in this rare group of paediatric patients. Methods: In our prospective pilot study, we examined amblyopes with eccentric fixation during 12 months of occlusion treatment. We evaluated their visual acuity, recorded patching duration using a TheraMon®-microsensor, and determined their fixation with a direct ophthalmoscope. Dose-response relationship and treatment efficiency were calculated. Results: The study included 12 participants with strabismic and combined amblyopia aged 2.9–12.4 years (mean 6.5). Median prescription of occlusion was 7.7 h/day (range 6.6–9.9) and median daily received occlusion was 5.2 h/day (range 0.7–9.7). At study end, median acuity gain was 0.6 log units (range 0–1.6) and residual interocular visual acuity difference (IOVAD) 0.3 log units (range 0–1.8). There was neither significant acuity gain nor reduction in IOVAD after the 6th month of treatment. Children younger than 4 years showed best response with lowest residual IOVAD at study end. Efficiency calculation showed an acuity gain of approximately one line from 100 h of patching in the first 2 months and half a line after 6 months. There was a significant decline of treatment efficiency with age (p = 0.01). Foveolar fixation was achieved after median 3 months (range 1–6). Three patients (> 6 years) did not gain central fixation. Conclusion: Eccentric fixation is a challenge to therapy success. Based on electronic monitoring, our study quantified for the first time the reduction of treatment efficiency with increasing age in amblyopes with eccentric fixation. Despite some improvement in patients up to 8 years, older patients showed significantly lower treatment efficiency. In younger patients with good adherence, despite poor initial acuity, central fixation and low residual IOVAD could be attained after median 3 months. Hence, the necessity of early diagnosis and intensive occlusion should be emphasized.
The aim of the current study was to analyze two major pitfalls in forensic entomological casework: delayed evidence sampling and the effect of low-temperature storage of the body. For this purpose, temperature profiles of heavily infested corpses during cooling and cases in which insect evidence was collected both at the scene and during autopsy were evaluated with regard to species composition and development stages found. The results show that the temperature in the body bags remained at higher average temperatures up to 10 °C relative to the mortuary cooler, therefore, sufficient for larval development, with significant differences in temperature between larval aggregations on one and the same body. In addition, we found large differences both in species number, species composition, and the developmental stages found at the scene and during the autopsy. These data and observations underscore the importance of sampling evidence at the scene and recording temperatures throughout the cooling period of a body.
The COVID-19 pandemic has caused strains on health systems worldwide disrupting routine hospital services for all non-COVID patients. Within this retrospective study, we analyzed inpatient hospital admissions across 18 German university hospitals during the 2020 lockdown period compared to 2018. Patients admitted to hospital between January 1 and May 31, 2020 and the corresponding periods in 2018 and 2019 were included in this study. Data derived from electronic health records were collected and analyzed using the data integration center infrastructure implemented in the university hospitals that are part of the four consortia funded by the German Medical Informatics Initiative. Admissions were grouped and counted by ICD 10 chapters and specific reasons for treatment at each site. Pooled aggregated data were centrally analyzed with descriptive statistics to compare absolute and relative differences between time periods of different years. The results illustrate how care process adoptions depended on the COVID-19 epidemiological situation and the criticality of the disease. Overall inpatient hospital admissions decreased by 35% in weeks 1 to 4 and by 30.3% in weeks 5 to 8 after the lockdown announcement compared to 2018. Even hospital admissions for critical care conditions such as malignant cancer treatments were reduced. We also noted a high reduction of emergency admissions such as myocardial infarction (38.7%), whereas the reduction in stroke admissions was smaller (19.6%). In contrast, we observed a considerable reduction in admissions for non-critical clinical situations, such as hysterectomies for benign tumors (78.8%) and hip replacements due to arthrosis (82.4%). In summary, our study shows that the university hospital admission rates in Germany were substantially reduced following the national COVID-19 lockdown. These included critical care or emergency conditions in which deferral is expected to impair clinical outcomes. Future studies are needed to delineate how appropriate medical care of critically ill patients can be maintained during a pandemic.
Inflammatory diseases including psoriasis are associated with metabolic and cardiovascular comorbidities, including obesity and metabolic syndrome. Obesity is associated with greater psoriasis disease severity and reduced response to treatment. Therefore, targeting metabolic comorbidities could improve patients’ health status and psoriasis-specific outcomes. METABOLyx is a randomized controlled trial evaluating the combination of a lifestyle intervention program with secukinumab treatment in psoriasis. Here, the rationale, methodology and baseline patient characteristics of METABOLyx are presented. A total of 768 patients with concomitant moderate to severe plaque psoriasis and metabolic syndrome were randomized to secukinumab 300 mg, or secukinumab 300 mg plus a tailored lifestyle intervention program, over 24 weeks. A substudy of immunologic and metabolic biomarkers is ongoing. The primary endpoint of METABOLyx is PASI90 response at week 24. Other endpoints include patient-reported outcomes and safety. METABOLyx represents the first large scale clinical trial of an immunomodulatory biologic in combination with a standardized lifestyle intervention.
PKCζ and PKCι/λ form the atypical protein kinase C subgroup, characterised by a lack of regulation by calcium and the neutral lipid diacylglycerol. To better understand the regulation of these kinases, we systematically explored their interactions with various purified phospholipids using the lipid overlay assays, followed by kinase activity assays to evaluate the lipid effects on their enzymatic activity. We observed that both PKCζ and PKCι interact with phosphatidic acid and phosphatidylserine. Conversely, PKCι is unique in binding also to phosphatidylinositol-monophosphates (e.g., phosphatidylinositol 3-phosphate, 4-phosphate, and 5-phosphate). Moreover, we observed that phosphatidylinositol 4-phosphate specifically activates PKCι, while both isoforms are responsive to phosphatidic acid and phosphatidylserine. Overall, our results suggest that atypical Protein kinase C (PKC) localisation and activity are regulated by membrane lipids distinct from those involved in conventional PKCs and unveil a specific regulation of PKCι by phosphatidylinositol-monophosphates.
Objective: We aimed to estimate the incidence of cerebral sinus and venous thrombosis (CVT) within 1 month from first dose administration and the frequency of vaccine-induced immune thrombotic thrombocytopenia (VITT) as the underlying mechanism after vaccination with BNT162b2, ChAdOx1, and mRNA-1273, in Germany. Methods: A web-based questionnaire was e-mailed to all departments of neurology. We requested a report of cases of CVT occurring within 1 month of a COVID-19 vaccination. Other cerebral events could also be reported. Incidence rates of CVT were calculated by using official statistics of 9 German states. Results: A total of 45 CVT cases were reported. In addition, 9 primary ischemic strokes, 4 primary intracerebral hemorrhages, and 4 other neurological events were recorded. Of the CVT patients, 35 (77.8%) were female, and 36 (80.0%) were younger than 60 years. Fifty-three events were observed after vaccination with ChAdOx1 (85.5%), 9 after BNT162b2 (14.5%) vaccination, and none after mRNA-1273 vaccination. After 7,126,434 first vaccine doses, the incidence rate of CVT within 1 month from first dose administration was 0.55 (95% confidence interval [CI] = 0.38–0.78) per 100,000 person-months (which corresponds to a risk of CVT within the first 31 days of 0.55 per 100,000 individuals) for all vaccines and 1.52 (95% CI = 1.00–2.21) for ChAdOx1 (after 2,320,535 ChAdOx1 first doses). The adjusted incidence rate ratio was 9.68 (95% CI = 3.46–34.98) for ChAdOx1 compared to mRNA-based vaccines and 3.14 (95% CI = 1.22–10.65) for females compared to non-females. In 26 of 45 patients with CVT (57.8%), VITT was graded highly probable. Interpretation: Given an incidence of 0.02 to 0.15 per 100,000 person-months for CVT in the general population, these findings point toward a higher risk for CVT after ChAdOx1 vaccination, especially for women.
Introduction: Surgical practices constitute a common topic of complaint among medical students. The aim of this study is to analyze the type of surgical training that students receive in medical school and the impact of SARS-CoV-2 pandemic.
Methods: A survey based on the National Spanish Agency for the Quality of Evaluation and Accreditation (ANECA) guidelines was spread on social media between medical students and physicians waiting to start their residency. The time spent in surgical practices, the number of times that certain abilities were performed, and the desire of choosing a surgical specialty were analyzed.
Results: 1053 surveys were analyzed. Significant differences between the number of months that students rotate and the number of procedures performed as they gained seniority were found. A weak positive correlation between the number of months rotating and the number of procedures performed was found. The desire of choosing a surgical specialty was not associated with the time spent in surgical practice. SARS-CoV-2 pandemic has reduced the time spent in surgical practice and some of the surgical procedures performed.
Conclusion: The amount of surgical procedures performed by students is below the requirements of ANECA guidelines. A different level of dexterity between 6th year students’ group affected by SARS-CoV-2 pandemic and physicians’ group should not be expected because of the low number of procedures performed by both groups. Students’ role in the operating room and the need for different systems of skills learning should be reconsidered.
Invasive fungal disease (IFD) in hematopoietic stem cell transplantation is associatedwith high morbidity and mortality. As the antifungal host response determines risk and outcomeof IFD, there is growing interest in adoptive immunotherapy using T cells or natural killer (NK)cells. Although the NK-92 cell line has been tested as anticancer therapy in clinical trials, data onthe antifungal activity of NK-92 cells are lacking. Here, we show that the NK-92 cell line exhibitsconsiderable fungal damage on all medically important fungi tested, such as different species ofAspergillus,Candida, mucormycetes, andFusarium. The extent of fungal damage differs acrossvarious species of mucormycetes andFusarium, whereas it is comparable across different species ofAspergillusandCandida. Interferon (IFN)-γlevels in the supernatant were lower when NK-92 cells areco-incubated withAspergillus fumigatus,Candida albicans, orRhizopus arrhizuscompared to the levelswhen NK-92 cells are incubated alone. Different to primary human NK cells, no increase of perforinlevels in the supernatant was observed when the fungi were added to NK-92 cells. Ourin vitrodatademonstrated that the NK-92 cell line could be a feasible tool for antifungal immunotherapy, butdata of animal models are warranted prior to clinical trials.
Abstract In the middle of the twentieth century, the from North America sooty bark disease (SBD) of maples was first discovered in England and has spread in the last decades in Central Europe, in particular. The trigger of SBD is the mould fungus Cryptostroma (C.) corticale. The most common infested maple is the sycamore, Acer pseudoplatanus, a common tree in woods and parks. The disease is characterised by peeling of the outer layer of the bark and brownish-black spores under the peeled off bark. These spores can cause maple bark disease (MBD) in humans, a hypersensitivity pneumonitis (HP) with similar symptoms like COPD, allergic asthma, influenza or flu-like infections and interstitial pneumonia. Persons who have intensive respectively occupational contact with infested trees or wood, e.g., woodman, foresters, sawyers or paper mill workers, are at risk in particular. Since C. corticale favours hot summers and host trees weakened by drought, SBD will increasingly spread in the future due to ongoing climate change. Consequently, the risk of developing MBD will increase, too. As with all HPs, e.g., farmer’s lung and pigeon breeder’s disease, the diagnosis of MBD is intricate because it has no clear distinguishing characteristics compared to other interstitial lung diseases. Therefore, the establishment of consistent diagnosis guidelines is required. For correct diagnosis and successful therapy, multidisciplinary expertise including pulmonologists, radiologists, pathologists and occupational physicians is recommended. If MBD is diagnosed in time, the removal of the triggering fungus or the infested maple wood leads to complete recovery in most cases. Chronic HP can lead to lung fibrosis and a total loss of lung function culminating in death. HP and, thus, MBD, is a disease with a very high occupational amount. To avoid contact with spores of C. corticale, persons working on infested wood or trees have to wear personal protective equipment. To protect the public, areas with infested maples have to be cordoned off, and the trees should be removed. This is also for impeding further spreading of the spores.
Background: To test the effect of variant histology relative to urothelial histology on stage at presentation, cancer specific mortality (CSM) and overall mortality (OM) after chemotherapy use, in urethral cancer.
Materials and Methods: Within the Surveillance, Epidemiology and End Results (2004–2016) database, we identified 1,907 primary variant histology urethral cancer patients. Kaplan-Meier plots, Cox regression analyses, cumulative incidence-plots, multivariable competing-risks regression models and propensity score matching for patient and tumor characteristics were used.
Results:Of 1,907 eligible urethral cancer patients, urothelial histology affected 1,009 (52.9%) vs. squamous cell carcinoma (SCC) 455 (23.6%) vs. adenocarcinoma 278 (14.6%) vs. other histology 165 (8.7%) patients. Urothelial histological patients exhibited lower stages at presentation than SCC, adenocarcinoma or other histology patients. In urothelial histology patients, five-year CSM was 23.5% vs. 34.4% in SCC (Hazard Ratio (HR) 1.57) vs. 40.7% in adenocarcinoma (HR 1.69) vs. 43.4% in other histology (HR 1.99, p<0.001). After matching in multivariate competing-risks regression models, variant histology exhibited 1.35-fold higher CSM than urothelial. Finally, in metastatic urethral cancer, lower OM was recorded after chemotherapy in general, including metastatic adenocarcinoma and other variant histology subtypes, except metastatic SCC.
Conclusion: Adenocarcinoma, SCC and other histology subtypes affect fewer patients than urothelial histology. Presence of variant histology results in higher CSM. Finally, chemotherapy for metastatic urethral cancer improves survival in adenocarcinoma and other variant histology subtypes, but not in SCC.
Chronic myeloid leukemia (CML) has been a “model disease” with a long history. Beginning with the first discovery of leukemia and the description of the Philadelphia Chromosome and ending with the current goal of achieving treatment-free remission after targeted therapies, we describe here the journey of CML, focusing on molecular pathways relating to signaling, metabolism and the bone marrow microenvironment. We highlight current strategies for combination therapies aimed at eradicating the CML stem cell; hopefully the final destination of this long voyage.
Human babesiosis in Europe
(2021)
Babesiosis is attracting increasing attention as a worldwide emerging zoonosis. The first case of human babesiosis in Europe was described in the late 1950s and since then more than 60 cases have been reported in Europe. While the disease is relatively rare in Europe, it is significant because the majority of cases present as life-threatening fulminant infections, mainly in immunocompromised patients. Although appearing clinically similar to human babesiosis elsewhere, particularly in the USA, most European forms of the disease are distinct entities, especially concerning epidemiology, human susceptibility to infection and clinical management. This paper describes the history of the disease and reviews all published cases that have occurred in Europe with regard to the identity and genetic characteristics of the etiological agents, pathogenesis, aspects of epidemiology including the eco-epidemiology of the vectors, the clinical courses of infection, diagnostic tools and clinical management and treatment.
Background: The benefit of adjuvant therapy in synovial sarcoma (SS) treatment is under debate. Long-term follow-up data are missing.
Methods: SS patients treated in the consecutive trials CWS-81, CWS-86, CWS-91, CWS-96, CWS-2002-P, and the SoTiSaR-registry till 2013 were analyzed.
Results: Median age of 185 patients was 13.9 years (0.1–56)—with median follow-up of 7.4 years for 163 survivors. Most tumors (76%) were located in extremities. Size was < 3 cm in 58 (31%), 3–5 cm in 59 (32%), 5–10 cm in 42 (23%), and > 10 cm in 13 (7%) (13 missing). In 84 (45%) tumors, first excision was complete (R0 corresponding to IRS-I-group) and in 101 (55%) marginal (R1 corresponding to IRS-II-group). In a subsequent surgical intervention during chemotherapy, R0-status was accomplished in 23 additional IRS-II-group patients with secondary surgery. Radiotherapy was administered to 135 (73%), thereof 62 with R0-status and 67 R1-status (6 missing information). Adjuvant chemotherapy was administered to all but six patients. 5-year event-free (EFS) and overall survival (OS) was 82.9% ± 5.7 (95%CI) and 92.5% ± 3.9. Local and metastatic relapse-free survival was 91.3% ± 4.3 and 92.3% ± 4.1 at 5 years, respectively. In the multivariate analysis, tumor size and no chemotherapy were independently associated with EFS. Size and site were associated with OS. In a detailed analysis of local and metastatic events, tumor size was associated with an independent risk for developing metastases. No independent factor for suffering local recurrence could be identified.
Discussion: Omission of chemotherapy in a non-stratified way seems not justified. Size governs survival due to high linear association with risk of suffering metastatic recurrence in a granular classification.
The genetic background of pain is becoming increasingly well understood, which opens up possibilities for predicting the individual risk of persistent pain and the use of tailored therapies adapted to the variant pattern of the patient’s pain-relevant genes. The individual variant pattern of pain-relevant genes is accessible via next-generation sequencing, although the analysis of all “pain genes” would be expensive. Here, we report on the development of a cost-effective next generation sequencing-based pain-genotyping assay comprising the development of a customized AmpliSeq™ panel and bioinformatics approaches that condensate the genetic information of pain by identifying the most representative genes. The panel includes 29 key genes that have been shown to cover 70% of the biological functions exerted by a list of 540 so-called “pain genes” derived from transgenic mice experiments. These were supplemented by 43 additional genes that had been independently proposed as relevant for persistent pain. The functional genomics covered by the resulting 72 genes is particularly represented by mitogen-activated protein kinase of extracellular signal-regulated kinase and cytokine production and secretion. The present genotyping assay was established in 61 subjects of Caucasian ethnicity and investigates the functional role of the selected genes in the context of the known genetic architecture of pain without seeking functional associations for pain. The assay identified a total of 691 genetic variants, of which many have reports for a clinical relevance for pain or in another context. The assay is applicable for small to large-scale experimental setups at contemporary genotyping costs.